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Angiogenesis, or the growing, expansion and remodeling of blood vessels in a 
developing vascular network, is considered of utmost importance in the 
development of new tissue. Vascularization is of relevance in tissue regeneration 
strategies by allowing cell survival through the supply of oxygen and nutrients 
for cells in tridimensional structures, such as tissues or artificial matrices. 
Synergetic strategies combining different biomaterials and components of the 
cellular microenvironment (cells, biomolecules and extracellular matrix 
components) have been proposed as a promising way to promote the 
regeneration of vascularized tissues.  
Although endothelial cells, the cells lining blood vessels, seem to play the major 
role in new vessel formation, other cell types have been implicated in this 
phenomenon and their inter-relationships with endothelial cells have been 
explored. However, the interplay between fibroblasts and endothelial cells is far 
from understood, despite the fact that fibroblasts play key roles in wound 
healing and in vessel stabilization. Taking this into account, the present work is 
intended to investigate if angiogenesis and vasculogenesis can be modulated by 
fibroblasts in tissue regeneration.  
In an initial approach the effect of growth factors (VEGF and bFGF) produced by 
fibroblasts were first observed to positively influence the viability of endothelial 
cells entrapped in RGD-alginate. Similarly, in angiogenesis assays, fibroblasts 
entrapped in RGD-alginate demonstrated the ability to improve the viability of 
endothelial cells and to support capillary-like structures assembly and increased 
length.  
Indirect and direct cocultures studies were also performed to further elucidate 
the crosstalk between endothelial cells and fibroblasts. Results obtained showed 
that the two cells types interact with each other through exchange of growth 
factors, namely VEGF, bFGF, TGF-β1 and IL-8, which are known to influence 
angiogenesis. Fibroblasts promoted the formation and organization of capillary-
like structures by endothelial cells, increased the amount of collagen in the 
cocultures and further determined the expression of alkaline phosphatase. High 
alkaline phosphatase expression could be co-localized with capillary-like 
structures and the interaction between the two cells types induced fibroblasts 
activation near microvessel-like structures.  
Finally, the role of fibroblasts in the recruitment of endothelial cells was 
explored in vivo, to assess their influence on the formation of new blood vessels. 
Fibroblasts were entrapped in growth factor-reduced matrigel subcutaneously 
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implanted in mice. The vessels formed exhibited higher levels of hemoglobin, 
compared to the control matrix, implanted without fibroblasts, in which no 
vessel formation could be observed. The presence of vessels originating from 
the host vasculature suggested that host vascular response was involved, which 
constitutes a fundamental aspect in the process of neovascularization. 
Fibroblasts implanted within matrigel increased the presence of endothelial cells 
with positive staining for CD31 and for CD34, indicating the involvement of 
mature and also endothelial progenitor cells, and influenced the production of 
collagen, thus inducing the angiogenic process and promoting the formation of 
microvessels.   
In conclusion, this work demonstrated the capacity of fibroblasts to modulate 
angiogenesis through the production of growth factors and extracellular matrix, 
thereby created a microenvironment capable of stimulating angiogenesis in situ, 
and can potentially be used in regenerative medicine or in delineation of new 
strategies in tissue engineering where vascularization is essential. 
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A angiogénese, ou o crescimento, expansão e remodelação dos vasos 
sanguíneos sob a forma de uma rede vascular em desenvolvimento, é 
considerada de extrema importância no desenvolvimento de novos tecidos. A 
vascularização é importante nas estratégias de regeneração de tecidos por 
permitir a sobrevivência das células através do fornecimento de oxigénio e 
nutrientes às células em estruturas tridimensionais, tais como tecidos ou 
matrizes artificiais. Têm sido propostas estratégias sinérgicas, combinando 
diferentes biomateriais e componentes do microambiente celular (células, 
biomoléculas e componentes da matriz extracelular), como formas promissoras 
de promover a regeneração dos tecidos vascularizados. 
Embora as células endoteliais, as células que revestem os vasos sanguíneos, 
pareçam desempenhar o papel preponderante na formação de novos vasos, têm 
sido implicados outros tipos de células neste processo e as suas inter-relações 
com as células endoteliais têm sido exploradas. No entanto, a interação entre os 
fibroblastos e as células endoteliais está longe de ser compreendida, apesar do 
papel fundamental dos fibroblastos na cicatrização de feridas e na estabilização 
de vasos. Tendo isto em conta, o presente trabalho pretende investigar se a 
angiogénese e a vasculogénese, outro processo de vascularização relevante na 
regeneração de tecidos, podem ser moduladas pelos fibroblastos na 
regeneração de tecidos. 
Numa abordagem inicial, foi observado que fatores de crescimento (VEGF e 
bFGF) produzidos pelos fibroblastos influenciaram positivamente a viabilidade 
das células endoteliais encapsuladas em alginato-RGD. De forma similar, através 
de ensaios de angiogénese, fibroblastos encapsulados em alginato-RGD, 
demonstraram capacidade para melhorar a viabilidade das células endoteliais e 
de suportar a organização de estruturas capilares e de aumentar o seu 
comprimento. 
Foram também realizados estudos em coculturas para elucidar a inter-
comunicação entre as células endoteliais e os fibroblastos. Os resultados 
obtidos mostraram que os dois tipos de células interagem através da troca de 
fatores de crescimento, ou seja, VEGF, bFGF, TGF-β1 e IL-8, que são conhecidos 
por influenciar a angiogénese. Os fibroblastos promoveram a formação e 
organização de estruturas semelhantes a capilares pelas células endoteliais, o 
aumento da quantidade de colagénio nas coculturas e promoveram ainda a 
expressão de fosfatase alcalina. A elevada expressão de fosfatase alcalina pôde 
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ser co-localizada com estruturas semelhantes a capilares e a interação entre os 
dois tipos de células induziu a ativação dos fibroblastos em zonas adjacentes 
às estruturas microvasculares. 
Finalmente, o papel dos fibroblastos no recrutamento de células endoteliais foi 
explorado in vivo, para avaliar a sua influência na formação de novos vasos 
sanguíneos. Os fibroblastos foram encapsulados em matrigel com fatores de 
crescimento reduzidos e implantados subcutaneamente em ratinhos. A presença 
de fibroblastos levou a um aumento da densidade vascular, avaliado pelo níveis 
superiores de hemoglobina, em comparação com a matriz do controlo, 
implantada na ausência de fibroblastos. A presença de vasos provenientes da 
vasculatura do hospedeiro sugeriu a envolvência de uma resposta vascular do 
hospedeiro, o que constitui um aspecto fundamental no processo de 
neovascularização. Os fibroblastos implantados em matrigel aumentaram a 
presença de células endoteliais com marcação positiva para CD31 e CD34, 
indicando o envolvimento de células endoteliais maduras bem como 
progenitoras, e influenciou a produção de colagénio, induzindo assim o 
processo angiogénico e promovendo a formação de microvasos. 
Em conclusão, este trabalho demonstrou a capacidade dos fibroblastos para 
modular a angiogénese através da produção de fatores de crescimento e de 
matriz extracelular, criado assim um microambiente capaz de estimular a 
angiogénese in situ, o que pode potencialmente ser utilizado em medicina 
regenerativa ou na concepção de novas estratégias para engenharia de tecidos, 
onde a vascularização é essencial. 
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The present research work was developed as a contribution to overcome the 
difficulty in promoting vascularization in tissue regeneration. Cells, growth 
factors and the extracellular matrix play key roles in angiogenesis and 
vasculogenesis and their interplay, leading to successful vascularization, is far 
from understood. Based on previous work from research teams involved, on the 
crosstalk between endothelial cells and bone cells in the framework of bone 
tissue regeneration, the present work is intended to investigate if angiogenesis 
and vasculogenesis can be modulated by fibroblasts in tissue regeneration.  
 
In this context, chapter I aims to introduce and summarize the central role of 
angiogenesis and vasculogenesis in tissue regeneration, as well as the different 
mechanisms, cells, biomolecules and extracellular matrix components that are 
known to contribute to this phenomena. This chapter is especially focused on 
the relevance, demonstrated over the last decade, of using synergetic strategies 
combining biomaterials and components of the cellular microenvironment to 
promote the regeneration of vascularized tissues. 
 
In chapter II, the first experimental chapter of this work, the aim was to critically 
explore issues reported in previous studies of the research team, namely to 
improve the viability of cultured endothelial cells. The effect of entrapped 
fibroblasts in endothelial cells was explored, in terms of cell viability and ability 
to organize in tubular-like structures. An additional goal consisted in assessing 
the behavior of fibroblasts entrapped in alginate. 
 
In chapter III, and following the assumptions outlined in the previous chapter, it 
was aimed to further assess how fibroblasts would influence the organization of 
endothelial cells in coculture systems, with a view to promoting vascularization. 
During this study different microenvironments were created (in direct or indirect 
contact) to investigate the interaction between endothelial cells and fibroblasts. 
Besides the influence of the cells themselves, the role of growth factors, the 
extracellular matrix and glicoproteins, namely alkaline phosphatase, were 
investigated in the development of the microvessel-like structures. 
 
In chapter IV the role of fibroblasts in the recruitment of endothelial cells was 
explored in vivo, to assess their influence on the formation of new blood vessels. 
Fibroblasts were entrapped in growth factor-reduced matrigel, subcutaneously 
Preface 
 
 
xxx 
 
implanted in mice and the ability of this system to influence vascularization of 
the implant was assessed biochemically and immunohistologically.  
 
Finally, chapter V constitutes a critical discussion on all the issues previously 
raised, recurring to comparisons with the available literature on related matters, 
and where new hypotheses are put forward that had not been previously 
addressed regarding the modulation of angiogenesis by fibroblasts in tissue 
regeneration. Perspectives on future work are also discussed. 
 
The appendix includes the publication entitled “Pectin-based injectable 
biomaterials for bone tissue engineering”, in which the author of this thesis is a 
co-author, having contributed with know-how in several aspects. This 
publication relies in the same techniques used in this thesis for cell entrapment 
and assessment of their biological behavior. The development of such injectable 
cell entrapment systems is relevant in the framework of this thesis, as 
highlighted in the previous chapters. 
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1. Angiogenesis and vasculogenesis in tissue regeneration 
 
 
The term tissue regeneration became widely spread in the 1990s with the 
emergence of the field of tissue engineering. Tissue regeneration involves the 
capacity of the cells to renew and grow in order to generate new tissue for 
replacing diseased or damaged tissues or organs. Although coined only in the 
1990s [1], the foundation of tissue engineering concepts, bridging biology and 
engineering knowledge, dates back from the 1930s, when Alexis Carrel with 
Charles Lindberg established the basic principles to grow viable and functional 
tissues and organs in vitro for use as replacement body parts [2]. However, only 
in the 1990s, Langer and Vancati [3] successfully regenerated cartilage through 
mouse subcutaneous implantation of synthetic biodegradable scaffolds seeded 
with chondrocytes. This interdisciplinary field uses principles of engineering and 
life sciences towards the development of biological substitutes that restore, 
maintain, or improve tissue function or a whole organ [2]. Fig. 1 illustrates the 
challenge of using stem cells obtained from the bone marrow, in combination 
with a scaffold material that mimics the architecture of the tissue, in order to 
regenerate tissue function [4]. Vascularization plays a crucial role in 
regenerative medicine and is a phenomenon yet to be totally understood and 
mastered [4]. Through the restoration of the vascular system exchanges of 
oxygen, nutrients, growth factors and elimination of metabolites are possible, 
allowing survival of the new tissue [5]. The diffusion limit for oxygen is about 
200 µm from blood vessels [6]. Thus, the recruitment of new blood vessels by 
activation of vasculogenesis and angiogenesis (the two main processes of 
vascularization), is still a great challenge in regenerative medicine.  
In vasculogenesis blood vessel formation is directly orchestrated by endothelial 
precursor cells or angioblasts. In the past, vasculogenesis was exclusively 
associated with the concept of blood vessel formation during embryogenesis. 
However, recent data documented the presence of circulating endothelial 
progenitors cells in the adult leading to the assumption that vasculogenesis can 
also occur in adults [4, 6-9]. In angiogenesis new blood vessels are formed from 
the pre-existing vasculature [10, 11], which has proven to be essential for 
maintenance of tissue and organ regeneration [12, 13]. 
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Figure 1. Tissue and organ regeneration recurring to ex vivo expansion of cells and 
their attachment to three-dimensional scaffolds. From Ingber et al. [4]. 
 
 
Arteriogenesis is the process of structural enlargement and remodeling of pre-
existing small arterioles into larger collateral vessels [14]. Fig. 2 illustrates the 
development of the vascular system, from progenitor endothelial cells to tissue-
specific specializations that determine the diversity of properties of endothelial 
cells. 
In adults, angiogenesis is basically restricted to the female reproductive organs 
and wound healing on injured tissues [15]. For successful vascularization in 
regenerative medicine it is considered that the implanted construct needs to 
stimulate a quick and directional vascular growth from the host [16]. 
The body regulates angiogenesis by producing a precise balance of pro- and 
anti-angiogenic molecules that arise from different sources, such as endothelial, 
pericytes, smooth muscle, fibroblasts and blood cells and extracellular matrix 
components [18]. 
Angiogenesis is related with wound healing, inflammation as well as with 
pathological conditions such as rheumatoid arthritis, endometriosis, diabetic 
retinopathy, macular degeneration and tumor growth [19, 20]. On the other 
hand, angiogenesis is also related to growth repair, bone remodeling and tissue 
regeneration [21].  
 
Regeneration master regu lators
Stem cell biology Tissue engineering
Prosthetics and
transplantation
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Figure 2.  The road of the vascular system development, from progenitor 
endothelial cells to tissue-specific specializations. In vasculogenesis angioblasts may 
acquire arterial (red) or venous (blue) phenotype and shape into the dorsal aorta and 
cardinal vein, respectively, in the embryo. On the other hand, blood islands may be 
formed from angioblasts and create the primitive plexus. Then, the hierarchical network 
of arteries, arterioles and capillary beds may be organized by angiogenic remodeling. 
Mural cells are recruited to stabilize and to promote the maturation of the nascent 
vessels pericytes and smooth-muscle cells. In addition, the lymphatic system derived 
from venous vessels returns lymph fluid back to the vasculature. The tissue-specific 
specialization determines by new molecular cues the diversity of properties of 
endothelial cells. Adapted from Herbert et al. [17]. 
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Taken into consideration the above-described process regarding vessels 
formation a detailed description of the cells, factors and the extracellular 
matrices involved is given below. Other variables are capable of influencing 
tissue vascularization, such as mechanical forces, electrical and chemical stimuli, 
which may considerably influence the new microenvironment. However, a review 
of these factors is out of the scope of the present manuscript and is available 
elsewhere [22-26]. 
 
 
1.1. Cells and tissues 
 
The vascular system is responsible for blood transport to all tissues. Although 
there are different types of vessels (arteries, veins, venules and arterioles), 
vessels are formed by a layer of endothelial cells, which are covered by mural 
cells such as pericytes and smooth muscle cells (Fig.3).  
 
 
 
Figure 3.  Scheme of vessels constitution. (a) Nascent vessels consist of a tube of 
endothelial cells. These mature into the specialized structures of capillaries, arteries 
and veins. (b) Capillaries, the most abundant vessels in our body, consist of 
endothelial cells surrounded by the basement membrane and a sparse layer of 
pericytes embedded within the endothelial cells basement membrane. Adapted from 
Jain [27]. 
 
 
Large blood vessels have a common basic structure, consisting of three different 
layers: the tunica intima, constituted by endothelium supported by a basement 
membrane and delicate collagenous tissue, an intermediate muscular layer, 
which is named the tunica media, and an outer supporting tissue layer called the 
tunica adventitia [27]. 
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1.1.1. Endothelial cells 
 
Endothelial cells play a pivotal role in angiogenesis. They form the endothelium, 
which is no longer considered an inert single layer of cells, that passively allows 
the passage of water and small molecules across the vessel wall, but an 
important player in the maintenance of tissues and its regeneration [28]. 
Endothelial cells are characterized by the expression of endothelial cell markers, 
such as von Willebrand factor (vWF), platelet endothelial cell adhesion molecule-
1 (PECAM-1 or CD31) and vascular endothelial (VE)-cadherin. [29]. On the other 
hand, endothelial progenitor cells express other markers that characterize their 
immature stage of differentiation, 
such as CD133 and CD34 [7, 30]. Vascular endothelial growth factor (VEGF) 
receptor-2 is a marker of active endothelial cells, present in nonquiescent 
endothelium as well as progenitor cells [29]. 
Depending on the tissues and organs the endothelium can acquire several 
features, namely continuous, fenestrated or discontinuous. In continuous 
capillaries endothelial cells line along all the surface of the vascular wall and can 
be found in the skin and muscles [31]. Fenestrated capillaries have small 
openings (80-100 nm in diameter) and can be found in the intestine, endocrine 
glands and kidney [31]. Finally, discontinuous capillaries or sinusoids have large 
gaps, many fenestrations and a discontinuous, or even absent, basal lamina and 
can be found in the liver, spleen and bone marrow [31]. Besides the assembly of 
vessel lumen, endothelial cells accomplish many other roles within our body. 
These cells are organized as a thin layer on the interior surface of all vessels and 
interactions with other cells and the extracellular matrix are crucial in 
endothelial cell function, such as in inflammation, angiogenesis cascade and 
transport of molecules through the vessel wall (either by active or passive 
mechanisms) [28]. 
 
1.1.2. Pericytes 
 
Maturation of the nascent vessels involves the formation of a basement 
membrane and the support of new vessels by pericytes and smooth muscle cells. 
Pericytes have a prominent nucleous and a small cytoplasm and are associated 
with capillaries and post-capillary venules, providing structural support to 
endothelial cells [32]. Pericytes are plastic and have the capacity to differentiate 
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into other mesenchymal cell types, such as smooth muscle cells, fibroblasts or 
osteoblasts [28], although their ontogeny is not yet well understood. Gerhardt et 
al. report that pericytes have an intermediate phenotype between vascular 
smooth muscle cells and fibroblasts [33]. Some pericytes heterogeneity has 
been suggested based on the expression of α-smooth muscle actin (α-SMA) [34]. 
Pericytes can synthesize extracellular matrix proteins such as fibronectin, 
laminin [35], collagen [36] and glycosaminoglycans [37]. Hirschi et al. reported 
that the action of pericytes on the vasculature [32] seems to match the scope of 
ideal cells for tissue repair taken into account their recently documented 
multipotency [38]. 
 
1.1.3. Smooth muscle cells 
 
Smooth muscle cells (SMC) secrete essential growth factors for vessel 
stabilization and preserve tissue integrity. SMC synthesize the connective tissue 
matrix of the vessel wall, which is composed by elastin, collagen and 
proteoglycans. Like endothelial cells, SMC have a very low proliferation rate in 
the normal artery but a high proliferate rate in response to vessel injury. SMC 
constitutes the vascular smooth muscle around the blood vessels whose 
function is to contract and to regulate blood vessel tone-diameter, blood 
pressure, and blood flow distribution [39]. Platelet-derived growth factor (PDGF) 
stimulates migration of smooth muscle precursors, during vascular development, 
which is necessary for the vessel wall formation [40]. 
 
1.1.4. Stromal cells 
 
In general, the connective tissue can be formed by fibroblasts, adipocytes and 
persistent mesenchymal stem cells [41, 42]. In this context fibroblasts can be 
important regulators of angiogenesis. 
Embryologically, fibroblasts arise from the relatively undifferentiated 
mesenchymal stem cells. Some of them remain in tissues such as the connective 
tissue. Fibroblasts are flat and irregular cells that synthesize the extracellular 
matrix of the connective tissue. Fibroblasts produce collagen, proteoglycans and 
elastin [43-45]. In addition, they secrete stimulatory growth factors, which 
provides as optimum environment to support epidermis formation and to 
facilitate skin wound healing [46]. Incorporation of fibroblasts in tissue 
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substitutes may be important as it acts as the key orchestrator in wound healing 
and enhances re-epithelialization [46]. Furthermore, there are no reports of 
hypertrophic scarring or keloid scarring following the intradermal injection of 
autologous fibroblasts, suggesting that fibroblast proliferation and collagen 
synthesis are naturally regulated by cell–cell and cell–ECM contact and by 
negative feedback [46]. Fibroblasts are activated when they express α-smooth 
muscle actin and some cytokines play a role in their activation, such as 
interleukin (IL)-1, tumor necrosis factor (TNF-α), platelet-derived growth factor 
(PDGF), fibroblast growth factor (FGF) and transforming growth factor-β (TGF-β) 
[47]. These findings support the interest in studying the interactions between 
endothelial cells and fibroblasts, which may help to understand the crosstalk 
between these two types of cells and its implications in angiogenesis. 
 
 
1.2. Growth factors 
 
Growth factors are soluble peptides that are produced to induce cellular specific 
responses in order to restore the cellular homeostasis [48]. Depending of the 
distance of the site of synthesis (source) and site of action (target), the 
mechanisms can be designated as autocrine (effect on the producer cell itself), 
paracrine (effect on the neighboring cells) or endocrine (growth factors released 
directly into the circulation). Growth factors can affect cellular activities such as 
proliferation, differentiation, migration or gene expression [49]. When growth 
factors bind to the corresponding receptor, the signal is translated into the cell 
through signaling pathways that lead to gene expression induction or 
repression and specific biological response (Fig. 3); the response can differ from 
one cell type to another.  
Experiments using conditioned media from cultured cells have proven to be an 
interesting and useful source of factors that may help to study the interactions 
between different cell types, although growth factors have short biological half-
life periods. A variety of growth factors are involved in angiogenesis, such as 
VEGF, basic FGF, PDGF and TGF-β1 [6, 50]. 
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Figure 3. Illustration of growth factors presentation in a temporal and spatial 
fashion with cells and extracellular matrix. The producer cell secretes growth factors 
that create a gradient in the extracellular matrix. These growth factors will bind to target 
cell receptors and induce a specific biological response, or it will be stored in the 
extracellular matrix until its remodeling. From Lee et al. [51]. 
 
 
1.2.1. Vascular endothelial growth factor  
 
VEGF is a homodimeric glycoprotein described as a vascular permeability factor 
with a heparin-binding domain [52, 53]. Four different major VEGF isoforms are 
generated through splicing: VEGF
121
, VEGF
165
, VEGF
189
, and VEGF
206  
[54-56]. VEGF
121
 
is a free diffusible protein, unlike VEGF
165  
that is secreted but linked to the cell 
surface and the extracellular matrix via its heparing-binding domain. These two 
isoforms induce mitogenic and permeability-enhancing activities on endothelial 
cells [54, 55, 57, 58]. In vivo VEGF has a complex and multifaceted role in 
angiogenesis and vasculogenesis. VEGF can bind to VEGF receptors 1 (VEGFR-1) 
and 2 (VEGFR-2), and in endothelial cells VEGFR-2 translates VEGF signals [6]. 
VEGF have been shown to promote permeability [59], to induce integrin 
expression [60], to enhance endothelial cell survival [61] and to induce matrix 
metalloproteinases (MMPs) secretion [62]. Bone marrow-derived mesenchymal 
progenitor cells secrete VEGF [63]. Additionally, VEGF is implicated in the 
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crosstalk between many types of cells, including neurons [64], smooth muscle 
cells [65], adipocytes [66] and fibroblasts [67]. 
 
1.2.2. Basic fibroblast growth factor 
 
FGF has been associated with a wide range of cellular behaviors, including cell 
proliferation, differentiation, migration and survival [68, 69]. In humans 18 
signaling FGFs have been found. FGFs are a family of small proteins containing a 
conserved core domain and two separate binding sites (one for FGF receptors 
and another one for heparin sulphate). The interaction of FGF with cell FGF 
receptor involves the formation of a FGF-heparin sulphate complex. FGF binds to 
heparin sulphate proteoglycans in the ECM, which protects FGF against 
degradation sequestering it [70]. FGF signaling is a complex and highly 
regulated process. Basic FGF (bFGF or FGF-2) influenced in an autocrine or 
paracrine manner the proliferation and differentiation of cells from epithelial, 
neuroectodermal and mesenchymal origin [71, 72]. bFGF has been shown to 
have a central role in fracture healing, bone remodeling and osteogenesis [68]. 
In addition, bFGF has been shown to be expressed by bone marrow stromal and 
peripheral blood cells [73]. 
Experimental evidence shows that bFGF can induce in vitro and in vivo a pro-
angiogenic phenotype in endothelial cells, modulating endothelial cell 
proliferation [74] and migration [75, 76], protease production [76], and integrin 
and cadherin receptors expression [77-79].  
As a consequence of its role in angiogenesis attempts of the use bFGF in tissue 
engineering are widely available [69, 80]. bFGF has been implicated in normal 
and pathological processes ranging from modulation of endocrine responses, 
embryogenesis, limb regeneration, and repair process as in neural, cartilage and 
soft tissues injury [81]. In wound healing, bFGF influences the proliferation of 
fibroblasts, endothelial cells, keratinocytes and smooth muscle cells [49]. bFGF 
is considered a potent angiogenic factor and its receptors can be found in 
almost all tissues in the body [49]. 
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1.2.3. Transforming growth factor- β1 
 
TGF-βs constitute a family of local mediators that regulate proliferation, 
differentiation and extracellular matrix metabolism [49]. In order to induce a 
biological response TGF-β needs to bind to cell surface receptors, consisting of 
multi-domain-transmembrane proteins with extracellular and intracellular 
domains with cinases activities [49]. TGF-β1 has been shown to possess pro- and 
anti-antiogenic effects in endothelial and other cells types: low doses seem to 
contribute to the angiogenic switch and high doses seem to led to inhibition of 
endothelial cells proliferation and migration [82, 83]. TGF-β1 stimulates the 
recruitment and proliferation of mesenchymal cells, and may modulate 
inflammation [69]. This growth factor has the capacity to bind to the 
extracellular matrix components, including type IV collagen, fibronectin, 
proteoglycans and heparin [49]. TGF-β has been proposed to be used in the 
clinical practice in the areas of soft and hard tissue healing, and control of 
chronic inflammatory diseases, associated with fibrosis and suppression of 
autoimmune diseases [84]. TGF-β is also involved in the process of wound 
healing. TGF-β1 levels show a transient increase after injury but in fibrosis TGF-
β1 levels stay high for long periods. On the other hand, a decreased response to 
TGF-β1 by fibroblasts occurs in diabetic ulcers [85, 86]. 
 
1.2.4. Other factors that influence the angiogenic microenvironment  
 
Other growth factors and cytokines may influence the process of angiogenesis 
and inflammation in order to orchestrate or to create an equilibrium leading to 
the formation of a new vascularized tissue. PDGF is mitogenic for fibroblasts, 
indirectly influences the production of collagen [87] and recruits the smooth 
muscle cells around nascent vessels to stabilize then into mature vessels [88]. 
Hepatocyte growth factor (HGF) induces angiogenesis in various animal models, 
stimulates the growth of endothelial cells and acts as a survival factor against 
endothelial cell death [89]. Cytokines, including interleukin (IL)-6 and IL-8, have 
been involved in the recruitment of endothelial cells and their organization due 
to the interplay between angiogenesis and inflammation [90, 91].  
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1.3. Extracellular matrix 
 
The ECM plays fundamental roles during angiogenesis by providing the 
mechanical support and contributing to the maintenance of the tissue 
architecture, and also by providing the soluble and insoluble signaling required 
as described previously. The ECM can be described as a dynamic structure that 
regulates migration, proliferation and differentiation of endothelial cells due to 
intracellular signaling [92, 93]. The first step, in angiogenesis is the degradation 
of the sub-endothelial basement membrane and surrounding ECM. Therefore, 
several proteinase families are involved such as, plasminogen activators, matrix 
metalloproteinases (MMP) and their corresponding inhibitors, namely 
plasminogen activator inhibitor and tissue-type inhibitor of MMP (TIMP), 
respectively [94]. The fragmentation of the ECM leads to the release of matrix-
bound angiogenic activators like bFGF, VEGF and TGF-β. In this regard, the 
remodeling of the ECM is intrinsically related with angiogenesis [82], and is 
implicated in vessel formation [95, 96] and vessel regression [97, 98].  
The basement membrane consists of a network of molecules such as collagen IV, 
laminin and heparin sulphate proteoglycans [28], whereas typically components 
of the interstitial matrix are fibrillar collagens and glycoproteins, such as 
fibronectin [28]. The structured part consists of fibrous material, while the 
unstructured section can be described as an amorphous ground substance, that 
contains glycoproteins and electrolytes and other soluble substances of blood 
plasma. 
After a skin injury, the development of a suitable ECM is necessary to allow cells 
to migrate. This matrix is formed by fibroblasts, monocytes, macrophages, 
lymphocytes and endothelial cells [99]. Collagen lead to the spreading of 
fibroblasts and endothelial cells, allowing the formation of capillaries [100].  
 
1.3.1. Interactions between cells and ECM  
 
Integrins are heterodimeric transmembrane proteins (each consisting of one α 
chain and one β chain) that mediate cell adhesion to the ECM and to the 
immunoglobulin superfamily. Integrins are important mediators in the 
regulation of intracellular signaling, due to the cell-ECM interactions [101]. The 
integrins pattern expressed in the cell surface dictates the cell adherence and 
the cell migration on different matrices. Integrins directly bind components of 
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the extracellular matrix such as fibronectin, collagen and laminin. Integrins also 
control the release of proteases that remodel the ECM, allowing cell motility. 
The sequence argine-glycine-aspartic acid (RGD) allows the interaction between 
the protein and the integrin receptors αVβ3 and α5β1 of the cell [102]. Arginine–
glutamic acid-aspartic acid-valine (REDV) is an alternative splice from fibronectin, 
and it is recognized by α4β1 receptor in endothelial cells [103]. In the context of 
developmental and postnatal angiogenesis, vascular integrins appear as a target 
to improve or inhibit the neovascularization of the tissue [104].  
Different combinations of integrin–growth factor receptors followed by distinct 
intracellular signaling pathways can avoid cell apoptosis. In the case of 
endothelial cells the crosstalks between αvβ3-bFGF and αvβ5-VEGFR-2 prevent 
apoptosis: the first preventing the intrinsic apoptosis pathway (is triggered by 
cellular stress) [105] and the second inhibiting extrinsic apoptosis (initiated 
through the stimulation of the transmembrane death receptors) [106]. 
For vessel stabilization endothelial cell-pericyte interactions are necessary and 
recent studies suggest the interaction of integrin α4β1on endothelial cells with 
vascular cell adhesion molecule 1 (VCAM1) on pericytes [107]. 
In tissue engineering the RGD sequence has been grafted to biomaterials to 
enhance adherence and viability of the cells [108, 109], unlike in cancer therapy 
where they are used to induce cell death [110, 111]. Regarding the soluble RGD-
peptide, Aguzzi et al. reported a pro-apoptotic effect in endothelial cells [112, 
113]. Interestingly, Kim et al. reported that in the case of endothelial progenitor 
cells the pro-apoptotic effect was not observed, but only an inhibition of the 
differentiation of the cells, maybe due to anti-adhesiveness of the RGD-peptide 
[114].  
 
1.3.2. Collagen 
 
Collagen is the most abundant protein in the ECM. All members of the collagen 
family are trimeric molecules composed of three polypeptide ? chains resulting 
in a (Glycine-X-Y)
n
 repeated structure (the X and Y position are often substituted 
by proline and hydroxyproline). In the endoplasmatic reticulum (ER) post-
translational modifications occur in order to form the intramolecular hydrogens 
bonds, which will give stability to the structure. In connective tissues collagen 
types I, II, III, V and IX exist, being type I the most abundant in skin and bone. 
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Collagen plays an important role in organ development, wound healing and 
tissue repair, because of its interaction with growth factors and integrins of the 
cells, influencing adhesion, differentiation, growth and cellular reactivities [115].  
Fibroblasts secrete and influence the alignment of collagen fibers in the ECM 
[116]. Collagen is found in high concentration in tendons, skin, bones, 
cartilages and ligaments, and these tissues are appropriate and abundant 
sources for isolation of this natural polymer [117].  
Collagen can be readily processed into porous sponges, films and injectable cell 
carriers. Collagen has been used in cell encapsulation/entrapment due to its 
biocompatibility, biodegradability, abundance in nature and natural ability to 
bind cells [117, 118]. Challenges of using collagen as a material for cell delivery 
include the high purification cost, the natural variability of isolated collagens 
and the variation in enzymatic degradation (which depends on the location and 
state of the implant site) [118]. Collagen is a natural choice as artificial 
extracellular matrix in tissue engineering and has been used to engineer a large 
variety of tissues, including skin [119], bone [120, 121], heart valve [122], and 
ligaments [123], among many others. 
 
1.3.3. Glycoproteins 
 
Glycoproteins are carbohydrate-protein conjugates through a glycosidic link to 
the –OH of a serine or threonine residue (O-linked) or through an N-glycosyl link 
to the amide nitrogen of an aspargine residue (N-linked). The glycoproteins can 
be found in the blood, extracellular matrix, plasma membrane and inside some 
organelles of the cell. The length, variety and number of glycoconjugates allows 
many combinations that give proteins some tissue-specification and provides 
specific interactions between the cell membrane and the ECM [124]. The 
glycoproteins group represents 25% of non-collagenous proteins, which includes 
for instance alkaline phosphatase (ALP) [125, 126].  
 
1.3.3.1. Alkaline phosphatase 
 
In contrast to the large amount of evidence concerning the role of ALP in bone 
tissue, still very little is known about the clinical relevance of this protein in 
tissue regeneration. ALP is normally located either on the plasma membrane 
[127, 128] or in secretory vesicles [129] and, possibly, in the membrane 
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surrounding lipid droplets [130]. ALP is bound to cell membranes via a 
glycosylphosphatidyl-inositol (GPI) anchor [131, 132]. So, ALP is a glycoprotein 
that functions mainly as an ectoenzyme. Four isoenzymes have been described 
in humans: placental ALP (PALP), germ cell ALP (GCALP), intestinal ALP (IALP) and 
tissue-unspecific ALP (TNS-ALP). The endogenous substrates of ALP and its exact 
function are still not completely known [128, 130]. There is experimental 
evidence that the enzyme is involved in tissue development [133, 134], cellular 
differentiation [135, 136] and cell-cell interactions [137], although its precise 
role in these cellular events is also still not known. Hui et al. reported that 
collagen phagocytosis and apoptosis are induced by high levels of alkaline 
phosphatase expression in rat fibroblasts [138].  
It has been hypothesized that ALPs may play a role in the processes of cell 
guidance and migration in a large variety of non-mammalian species. Several 
studies have demonstrated a potential involvement of ALP expression both in 
the migration of the pronephric duct during development in salamander [139, 
140] and in growth cone guidance during axonal outgrowth from the distal limb 
in the developing grasshopper [141]. In addition, ALP expression is often 
restricted both temporally and spatially to cell populations that are involved in 
migration or morphogenesis [142]. Abnormal ALP isoenzymes expression has 
been found in malignant tissues, being often established as a useful prognostic 
indicator [137, 143].  
 
 
2. Strategies to promote vascularization of bioengineered 
tissues 
 
In tissue regeneration it seems fundamental to recreate a microenvironment 
capable of influencing cell guidance towards the regeneration process, instead 
of fibrosis or tumor development. Despite the same molecules and cells being 
involved in different processes, their proportions and half-life are different, 
resulting in microenvironment changes in different situations. Many strategies 
have been developed to promote vessel structure assembly and branching in 
order to maintain cellular functions and tissue integrity [144]. It seems 
important to identify a master regulator that leads to regeneration, due to the 
complexity of the process, in addition to understanding what happens in lower 
Chapter I 
 
 
17 
 
organisms and in our embryology [4, 8, 145, 146]. Some approaches aiming at 
promoting vascularization will be presented and discussed, using growth factors, 
cells and artificial ECMs. 
 
 
2.1. Growth factor delivery 
 
Strategies involving the delivery of growth factors are aimed at using their 
signaling properties to stimulate the cells in the area to migrate, proliferate and 
differentiate. Regulation of angiogenesis involves the recruitment of endothelial 
cells to rapidly restore the vascularization of the new tissue formed and achieve 
homeostasis (oxygen and nutrients) of the tissue [147].  
VEGF and bFGF have been often used to improve neovascularization by injecting 
these proteins in the circulation or into the target tissue [148, 149]. Growth 
factors delivered improved the chemotaxis of the cells and in vivo studies using 
their ‘cocktails’ [150] reported that recombinant human growth factors supplied 
additional blood flow to underperfused and incompletely revascularized areas 
[148, 151].  
However, a number of studies reported that the subcutaneous injection of VEGF 
and bFGF presents several limitations related to their natural instability in vivo 
and to the possibility of uncontrolled effects at distant sites [152, 153]. Clinical 
trials reported that the administration of VEGF (Phase I) [148] and bFGF [154] 
was safe and feasible. However, VEGF (VIVA studies) in ischemia for vascular 
angiogenesis [155] and bFGF (FIRST study) in coronary artery disease [149] have 
not shown the expected benefit to the patients. Some disadvantages were 
appointed, such as their rapid clearance from the body, which lead to increasing 
the administered doses of these factors systemically into the body that, in turn, 
lead to unspecific and undesirable side effects, such as bleeding, tumor growth, 
atherosclerosis and restenosis [156-158]. Taken this in account it is important 
to understand the kinetics of the growth factors and their time-life in order to 
obtain the optimal dose and route of administration [8, 155]. Also, even though 
growth factors stimulate vessels formation, the newly formed vessels need to 
become mature vessels in order to maintain their stability and not regress. 
Taking this into account, the simple injection of angiogenic factors may be 
insufficient for stable vessel formation, and may even be dangerous [159]. 
Localized and sustained delivery of growth factors at specific sites instead of 
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free delivery in the circulation will probably allow a better and safer promotion 
of angiogenesis. 
 
 
2.2. Cell transplantation  
 
Several strategies designed to induce tissue vascularization rely on the 
transplantation of cells, mainly of the endothelial cell (EC) type. Several of these 
strategies have succeeded in promoting some vascularization although, 
generally, they were proven insufficient, with several limitations relying in the 
lost of cell viability after injection, the dispersion of the cells, their rapid 
clearance from the injection site and the lack of the right cues to develop their 
original role.  
In general, the use of stem cells for transplantation, although promising, still 
involves several hurdles to be overpassed, namely the efficiency in the isolation 
process and the long culture time required to obtain the necessary amount of 
cells. Undifferentiated cells are more proliferative and present a higher 
regenerative potential compared to differentiated cells with endothelial 
phenotype [160]. In addition, mature ECs generally show less survival rates 
when injected in ischemic areas [161].  
Cell transplantation in order to improve vascularization in the treatment of 
ischemic tissue in heart diseases is the basis of multiple animal studies and 
clinical trials [162]. In order to promote the regeneration of myocardial tissue, 
bone marrow-derived stem cells were injected in a mouse model and they 
differentiated in endothelial cells and smooth muscle cells that participated in 
the recovery of cardiac function [163]. 
Progenitor endothelial cells (EPC) are a source of endothelial cells, which are 
generated in bone marrow and circulate in the blood system participating in the 
neovascularization of new tissue [7, 164]. Transplanted endothelial progenitor 
cells have been shown to induce new vessel formation or restore the injured 
endothelial cell layers in the ischemic hindlimb [165]. In ischemic hindlimb EPCs 
showed better recovery of the limb when compared to simple injection of human 
microvascular vein ECs [165]. The EPC isolated from mononuclear cells from the 
peripheral blood express endothelial cells markers, but also monocytic markers 
and a delimited ability of expansion. On the other hand, outgrowth endothelial 
cells (OECs or late-EPCs) are another population of cells isolated from peripheral 
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blood showing high proliferative activity, when compared to EPC, and 
demonstrated a very stable phenotype during passages [29, 166]. These cells 
have demonstrated a capacity for use in cell-based therapies or in combination 
with biomaterials for improved angiogenesis [167]. 
Overall, the use of injected angiogenic cells as a strategy to promote 
vascularization has not been proved effective so far due to the limitations 
pointed above. Hence, the use of approaches involving cells combined with 
artificial extracellular matrices seems attractive in order to overcome several of 
the limitations described above. 
 
 
2.3. Angiogenic artificial extracellular matrices 
 
Different biomaterials are under investigation in order to promote 
vascularization of the new tissue formed in different organs such as in bone 
[168], heart [169], and skin [170]. The environment created by the scaffold 
should be designed to mimic the conditions of the natural tissue to be replaced, 
providing different soluble and insoluble signals, which will further influence 
cells in different ways, namely their migration, proliferation, and differentiation. 
Scaffolds have been designed with controlled biodegradation (matching tissue 
regeneration kinetics) and porosity to promote cellular colonization and 
ingrowth from the host, as well as with functionalities promoting cell adhesion 
[171-173]. Other requirements are biocompatibility and proper mechanical 
integrity of the scaffold [174].  
In angiogenesis strategies using natural and synthetic matrices have been 
developed. Synthetic matrices, such as polyethylene glycol (PEG), poly-
methacrylates, polylactides (PLA), due to lack of biological signaling ability, 
usually failed to induce vascularization [144]. Natural matrices, such as fibrin 
and collagen, are claimed to be more attractive for this purpose because of their 
natural biocompatibility and similarity with natural tissues [173, 175]. Callegari 
et al. reported that, after implantation in healthy or cryoinjured left ventricles of 
rats, a porous collagen scaffold was capable to induce a high angiogenic 
response [173]. 
In skin tissue engineering, clinically available acellular dermal substitutes, like 
Integra® (collagen) and Alloderm® (decellularized tissue matrix), are used for 
the treatment of burns and deep wounds and recommended as a temporary 
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barrier for skin grafts [170]. Although constituting useful therapeutic 
alternatives to traditional artificial skin products these products were shown to 
restore the epidermis but only a small part of the dermis, without a well-
vascularized dermal wound bed for healing full thickness burns [170]. Usually, 
re-grafting is required and one of the main challenges is still a material able to 
rapidly become vascularized [170]. 
Overall the implantation of materials alone has resulted in poor vascularization 
in vivo. Hence, several strategies have been proposed and investigated to 
promote the adhesion and recruitment of endothelial cells, which seem to be 
essential to promote the vascularization of the scaffold in an environment where 
a variety of cell types are competing and assemble for tissue regeneration. One 
key aspect relies in the ability of the scaffold to allow the migration of 
endothelial cells to form vessels, and therefore increasing the porosity and the 
interconnectivity of the pores has been proposed as one viable strategy [176]. 
Another strategy relies is the grafting of peptides capable of enhancing the 
adherence of the cells, such as the RGD sequence (arginine-glycine-aspartic acid), 
present in many ECM proteins, such as fibronectin, vitronectin, and collagen 
[172, 177]. Hyaluronan hydrogels with open porous structure and viscoelastic 
properties, modified with laminin [178], poly-D-Lysine [179] or RGD peptides 
[180], were reported to support cell ingrowth and angiogenesis in vivo in the 
case of brain injury.  
Other strategies have been developed in order to improve the selective 
recruitment of endothelial cells in the competitive microenvironment of the 
implant site, where smooth muscle cells and fibroblasts, among other cell types, 
are also present. One such strategy relies in grafting the arginine-glutamate-
aspartate-valine (REDV) sequence, derived from fibronectin. Hubbell et al. 
demonstrated that REDV-coated surfaces in vascular grafts could improve the 
attachment of endothelial cells (HUVEC) but not fibroblasts or smooth muscle 
cells [181, 182]. This interactions between HUVECs and the REDV sequence was 
reported to occur through integrin α
4
β
1
 [182]. Wei et al. also reported the 
selectivity of the REDV peptide for HUVECs compared to smooth muscle cells 
when immobilized onto a PEG structure [183].  
Alternative approaches have been proposed to improve the selectivity between 
progenitor endothelial cells and the neighboring endothelial cells in the re-
endothelialization of cardiovascular stents using an anti-CD34 antibody grafted 
to the surface of biomaterials for cardiovascular applications. A 
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polycaprolactone stent engrafted with an anti-CD34 antibody was shown to 
improve the adhesion of progenitor endothelial cells compared to HUVECs [184]. 
Lin et al. reported that an endothelialized stent coated with heparin/collagen 
multilayer coatings, and functionalized with an anti-CD34 antibody, was 
selective in promoting the attachment and growth of vascular endothelial cells 
and further demonstrated anti-restenosis effects [185]. 
Several alternative strategies have been proposed several of the components 
described previously, namely cells, growth factors and matrices, in order to 
improve cell-matrix interactions and to stimulate selective cell-signaling 
pathways leading to implant vascularization.  
 
 
2.4. Combined strategies 
 
In strategies to promote vascularization in regenerative medicine the 
extracellular matrices play fundamental roles by, on one hand, providing the 
support and the stability for cells to regenerate the injured area and, on the 
other hand, by additionally providing the insoluble and soluble signaling 
required to maintain cells viable, proliferating and differentiating.  
As previously described, one of the potent facilitators of angiogenesis described 
in the literature is VEGF, which influences mature endothelial cells as well as 
progenitor endothelial cells, demonstrating effects on endothelial cell 
proliferation, motility, and vascular permeability [11, 186, 187]. Alginate gels 
incorporating VEFG or bFGF increased the number of blood vessels, although 
VEGF lead to an increased density of blood vessels [188]. Tanihara et al. 
reported that, in vivo, alginate with heparin and incorporating bFGF promoted 
angiogenesis, comparing to the control without bFGF, which showed no cellular 
infiltration nor angiogenesis, and further suggested that the release of the 
growth factor should be slow and directed to the target area, affecting only the 
adjacent tissues in order to minimize the local inflammatory response [189]. 
Iwakura et al. reported that bFGF incorporated into gelatin hydrogels improved 
the vascular density of the infarct zone after 4 weeks in a rat model [190]. 
Microbeads of alginate loaded with FGF implanted in the rat omental pouch 
model after 7 days increased vascular density compared with control rats 
implanted without growth factor, despite the recruitment of mural cells was not 
found to increase in the presence o FGF [191]. The delivery of TGF-β1 from 
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alginate hydrogels enhanced the natural dental pulp regeneration capacity [192]. 
These growth factors entrapped in alginate showed induction of 
neovascularization in vivo compared to subcutaneous injection of angiogenic 
factors not entrapped in alginate [51, 193, 194].  
The combination more than one growth factors have also been investigated in 
order to obtain a stabilized vasculature instead of weaker blood vessels. Hao et 
al. reported that the sequential delivery of VEGF followed by PDGF from alginate 
hydrogels induced an angiogenic effect and functional improvement compared 
to the delivery of single factors after myocardial infarction [50]. Richardson et al. 
showed that co-delivery of PDGF and VEGF led to rapid formation of a mature 
vascular network after hind-limb ischemia induction compared to individual 
factors delivered alone [152]. Marui et al. incorporated, into collagen 
microspheres, bFGF and hepatocyte growth factor (HGF) and reported increased 
vessel formation and maturity [195]. Freeman et al., using alginate-sulfate 
hydrogels to deliver three angiogenic factors (VEGF, TGF-β1 and PDGF), showed 
an increase in vascularization compared to scaffolds delivering only bFGF [196]. 
Taken together, these examples indicate the importance of the action of 
multiple growth factor delivery for vascularization and hence better results in 
tissue regeneration. However, the optimal dose and spatial time delivery 
constitute aspects that clearly need to be further studied. In order to overcame 
these difficulties cells have been used, taking advantage of their capacity to 
secrete these pro-angiogenic growth factors and to provide feedback in reaction 
to the needs of the microenvironment.  
Several different endothelial cells types have been used for promoting 
angiogenesis and vasculogenesis in vitro an in vivo. Human umbilical vein ECs 
(HUVEC) and human dermal microvascular ECs (HDMEC) are among the mature 
EC types most widely used [197, 198]. Alginate grafted with RGD peptides has 
been shown to improve cell attachment and formation of tubular-like structures 
using HUVECs [199] and progenitor endothelial cells [200]. In addition, covalent 
attachment of RGD peptidomimetics containing poligoethylene glycol spacers in 
poly(ethylene terephthalate) (PET), an inert polymer, demonstrated the capacity 
of improve the adhesion of the endothelial cells from the human saphenous vein 
[201]. Endothelial progenitor cell types are also becoming increasingly 
investigated for this purpose due to the advantages that they provide, as 
previously explained. The use of outgrowth endothelial cells within alginate 
have been shown to constitute a good strategy to improve the vascularization in 
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tissue damage, because alginate does not seem to adversely affect these cells 
and the microenvironment created does not seem to reduce the cells angiogenic 
potential [200]. Progenitor endothelial cells in combination with RGD-alginate as 
a delivery system were shown capable to create new vascular beds in ischemic 
tissues [202].  
Vascularization strategies based in cocultures systems have shown that there 
are interactions between cells types with reciprocal beneficial effects in 
vascularization and tissue regeneration. In the case of endothelial cells different 
cells types showed ability to support the formation of pre-vascular structures, 
such as fibroblasts [203], smooth muscle cells [204], adipocytes [205], 
osteoblasts [198], as well as mesenchymal stem cells, in a general approach, 
due to their capacity to differentiate into different cell types [206]. The use of 
two or more cell types in coculture, creating and heterotypic microenvironment, 
also contributes to better understand cell behavior, in terms of spatial 
organization, proliferation and differentiation of the cells in two dimensional 
(2D) or three dimensional (3D) cultures. As a consequence, many cocultures 
studies are available using endothelial cells along with the major cell types of 
the tissue to regenerate, such as osteoblasts in bone, cardiomyocytes in heart 
and astrocytes in brain [206]. The crosstalk between endothelial cells and other 
cell types involve paracrine mechanisms (growth factors) and direct cell-cell 
communication that maintain the viability of the endothelial cells and stimulate 
the differentiation of the cells [207].  Villars et al. reported that connexin 43 is 
important in junctional communication between HUVECs and human 
osteoprogeniotor cells [208]. Connexin 43 expression in cardiac myocytes has 
also been promoted by microvascular endothelial cells [209]. Kaigler et al. 
reported improved vascularization in vivo using HUVECs and bone marrow 
stromal cells and further demonstrated the reciprocal beneficial interrelationship 
between the two cell types through exchange of VEGF, produced by the marrow 
cells, and bone morphogenetic protein (BMP)-2, produced by the ECs [210, 211]. 
Fuchs et al. reported that OECs cocultured with osteoblasts (MG63) or with 
progenitor osteoblasts formed a vascular-like network, and that this network 
was not formed using HUVECs [212]. Aguirre et al. highlighted the importance 
of the differentiation stage and the origin of mesenchymal stem cells in order to 
promote the formation of capillary-like structures when cocultured with EPCs 
[213].  
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The interaction between endothelial cells and fibroblasts are yet unclear, 
although the contribution of the latter cell type in tissue vascularization is 
considered important [42]. Cocultures of HUVECs and human periodontal 
ligament fibroblasts induced capillary formation [214]. Berthod et al. reported 
the importance of ECM produced by fibroblasts in the promotion of this 
capillary-like structures [203]. ECM and growth factors influenced the tubule 
formation, stability and differentiation. Conditioned media collected from 
alginate-bioactive glass beads cultured with fibroblasts showed an enhancement 
in endothelial cell proliferation due to the presence o VEFG secreted by 
fibroblasts [215].  
Anastomosis of the newly formed vessels with the host vasculature is another 
major obstacle in the development of vascularization strategies. Ferreira et al, 
reported that endothelial-like and smooth muscle-like cells isolated from human 
embryonic stem cells, when subcutaneous implanted within Matrigel, formed 
microvessels structures and, I some cases, anastomosis with the host 
vasculature was observed [216]. An alternative study showed that spheroids of 
cocultures of HUVECs with mesenchymal stem cells subcutaneously inoculated 
in nude mice promoted anastomosis with the host vasculature to some extent 
[217]. 3D silk fibroin scaffolds colonized with outgrowth endothelial cells 
showed capacity to form microvessel-like structures important in the 
interconnection between the tissue engineered construct and host vasculature 
[218]. Complex biomaterials made of a combination of fibrin with synthetic 
poly(L-lactic acid) and polylactic-glycolic acid sponges, colonized with 
endothelial cells and fibroblasts, promoted an improvement in the 
neovascularization and perfusion of the implanted grafts [219].  
The combination of matrices prevascularized with endothelial progenitor cells 
and hypoxia seems to be an alternative viable strategy to promote tissue 
vascularization favoring as well a link between the microvessels formed in the 
tissue construct and the existing vasculature from the host [220]. Tissue 
decellularization generated new insights in bioscaffold design [221]. Ott et al. 
described that a decellularized heart, when reseeded with endothelial and 
cardiac cells, was re-endothelialized and generated a pumping function [25]. 
Likewise, Baptista et al. reported the decellularization of a liver that maintained 
the vascular structure, which, when re-cellularized with endothelial and hepatic 
cells lead to right engraftment and re-vascularization, re-establishing basic liver 
functions [222]. The development of strategies to further elucidate these cell-
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matrix interactions seem fundamental to advance the field of tissue 
regeneration and biomaterials design with a view to promote functional 
anastomosis between microvessels formed in tissue constructs with the existing 
vasculature from the host.  
 
 
3. Hypothesis and specific aims 
 
 
The hypothesis guiding the research reported in the present thesis is that a 
functional and viable vascular network may be promoted in tissue regeneration 
through the appropriate delivery of fibroblasts and endothelial cell, combined or 
not with angiogenic growth factors, implanted within biofunctionalyzed 
biodegradable hydrogel carriers. 
 
In order to investigate this hypothesis different strategies were used with the 
following specific aims: 
 
i)   To assess if the survival and viability of endothelial cells can be improved 
and modulated by fibroblasts and/or angiogenic growth factors. 
 
ii)  To investigate if the functionality and ability of endothelial cells to form 
vessel-like structures can be influenced in indirect and direct coculture with 
fibroblasts. 
 
iii) To study if entrapped fibroblasts can recruit endothelial cells and induce 
angiogenesis in vivo. 
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Abstract 
 
Promoting angiogenesis in a damaged tissue is a major challenge for tissue 
regeneration. Recent findings in tissue engineering suggest that fibroblasts 
(FBs) play an important role in orchestrating the angiogenic process. Fibroblasts 
maintain the structural integrity of connective tissue by continuously secreting 
growth factors and extracellular matrix precursors, which are essential for 
endothelial cells (EC) adhesion and spreading, thus playing a crucial role in 
angiogenesis. We hypothesized that FBs immobilized in alginate gels grafted 
with the RGD peptidic sequence could influence the recruitment of ECs to 
improve vascularization. In this work the modulation of immobilized human FBs 
within the 3D synthetic extracellular matrix was assessed. Experiments using co-
cultures of ECs and FBs in indirect contact as well as angiogenic assays were 
performed to assess the influence of FBs immobilized in RGD-alginate in ECs 
viability, stabilization, sprouting and assembly into capillary-like structures. This 
study demonstrates the ability of FBs immobilized within RGD-alginate 
microspheres to modulate and support capillary-like structures’ assembly. These 
findings indicate that the microenvironment created by these stromal cells in the 
scaffold modulates capillary morphogenesis, thus stimulating angiogenesis in 
situ, and can potentially be used in regenerative medicine, in clinical scenarios 
where vascularization is essential. 
 
Keywords: Alginate, angiogenesis, endothelial cells, fibroblasts, RGD peptide, 
injectable biomaterials.   
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1. Introduction 
 
Strategies promoting tissue vascularization continue to represent a great 
challenge in regenerative medicine. A promising approach to address the 
problem of vascularization deficit of new tissue is the use of implantable three-
dimensional (3D) biomaterials that can provide support and protection to cells 
transplanted for regeneration of skin (32), nerve (3), mammary gland (23), 
cardiovascular tissue (48), and bone (14,17,21,38). The 3D biomaterial structure 
is intended to mimic the extracellular matrix (ECM), thus creating an adequate 
microenvironment to allow the interaction between cells and the ECM. These 
interactions are fundamental in cell polarization and function and crucial for 
vascularization of the newly formed tissue (12). Angiogenesis, or the 
recruitment of new vessels to the tissue formed, is a process that plays a key 
role in various physiological conditions, including embryonic development, 
wound repair, inflammation, and regeneration (7).  
In tissue engineering approaches, angiogenesis has been traditionally 
stimulated by paracrine signals, such as vascular endothelial growth factor 
(VEGF) (39) and basic fibroblast growth factor (bFGF) (13), using biomaterials 
like hydrogels for bioactive molecule delivery. However, in the framework of 
tissue vascularization, the uncontrolled release of angiogenic growth factors 
and/or alterations of the production of natural angiogenic inhibitors could 
deregulate the angiogenic balance (22). Immobilization of cells in 3D structures, 
instead of growth factors immobilization, constitutes an alternative strategy. 
The immobilization of cells inside alginate microspheres is here proposed as a 
minimally invasive (injectable) strategy for tissue regeneration (14,37,43). 
Alginate is an hydrogel that has been used as a biomaterial, both in vitro and in 
vivo, due to its several advantages, including biocompatibility and ability to be 
crosslinked under harmless mild conditions to cells (12). Coupling arginine-
glycine-aspartic acid (RGD) peptidic sequence to alginate promotes cell 
attachment, leading to improvement of tissue formation (1). The present team 
previously demonstrated that immobilization of osteoprogenitor cells in RGD-
alginate is a valuable strategy to maintain cells viable during the period of 
osteoblasts differentiation (5,14,21). It has also been previously shown that 
endothelial cells (EC) influence osteoprogenitor cells by releasing bone 
morphogenetic protein-2 (BMP-2) to modulate their osteogenic differentiation in 
vitro and in vivo (24). Reciprocally, bone cells produce VEGF that enhances EC 
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viability (25), thus generating a crosstalk that seems to stimulate both cell 
types. However, in this system, a significant decrease in ECs viability was 
revealed upon immobilization, even in the presence of osteoblasts (21).  
Recent findings suggest that fibroblasts (FBs) also play an important role in 
orchestrating the angiogenic process (10,16,47). FBs are mesenchymal cells with 
many vital functions during development and in adult organisms (8). They are 
responsible for the synthesis of collagen, an ECM component that provides a 
structure for cell migration and release of angiogenic growth factors (8). 
However, the potential of FBs for improving vascularization in tissue 
regeneration strategies remains largely unexplored. Hence, in the present study 
it was hypothesized that FBs immobilized in RGD-alginate could influence ECs to 
improve vascularization. In this work the modulation of human ECs and FBs 
immobilized within a synthetic 3D extracellular matrix was assessed. 
Experiments using co-cultures in indirect contact and angiogenic assays were 
performed to assess the role of immobilized FBs in ECs viability, stabilization, 
sprouting and assembly into capillary-like structures. 
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2. Materials and Methods 
 
2.1. Culture of endothelial cells and fibroblasts 
 
Human umbilical vein endothelial cells (HUVECs, ScienceCell, herein called ECs) 
were cultured in M199 medium (Sigma), supplemented with 20% (v/v) 
inactivated fetal bovine serum (FBS; Gibco), 80 µg/mL heparin (Sigma), 30 µg/mL 
endothelial cell growth supplement (ECGS, BD Science), 100 U/mL penicillin G 
and 100 µg/mL streptomycin (Gibco). Cells were maintained in culture flasks 
coated with 0.2% gelatin (Sigma). Human dermal foreskin fibroblasts-1 (HFF-1, 
ATTC, herein called FBs) were cultured in Dulbecco's Modified Eagle Medium 
(DMEM, Gibco) with high glucose and with L-glutamine, supplemented with 15% 
(v/v) inactivated FBS (Gibco), 100 U/mL penicillin G and 100 µg/mL streptomycin 
(Gibco). The cells were maintained at 37ºC in a humidified 5% CO
2
 atmosphere 
until 90% confluence was reached. For each experiment, endothelial cells (ECs) 
and fibroblasts (FBs) were used at passages 6-8 and the culture medium was 
changed every 2 days.  
 
2.2. Preparation of modified alginate 
 
The alginate gel for cell immobilization was prepared according to the methods 
previously described by Evangelista et al. with minor modifications (14). Briefly, 
Protanal LF 20/40 sodium alginate (gift from FMC Biopolymers, Oslo, Norway) 
was used as high molecular weight (high content of guluronic acid units, high 
MW) component to prepare alginate microspheres. To obtain the low molecular 
weight (low MW) alginate γ-irradiation with a cobalt-60 source at a dose of 5 
Mrad was used, as previously described by Kong et al. (27). Alginate was then 
purified through dialysis (MWCO 3500 membrane, Spectra/Por®) against distilled 
and deionized water for 3 days. After, sodium periodate was used for alginate 
oxidation, as previously described (6). Finally, oligopeptides with a sequence of 
(Glycine)
4
-arginine-glycine-Aspartic acid-serine-proline (abbreviated as G
4
-RGDSP; 
Peptides International, USA) were covalently grafted to the oxidized alginate 
(16.7 mg of peptide per gram of alginate) by using the aqueous carbodiimide 
chemistry (37). After reaction for 24 h the alginate was purified by dialysis 
(MWCO 3500 membrane, Spectra/Por®), and then filtered, lyophilized and stored 
at -20ºC until further use. In the present experiments, a 2 wt-% RGD-modified 
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alginate solution in 0.9 wt-% NaCl (Sigma) was used, corresponding to a 50:50 
mixture of oxidized and RGD-modified alginate (25 wt-% high MW, 75 wt-% low 
MW) and unmodified high MW purified alginate (14). 
 
2.3. Immobilization and culture of cells within alginate microspheres 
 
Cells were tripsinized with 0.05% (w/v) trypsin/EDTA solution (Gibco), and the 
cell pellet was then resuspended in 0.9 wt-% NaCl (Sigma) solution and 
centrifuged in a 5 mL syringe. Afterwards, the cells were carefully homogenized 
with the 2 wt-% RGD-alginate in 0.9 wt-% NaCl solution using a dual-syringe 
system (5,14). A cell density of 20x106 cells/mL of RGD-alginate solution was 
used (5). Subsequently, the mixture prepared was extruded under a coaxial 
nitrogen flow using a Var J1 encapsulation unit (Nisco, Switzerland) at a speed of 
40 mL/h (Single-syringe infusion pump, Cole Parmer). The RGD-alginate 
microspheres were allowed to form in an isotonic 0.1 M CaCl
2
 solution, and were 
kept therein for 10 min. The microspheres thus obtained were rinsed in Tris-
buffered saline (TBS), followed by rinsing in culture medium. All microspheres 
produced were uniformly spherical (diameter of c.a. 800 µm). RGD-alginate 
microspheres containing cells were then cultured in dynamic culture conditions 
using 100 mL spinner flasks (Bellco Biotechnologies, Vineland, USA) maintained 
at 37ºC under a 5% v/v CO
2
 humidified atmosphere. The culture medium was 
changed every three days. RGD-alginate microspheres without cells were also 
prepared as a control and maintained in the same conditions. After 
immobilization, RGD-alginate microspheres containing ECs were cultured in the 
presence of 5 ng/mL of recombinant vascular endothelial growth factor (VEGF, 
from Biomedical Technologies Inc., USA), or 5 ng/mL VEGF combined with 5 
ng/mL recombinant basic fibroblast growth factor (bFGF, from Sigma, Portugal).  
 
2.4. Diffusional study 
 
The purpose of the diffusional study was to assess the diffusion of substances 
with distinct molecular weights into the RGD-alginate microspheres, namely 
albumin (Mw 6.9x104) and lysozyme (Mw 14.3x103). Microspheres were placed in 
a 15 mL centrifuge tube filled with a mixture of 7.5 mL of Tris-buffered saline 
(TBS, pH 7.4) and 0.25% of the diffusing solute (albumin or lysozyme, Sigma), as 
previously described by Orive et al. (33). At 15, 45 and 75 min, a 2 mL sample 
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was taken from the RGD-alginate microsphere suspension and analysed to 
measure the solute concentration. All diffusion experiments were performed 
under stirred conditions and in a 37ºC incubator. Albumin and lysozyme were 
measured by the micro BCA assay (41). 
 
2.5. Uptake of Dil-ac-LDL by endothelial cells 
 
Cells were incubated with fluorescent acetylated low-density lipoprotein (Dil-ac-
LDL, from Biomedical Techologies Inc., USA), a specific marker for endothelial 
cells. After 4 h of incubation (10 µg/mL medium) at 37°C, the medium 
containing Dil-Ac-LDL was removed and the cells were washed with probe-free 
medium. Immediately, the microspheres were visualized using a confocal laser 
scanning microscope (CLSM, Leica SP2 AOBS; Leica Microsystems) and LCS 
software (Leica Microsystems). 
 
2.6. Metabolic activity by resazurin assay 
 
The resazurin assay measures the innate metabolic activity of cells by assessing 
the fluorescence-intensity increase associated with the cellular reduction of 
resazurin to resorufin. Cell metabolic activity was assessed by culturing cells in 
10% (v/v) resazurin solution (Sigma) for 4h at 37°C. Afterwards, 100 µL/well 
were transferred to a 96-well black plate and fluorescence was measured at the 
excitation and emission wavelengths of 530 nm
Ex
 and 590 nm
Em
 in a Spectra Max 
Gemini XS (Molecular Devices). To allow recovery of cells immobilized in RGD-
alginate, 50 mM ethylenediamine tetraacetic acid (EDTA) solution in phosphate 
buffered saline (PBS, pH 7.4) for 5 min, was used.  
 
2.7. Cell viability by Flow Cytometry 
 
Apoptosis was determined using Annexin V-FITC staining (BD PharmingenTM) 
according to the manufacturer’s instructions. Propidium iodide (PI) is a standard 
flow cytometry viability probe and is used to distinguish viable from nonviable 
cells. Cells staining positive for annexin V-FITC and negative for PI are 
undergoing apoptosis. Samples of microspheres were transferred to a 24-well 
plate and incubated with 50 mM EDTA solution in PBS (pH 7.4) for 5 min to 
dissolve alginate and recover the cells, as previously described. Cells were then 
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washed in PBS and centrifuged at 1200 rpm for 5 min. Cells were then 
resuspended in 1x binding buffer at a concentration of 1x106 cells/mL. After 
transferring 100 µL of the solution (1x105 cells) to a tube, 5 µL of annexin V-
FITC and 5 µL of PI were added followed by incubation for 15 min at room 
temperature in the dark. Afterwards, 400 µL of 1x binding buffer were added to 
each tube and 1x104 cells were used for this analysis. Data was collected with a 
flow cytometer (FACS Calibur, Becton Dickinson) and analyzed with FlowJo 
software.  
 
2.8. Preparation of conditioned medium 
 
Conditioned culture medium was obtained by culturing ECs (CMECs) or FBs 
(CMFBs) during 24h in M199 medium supplemented with 10% FBS, 80 µg/mL 
heparin, 30 µg/mL ECGS, penicillin G (100 U/mL), and streptomycin (100 
µg/mL). The media were collected, centrifuged at 1200 rpm, during 5 min, and 
the supernatant frozen at -20ºC. Both cell types were separately plated at a 
density of 8x103 cells/cm2. After 24h incubation, media were changed: ECs were 
incubated in CMFBs and FBs were incubated in CMECs. Freshly prepared media 
were used as control for each cell culture. The metabolic activity of cells was 
then assessed by the Rezasurin assay upon a 24h incubation period.  
 
2.9. Co-culture of endothelial cells and fibroblasts in indirect contact 
 
FBs (3x103 cells) were seeded on the bottom of 24-well tissue culture plates and 
incubated for 24h. Afterwards, transwells with a membrane of 0.8 µm pores (BD 
Science) were coated with 50 µL of growth factor reduced-Matrigel® (GFR-
Matrigel, BD Biosciences) and incubated for 30 min at 37ºC (cf. Fig. 5A). Then, 
ECs (3x103 cells) were seeded on top of the transwell insert, in indirect contact 
with the FBs in M199 medium supplemented with 10% FBS, 80 µg/mL heparin, 
30 µg/mL ECGS, penicillin G (100 U/mL), and streptomycin (100 µg/mL). After 
24h of incubation, cell metabolic activity was measured by the resazurin assay 
and the assembly of capillary-like structures was monitored by microscopic 
analysis (Axiovert 200M, Zeiss). 
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2.10. Assessment of capillary-like structures formation and stability 
 
To assess the influence of FBs immobilized within RGD-alginate microspheres on 
capillary-like structures formation and development, a 3D assay was performed 
using growth factor reduced-Matrigel® (GFR-Matrigel, BD Biosciences)-coated 
plates, after adaptation from Soares et al. (42). Briefly, 200 µL of GFR-Matrigel® 
were added to a 24-well plate and incubated at 37º for 30 min to form a gel 
layer. Subsequently, RGD-alginate microspheres with or without (control) FBs 
were added to the well (approximately 54 ± 4 microspheres per well). Again, 
200 µL of GFR-Matrigel® were added to the samples and incubated at 37º for 30 
min. Afterwards, ECs (5x103 cells) were cultured on top of this gel in M199 
medium. Under these conditions, ECs are known to assemble into capillary-like 
structures after 24h (42). A semi-quantitative measurement of the structures 
formed was carried out as previously described (5,42). The plates were 
photographed after 1 and 5 days post incubation using an inverted microscope 
(Axiovert 200M, Zeiss). The capillary-like structures formed were then counted 
in each well and the length was measured using imageJ64.  
 
2.11. Ex-vivo assessment of sprouting using the aortic ring assay 
 
The aortic ring assay was performed as a microvessel outgrowth analysis. 
Thoracic aortae were removed from normal Wistar rats and washed in PBS. After 
fibroadipose tissue removal, aortas were cross-sectioned (approximately 2 mm), 
washed in cell media and embedded on GFR-Matrigel® (BD Biosciences). First, 
200 µL of GFR-Matrigel® were added to a 24-well plate and incubated at 37º for 
30 min to form a gel layer. Afterwards, a single aorta section was placed in one 
side of the well. In the opposite side RGD-alginate microspheres with or without 
(control) FBs were added. Again, 200 µL of GFR-Matrigel® were added to the 
samples and incubated at 37º for 30 min. The aorta section and the 
microspheres were then cultured together in M199 supplemented with 10% FBS. 
Four days after incubation, vascular sprouting from aortic rings was then 
visualized on an inverted microscope (Axiovert 200M, Zeiss) and photographed. 
The composite images of aortic ring assays were created by using the 
photomerge tool (Photoshop CS4) to merge all the photos taken from the same 
well. The area of the sprouting in the microphotographs were identified using an 
image J64 and contrast was created to clearly identify the microvasculature. 
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Animal experiments were conducted according to accepted standards of animal 
care (Declaration of Helsinki, European Community guidelines 86/609/EEC) and 
Portuguese Act 129/92) for the use of experimental animals.  
 
2.12. Statistical analyses 
 
All experiments were performed in triplicate. Quantifications are expressed as 
mean ± standard deviation (SD). Statistical significance of difference between 
various groups was evaluated by analysis of variance (ANOVA) followed by 
Bonferroni test. For comparison between two groups the Student’s t-test was 
used. A difference between experimental groups was considered significant with 
a confidence interval of 95%, whenever p<0.05. 
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3. Results 
 
3.1. Immobilization of endothelial cells and fibroblasts inside RGD-alginate 
microspheres 
 
After immobilization of ECs (Fig. 1A) or FBs (Fig. 1B) within RGD-alginate, 
homogeneous and spherical microspheres were obtained. In order to investigate 
if immobilized cells were having access to nutrients available in the medium, 
RGD-alginate microspheres without cells (Fig. 1C) were used. For that purpose, 
diffusional studies were carried out using two different solutes - albumin and 
lysozyme. The results evidence that both solutes investigated were able to 
diffuse into the microspheres and reach their equilibrium states at 15 min (Fig. 
1D). This data indicates that low molecular weight compounds diffused into the 
microspheres. 
 
3.2. Metabolic activity and viability of immobilized cells  
 
The immobilization of ECs within RGD-alginate may represent an in vitro model 
to study the effect of growth factors in the metabolic activity of these cells in a 
3D microenvironment. In our previous studies, ECs immobilized alone during 
one week within RGD-alginate microspheres presented decreased metabolic 
activity (21). In order to assess the effect of growth factors produced by FBs in 
the metabolic activity of immobilized ECs the resazurin assay was used as 
demonstrated in Fig. 2A. ECs immobilized in RGD-grafted alginate microspheres 
were cultured in medium supplemented with 5 ng/mL VEGF or with the same 
concentration of VEGF combined with 5 ng/mL bFGF. Additionally studies of dil-
ac-LDL incorporation were performed in order to evaluate cell distribution. 
Results reveal that EC immobilized within RGD-alginate microspheres, in 
medium supplemented with VEGF, were homogenously distributed and that 
viable cells indeed incorporated the dil-ac-LDL dye, as illustrated at day 3 (Fig. 
2B). For both conditions, the metabolic activity of immobilized ECs decreased 
during the period analyzed. However, the medium supplemented with the two 
growth factors provided a statistically significant improvement, which was 
higher at day 6, comparing to immobilized ECs cultured only in medium with 
VEGF (p<0.05 vs VEGF alone). 
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A      B 
  
C D 
  
  
Figure 1. ECs and FBs immobilized in RGD-alginate microspheres. Photomicrographs of RGD-
grafted alginate microspheres at day 4, illustrating the spherical and uniform shape of: (A) 
immobilized ECs; (B) immobilized FBs; and (C) without cells (control). Bar=500µm. (D) 
Quantification of albumin and lysozyme diffusion from the TBS solution into the RGD-alginate 
microspheres. Results are expressed as means±SD of at least three independent experiments.  
 
 
The effect of cell apoptotic and necrotic activities was also assessed by flow 
cytometry analysis. Therefore, cells were labeled for annexin V FITC (apoptosis 
marker) and propidium iodide (PI, a necrosis marker). Cells that, during this 
period of time, were negative for both annexin V and PI corresponded to the 
population of viable cells. Apoptotic cells were positive for annexin V and 
negative for PI, while necrotic cells were positive for both annexin V and PI. Flow 
cytometry analysis of ECs immobilized in alginate microspheres and cultured, 
during 6 days, in medium supplemented with VEGF alone revealed only 12% of 
viability (Fig. 2C). Their viability considerably increased to 85%, in the same 
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conditions, when the medium was supplemented with VEGF in combination with 
bFGF (Fig. 2D).  
 
 
 
A 
B 
  
  
C D 
 
 
 
 
Figure 2. (A) Metabolic activity of ECs after immobilization in RGD-grafted alginate 
during 6 days, as assessed by the Resazurin assay. Immobilized ECs were cultured in the 
presence of 5 ng/mL of VEGF or 5 ng/mL of VEGF combined with 5 ng/mL bFGF. An 
increase in metabolic activity was observed, during 6 days in culture, upon combination 
of VEGF with bFGF. Bars correspond to the mean ± SD, in comparison to control 
(immobilized ECs at day 0), n=3, *p<0.05. (B) Dil-labeled low density lipoprotein (Dil-Ac-
LDL) uptake by ECs, in medium supplemented with VEGF, at day 3, visualized using a 
confocal laser scanning microscope (bar=150 µm). (C) Flow cytometry data, at day 6, of 
ECs immobilized in RGD-grafted alginate and cultured in the presence of 5 ng/mL of 
VEGF. (D) Flow cytometry data, at day 6, of ECs immobilized in RGD-grafted alginate and 
cultured in the presence of 5 ng/mL of VEGF and 5 ng/mL of bFGF. The results were 
express in terms of percentage of cells expressing these markers.  
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When FBs were immobilized within RGD-alginate microspheres and cultured 
during 14 days their metabolic activity was also evaluated by the resazurin assay 
and the viability and apoptosis by flow cytometry analysis. Contrary to ECs, most 
of the immobilized FBs are autosufficient to maintain their metabolic activity 
during the whole experiment (Fig. 3A). Fig. 3B illustrates that immobilized 
fibroblasts present still approximately 69% viability at day 14 of culture. 
 
  
A B 
 
Figure 3. (A) Metabolic activity of fibroblasts after immobilization in RGD-grafted, as 
assessed by the Resazurin assay. These cells maintained their metabolic activity during 
14 days of culture. Bars correspond to the mean ± SD, in comparison to control 
(immobilized fibroblasts at day 0), n=3, *p<0.05 (B) Flow cytometry data of fibroblasts 
immobilized and cultured in RGD-grafted alginate during 14 days. The cells were labeled 
for annexin V FITC and propidium iodide. The results were expressed in terms of 
percentage of cells expressing these markers. 
 
 
3.3. Metabolic activity of cells using conditioned media 
 
In order to examine whether ECs or FBs, in 2D culture, affect each others 
metabolic activity in a paracrine manner, conditioned medium of each cell 
culture was obtained and used in the other cell culture. This effect was 
compared with control ECs or FBs cultured in fresh medium. In comparison to 
the control, conditioned medium from FBs (CMFBs) increased (p<0.05 vs control) 
the metabolic activity of ECs (Fig. 4). An increase in metabolic activity can also 
be observed in Fig. 4, in which FBs were cultured in the presence of conditioned 
medium from ECs (CMECs) (p<0.05 vs. control). 
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Figure 4. Metabolic activity of ECs or FBs in conditioned media. ECs were incubated 
during 24h in conditioned medium from fibroblasts (CMFBs) or in freshly prepared 
media (-, control). FBs were incubated during 24h in conditioned medium from EC 
(CMECs) or in freshly prepared media (-, control). Results are expressed as percentage of 
metabolic activity of cells in control media. Bars represent mean ± SD (n=3, *p<0.05 vs 
control). 
 
 
3.4. Capillary-like structures formation in co-cultures in indirect contact 
 
A transwell culture system was used to examine if FBs can influence the 
formation and organization of capillary-like-structures in indirect contact with 
ECs. For this purpose, FBs were cultured on the lower chamber of 24-well plates, 
and ECs were placed on a transwell insert coated with 50 µL of growth factor 
reduced (GFR)-Matrigel® (Fig. 5A). ECs co-cultured with FBs in indirect contact 
experienced a slight decrease in metabolic activity when compared to ECs in 
GFR-Matrigel® alone (Fig. 5B). However, the number of capillary-like-structures 
formed by ECs in GFR-Matrigel® when in co-culture with FBs was significantly 
higher than by ECs alone (Fig. 5C). 
 
Chapter II 
 
 
61 
 
A 
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Figure 5. Co-cultures of ECs with FBs in transwells. (A) The FBs were cultured on the 
bottom and ECs were cultured on top of Matrigel-coated transwell inserts. (B) Metabolic 
activity of ECs cultured alone or in the presence of FBs (ECs+FBs, co-culture) during 24h; 
(C) Semi-quantification of the number of capillary-like structures formed during 24h. 
Bars correspond to the mean ± SD (n=3, *p<0.05). 
 
 
3.5. Capillary-like structures formation by influence of immobilized FBs 
 
The GFR-Matrigel® assay was used to assess if the ability of ECs to form capillary-
like structures would be influenced by the presence of FBs. In Fig. 6A, the 
formation of capillary-like structures can be observed with ECs attaching and 
spreading to form typical polygonal forms after 24h. After 5 days of culture in 
GFR-Matrigel® the ability of ECs to form capillary-like-structures was not 
maintained (control ECs). On the contrary, the presence of fibroblasts 
immobilized within RGD-alginate (iFBs) maintained the assembly of ECs into 
capillary-like structures even after 5 days of culture (Fig. 6A). In the presence of 
iFBs a significant increase in the number of capillary-like structures formed 
could be observed, both at days 1 and 5, compared to the control (Fig. 6B).  
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Figure. 6. Effect of fibroblasts immobilized within RGD-alginate on formation of 
capillary-like structures by neighboring ECs. (A) After 1 day of culture, ECs formed 
capillary-like structures and after 5 days of culture only ECs on matrigel in the presence 
of immobilized fibroblasts (ECS+iFBs, arrow) maintained the capillary-like structures 
formation (Bar=500µm). (B) Quantification of capillary-like structures formation. (C) 
Quantification of the length of capillary-like structures formed after one day. Results are 
means±SD of independent experiments (n=3, *p<0.05). 
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Furthermore, after 5 days a significant decrease in the number of capillary-like 
structures in the control condition could be quantified, compared to day 1. 
However, in the presence of iFBs, ECs maintained the capillary network even 
after 5 days of culture. The length of capillary-like structures formed was also 
quantified at day 1. When ECs were cultured in the presence of immobilized FBs, 
a significant increase in capillary-like structures length was observed (p<0.05), 
in comparison to the control (Fig. 6C). Taken together, these data suggest that 
immobilized fibroblasts support and preserve the capillary network. 
 
3.6. Ex-vivo sprouting by influence of immobilized FBs 
 
To further examine the effect of FBs in the angiogenic process, and considering 
that, in vivo, it also involves other cell types, such as smooth muscle cells, an 
approach with increased complexity was used, namely the aortic ring sprouting 
assay. Aortic rings were cultured in GFR-Matrigel® in the presence or absence of 
FBs immobilized in RGD-alginate (Fig. 7). The distance between the 
microspheres and the aortic ring was of approximately 6 mm (Fig. 7C). 
Sprouting of vessels was observed in both cases. However, in the absence of FBs 
(control), the sprouting scattered throughout the whole aortic ring (Fig. 7A). In 
the presence of immobilized FBs, sprouting of new capillaries was preferentially 
oriented towards the microspheres containing immobilized FBs (Fig. 7B). The 
overall area of sprouting was also quantified using image J, showing a decrease 
when FBs were present and compared to the control (Fig. 7D).  
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Figure 7. Effect of fibroblasts immobilized within RGD-alginate in capillary-like 
structures sprouting. Representative images of aortic ring at day 4 in the presence of 
microspheres of RGD-alginate: (A) without fibroblasts (control) and (B) with fibroblasts. 
(C) Scheme of well with aortic ring and RGD-alginate microspheres. (D) Quantification of 
the area of sprouting. Results are means±SD (n=3, *p<0.05). Bar=500µm. 
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4. Discussion 
 
In tissue regeneration research, the use of models that mimic physiological 
conditions to test new strategies is of paramount importance since it depends 
on a number of intricate interactions between distinct cell types, growth factors 
and ECM components. One example is the formation of vessels, which is only 
possible in 3D assays of angiogenesis, a fundamental but yet unresolved 
problem in tissue regeneration. Interactions between mesenchymal and 
epithelial cells are known to play an important role in orchestrating the 
development and morphogenesis of tissues and organs (8). Bone cells of 
mesenchymal origin have been shown to exert a reciprocal influence on 
endothelial cells (4,18,21,25,45,46). Therefore, in the context of angiogenesis, 
it seems relevant to study how fibroblasts (FBs), which are committed 
mesenchymal cells, could influence the microenvironment of endothelial cells to 
trigger their assembly into capillary-like structures, and thus contributing to the 
regenerative process by promoting angiogenesis. Beyond the roles usually 
attributed to fibroblasts, namely contribution to pathological tumor 
development or fibrosis (26,29), these cells can also be advantageous in 
therapeutic applications since they are highly abundant, scattered throughout 
the organism and can be easily isolated in a noninvasive and patient-specific 
manner (40).  
The present study investigated the modulation of endothelial cells (ECs) 
behaviour by fibroblasts (FBs) in terms of viability, metabolic activity and ability 
to form capillary-like structures in 3D models. In our study, the effect of 
supplementing the medium of ECs with a combination of VEGF and bFGF 
showed a synergistic effect of the two growth factors in improving metabolic 
activity of ECs immobilized in RGD-alginate microspheres. VEGF alone did not 
promote the same effect. FBs secrete a number of growth factors, such us bFGF 
and VEGF (30,36) and Presta et al. presented evidence suggesting the possibility 
that bFGF indirectly induces neovascularization by activation of the VEGF/VEGFR 
system (35). Our results are in agreement with Korff et al., who showed additive 
effects of VEGF and bFGF in decreasing apoptosis in spheroid endothelial cell 
clusters (28). The VEGF family has been described as assuming a pivotal role 
during embryonic development in vasculogenesis and angiogenesis (15). Soluble 
factors produced by FBs, such us VEGF and bFGF, are required for ECs survival, 
differentiation, and network formation (30), although their function decreases 
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during time in culture (9). Therefore, the transplantation of co-cultures is hereby 
appointed as a better strategy rather than growth factor delivery.  
The use of co-cultures in tissue engineering is related with the fact that both cell 
types may support survival and growth of each other (11,21). In the present 
work, conditioned media from ECs and FBs demonstrated that both cell types 
produced soluble factors capable of influencing the metabolic activity of the 
other cell type, indicating the reciprocal inter-relationship between these two 
types of cells. Nevertheless, when ECs were cultured in GFR-Matrigel® and in the 
same chamber with FBs but in indirect contact, the metabolic activity of ECs did 
not change significantly, which can be explained by the fact that ECs were at 
different stages of development, namely proliferation or differentiation, thus 
exhibiting different levels of metabolic activity.  
Proliferation or differentiation of ECs can be influenced by the 3D environment, 
presence of growth factors or presence of other cell types, such as FBs. 
According to Kunz et al. (30), in spheroid co-cultures of ECs and FBs low viability 
is not found in areas where ECs can migrate and form capillary-like-structures in 
the spheroids. Korff and Augusting (28) investigated a similar model, showing 
that cells at the surface monolayer of spheroids differentiated to a degree that 
rendered them survival factor-independent, although dependence on survival 
factors was observed concerning the unorganized cells in the spheroid center 
(28).  
Having this in mind, co-cultures of ECs and FBs were used to study the influence 
of FBs immobilized within RGD-alginate in ECs viability and organization. 
Previous work from the present team showed that other cell types, namely 
preosteoblasts (MC3T3) (14) and human osteoprogenitor cells (5,21), can be 
stably immobilized in RGD-alginate, and maintained viable during long periods 
of time (29 days). These findings were confirmed in the present study, since 
fibroblasts immobilized in RGD-alginate microspheres during 14 days kept their 
high viability. The presence of the RGD sequence promoted cell adhesion to 
alginate and probably mediated survival signals that involve α
V
β
3
 integrin 
signaling pathways (2,14,21,34). Integrins are known to play a central role in 
neovascularization, being α
V
β
3
 integrin even considered a target for the 
development of anti-angiogenic therapies in cancer (35). In EC maturation and 
vessel wall assembly, ECM synthesis is a critical step. Previously, the production 
of collagen by MC3T3 cells, fundamental in the differentiation step, has been 
reported as significantly higher within RGD-alginate microspheres than in 
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unmodified alginate ones (14). Singh et al. found that FBs immobilized in 
alginate could produce collagen type I and, under adequate conditions, namely 
combination of hypoxia, BMP-2 supplementation, and long-term intermittent 
application of dynamic hydrostatic pressure, could be differentiated into the 
chondrogenic pathway (40). Additionally, Levenberg et al. suggested a close 
relationship between neosynthesis of ECM and increasing levels of VEGF 
secreted by FBs in the formation and maintenance of microvasculature (31). 
In the present work the GFR-Matrigel® assay demonstrated that FBs immobilized 
within RGD-alginate were capable of influencing the formation of capillary-like 
structures by neighboring ECs, which is in agreement with our previous studies 
demonstrating similar results when using human mesenchymal stem cells (5). 
The length of capillary-like structures formed in the presence of immobilized FBs 
was higher than when ECs were cultured alone. Nevertheless, after 5 days of 
culture only the network formed in the presence of immobilized FBs was 
maintained. The preservation of the capillary like-structures with time is a 
fundamental issue in tissue regeneration. These results suggest that growth 
factors produced by FBs could act in a paracrine manner to induce and maintain 
capillary-like structures. Also, the ability of FBs to contribute to ECs survival and 
vessel assembly is probably closely related to their capacity to produce new ECM, 
thus creating a more adequate environment for capillary structure formation and 
maintenance. Grajar et al. reported that FBs stimulate ECs to form mature 
capillary networks and that this FBs-mediated capillary morphogenesis is 
dependent from matrix metalloproteinase production (20).  
Given the complexity of the angiogenesis process, namely the existence of other 
structures and cells types besides ECs and FBs, such as pericytes and smooth 
muscle cells, the aortic ring assay was used to further assess the influence of 
immobilized FBs in the formation of capillary-like structures. The results suggest 
that the presence of immobilized FBs induced significant changes in the 
formation of capillary-like structures by ECs, namely a decrease in the overall 
area of sprouting of ECs when immobilized FBs were present, although, in the 
presence of FBs, the new capillaries formed showed a preferential orientation 
towards the microspheres containing FBs. Probably, a gradient of growth factors 
(e.g. bFGF) was produced by the immobilized FBs, directing sprouting. Soluble 
factors, like bFGF and other established angiogenic factors, can promote 
endothelial cell scattering during the first steps of the angiogenesis process and, 
along with the formation of cell-cell interactions, are required phenomena for 
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vessel maturation (35,44). For instance, bFGF has been reported to initially 
promote the disruption of the basal lamina by inducing protease production of 
various ECM components by ECs (19), thus contributing to the maturation of the 
vessels (35). The present study was able to show that FBs immobilized in RGD-
alginate improved the heterotypic interactions within the microenvironment, 
resulting in a direct mechanism required for capillary formation.  
 
 
5. Conclusions 
 
The current study used different angiogenesis assays to test the influence of 
fibroblasts in the vascularization process. This study demonstrated the ability of 
FBs immobilized in RGD-alginate to modulate and support capillary-like 
structures assembly by endothelial cells. Taken together, these findings indicate 
that the microenvironment created by these stromal cells in the scaffold 
modulates capillary morphogenesis, thus stimulating angiogenesis in situ and 
can potentially be used in tissue regeneration strategies, in clinical scenarios 
where vascularization is essential. 
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Abstract 
 
Interactions between the different cell-types, growth factors and extracellular 
matrix components involved in angiogenesis are crucial in the mechanisms of 
new vessel formation for tissue regeneration.  The aim of the present study was 
to investigate if cocultured fibroblasts and endothelial cells (from macro- or 
microvasculature) could modulate growth factor production (VEGF, bFGF, TGF-β1 
and IL-8), influence the formation of microcapillary-like structures by endothelial 
cells and affect fibroblast differentiation. Results obtained show that the two 
cells types interact with each other through exchange of growth factors (e.g., 
fibroblasts produce VEGF, which is known to influence angiogenesis). 
Fibroblasts promoted the formation and organization of capillary-like structures 
by endothelial cells, increased the amount of collagen in the cocultures and 
determined the expression of alkaline phosphatase. High alkaline phosphatase 
expression could be co-localized with capillary-like structures and the 
interaction between the two cells types induced fibroblast activation near 
microvessel-like structures.  
 
Keywords: Alkaline phosphatase, angiogenesis, collagen, endothelial cells, 
fibroblasts, growth factors, regenerative medicine, tissue engineering. 
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1. Introduction 
 
The formation of new blood vessels to support tissue growth and/or 
homeostasis in cancer or after injury and trauma is a critical issue in new 
therapeutic approaches in regenerative medicine. From the parallelism in the 
first steps of tissue regeneration, cancer and embryogenesis it is clear that 
vascularization is needed for tissue growth and development [1-3], as this allows 
the exchange of nutrients, gases and growth factors between blood and tissue. 
However, in tissue regeneration the establishment of a functional vascular 
system is a milestone yet to be achieved [4]. Stromal cells are of paramount 
importance in tissue regeneration in the adult, but their role in vascularization is 
still poorly understood [4-6]. 
Stromal cells, like fibroblasts, secrete growth factors, such as vascular 
endothelial cell growth factor (VEGF) [7, 8], basic fibroblast growth factor (bFGF) 
[9], transforming growth factor beta (TGF-β) [10] and interleukin 8 (IL-8) [11], 
that may act in a paracrine manner to modulate the healing process. Fibroblasts 
produce collagen, thereby creating a new matrix to fill a defect in the injured 
site [10] and to allow migration and sprouting of endothelial cells (ECs) to 
vascularize the newly formed tissue. The extracellular matrix (ECM) is a key 
factor for successful angiogenesis [12, 13]. Collagens form one of the major 
protein families in the ECM and can drive ECs migration by both chemotaxis and 
haptotaxis [13]. Recent findings in tissue engineering suggest that fibroblasts 
have important roles in orchestrating the angiogenic process [14-16] and in 
regulating the associated immune responses [17, 18]. Fibroblasts are connective 
tissue cells and have been shown to exhibit plasticity by differentiating into 
other members of the connective tissue family, including cartilage, bone, 
adipose tissue and smooth muscle cells [17]. So far, it is not clear if fibroblasts 
present within the connective tissue, besides maintaining the ECM and 
connective tissue homeostasis, also act as tissue-resident progenitors cells [19, 
20].  
The communication between different cell types also plays a paramount role in 
the regeneration process. Coculture systems constitute a promising instrument 
to mimic physiological processes in tissue regeneration and vascularization and 
may provide new insights into the underlying molecular mechanisms [21]. 
Cocultures of human mesenchymal stem cells/ECs [21-23], osteoblasts/ECs [12, 
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24], fibroblasts/ECs [4, 25], adipocytes/ECs [26, 27], smooth muscle cells/ECs 
[28], pericytes/ECs [29], fibroblasts/macrophages [5] and fibroblasts/ 
osteoblasts [30] show that the behavior of each cell type in terms of 
proliferation, migration and differentiation can be modulated in the presence of 
another cell type. It appears that fibroblasts are not just passive players in the 
angiogenesis process, and thus their coculture with ECs may further elucidate 
the contribution of fibroblasts to this important phenomenon. 
The present study was aimed at investigating if fibroblasts in coculture with ECs, 
in indirect and direct contact, could modulate the vascularization process. ECs 
from macro- and microvasculature were used. The present findings show that 
fibroblasts influence the formation and organization of capillary-like structures 
by ECs, through the exchange of relevant growth factors, production of collagen 
and expression of alkaline phosphatase. Areas with co-localization of high 
expression of ALP and the presence of capillary-like structures are here 
described for the first time. 
 
 
  
Chapter III 
 
 
80 
 
2. Materials and Methods 
 
2.1. Cell cultures 
 
Human umbilical vein endothelial cells (HUVECs) were isolated from donors 
according to a previously described protocol [31] and cultured in M199 medium 
(Sigma-Aldrich, Germany), supplemented with 20% fetal calf serum (FCS, 
Invitrogen, Germany), 2 mM Glumatax I (Sigma-Aldrich, Germany), 25 µg/mL 
sodium heparin (Sigma-Aldrich, Germany) and 25 µg/mL endothelial growth 
factor supplement (ECGS; Becton Dickinson, USA), penicillin G (100 U/mL, 
Invitrogen, Germany) and streptomycin (100 µg/mL, Invitrogen, Germany). 
Human dermal microvascular endothelial cells (HDMECs) were isolated from 
juvenile foreskin and cultured in endothelial cell basal medium MV (PromoCell, 
Germany) supplemented with 15% FCS (Invitrogen, Germany), basic fibroblast 
growth factor (bFGF, 2.5 ng/mL, Sigma-Aldrich, Germany), sodium heparin (10 
µg/mL, Sigma-Aldrich, Germany), penicillin G (100 U/mL, Invitrogen, Germany) 
and streptomycin (100 µg/mL, Invitrogen, Germany) [32]. HUVEC and HDMEC 
were cultured until confluence in culture flasks coated with 0.2% gelatin (Sigma-
Aldrich, Germany), in a humidified atmosphere at 37ºC (5% CO
2
), and used at 
passage 4. 
Human dermal fibroblasts (HDFs) were isolated from juvenile foreskin and 
cultured in Dulbecco’s modified eagle’s medium (DMEM) with 45000 mg/L 
glucose (Sigma-Aldrich, Germany), 10% FCS (Invitrogen, Germany), penicillin G 
(100 U/mL, Invitrogen, Germany), streptomycin (100 µg/mL, Invitrogen, 
Germany) and 2 mM Glutamax I (Life Technologies, Germany). Cells were 
cultivated in a humidified atmosphere at 37ºC (5% CO
2
) and used at passage 4.  
 
2.2. Cocultures of endothelial cells and fibroblasts 
 
Cocultures of HUVECs/HDFs and HDMECs/HDFs were prepared in endothelial 
cell basal medium MV (PromoCell, Germany) supplemented with 15% FCS 
(Invitrogen, Germany), bFGF (2.5 ng/mL, Sigma-Aldrich, Germany), sodium 
heparin (10 µg/mL, Sigma-Aldrich, Germany), penicillin G (100 U/mL, Invitrogen, 
Germany) and streptomycin (100 µg/mL, Invitrogen, Germany). Monocultures of 
HUVECs, HDMECs and HDFs were cultured in the same medium as a control for 
the different time periods studied.  
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2.2.1. Cocultures in indirect contact  
 
To determine the effects of indirect contact, cocultures of HUVECs or HDMECs 
with HDFs and monocultures of HUVECs, HDMECs and HDFs were cultured in 24-
well plate transwell with a pore size of 0.4 µm and with one individual cell-type 
seeded on each side of the membrane (HTS Transwell®, Corning, Germany). 
Firstly, HDFs (5x103 cells) were cultured on the bottom of the membrane. After 
2h, the plate was the turned and 100 µL of collagen type I (0.03 mg/mL, BD 
Biosciences, Germany) were added to the top of the transwell. After 1h at 37ºC 
HUVECs or HMDECs (15x103 cells) were added to the top of the coated 
membrane. Finally, membranes were inverted and endothelial cell basal medium 
MV (PromoCell, Germany) supplemented with 15% FCS (Invitrogen, Germany), 
bFGF (2.5 ng/mL, Sigma-Aldrich, Germany), sodium heparin (10 µg/mL, Sigma-
Aldrich, Germany), penicillin G (100 U/mL, Invitrogen, Germany) and 
streptomycin (100 µg/mL, Invitrogen, Germany) was added to the top and to the 
bottom chambers. After various incubation times the medium was collected and 
stored at -20ºC until further use. 
 
2.2.2. Cocultures in direct contact 
 
Cocultures of HUVECs or HDMECs with HDFs and monocultures of HUVECs, 
HDMECs and HDFs were cultured in 24 well-culture plates coated with 0.2% 
gelatin (Sigma, Germany). ECs and HDFs were seeded at the same time to the 
culture plate and cultured using the ratio of 2x104 ECs:1x104 HDFs.  For 
immunoflurescent staining, cocultures and monocultures were seeded onto 
Thermanox coverslips (13 mm, Nunc, Germany) and cultured in 24-well culture 
plates. After different time periods the medium was collected and kept at -20ºC 
until further analysis.  
 
2.3. Protein concentration by enzyme-linked immunosorbent assay (ELISA) 
 
As previously mentioned, culture supernatants collected from HUVECs, HDMECs 
and HDFs monocultures, as well as from HUVECs/HDFs and HDMECs/HDFs 
cocultures, were collected and stored at -20ºC. For cocultures in transwells 
(indirect coculture) the time points were 1 and 7 days. For cocultures in direct 
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contact the time points were 7, 14 and 21 days. The concentration of vascular 
endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), 
interleukin-8 (IL-8) and transforming growth factor-beta 1 (TGF-β1) was 
determined in triplicate using ELISA DuoSets® (R&D Systems), following the 
manufacturer’s instructions [21]. The optical density of each well was measured 
using a microplate reader (GENios plus, TECAN, Germany) at 450 nm. 
 
2.4. Immunofluorescent analysis of endothelial and fibroblastic markers  
 
Cocultures seeded onto Thermanox coverslips (13 mm, Nunc, Germany) were 
prepared for immunoflorescent staining of endothelial markers PECAM-1 (CD31) 
and von Willebrand factor (vWF), of fibroblastic marker vimentin and of the 
activated fibroblast marker, α-smooth muscle actin (α-SMA). After fixation with 
3.7% paraformaldehyde (Merck, Germany), cells were washed with PBS and 
permeabilized using 0.2% Triton-X 100/PBS for 10 min. After washing 4 times 
with PBS, cells were incubated for 45 min at room temperature with primary 
antibodies: mouse anti-human CD31 (1:50, Dako, Germany), rabbit anti-human 
vWF (1:8000, Dako, Germany), mouse anti-human α-SMA (1:100, Dako, Hamburg, 
Germany) and mouse anti-human vimentin (1:200, Progen, Germany) diluted in 
1% bovine serum albumin/PBS. After washing 3 times with PBS, cells were 
incubated for 45 min at room temperature with the secondary antibodies: anti-
mouse Alexa 488 (Molecular Probes, Germany) for CD31, vimentin and α-SMA 
staining and anti-rabbit Alexa 546 (Molecular Probes, Germany) for vWF, diluted 
1:1000 in 1% bovine serum albumin/PBS. This incubation was followed by a brief 
rinse in PBS. Finally, cell nuclei were counterstaining with 1 µg/mL DAPI 
(Molecular Probes, Germany) in PBS for 5 min.  After washing with PBS samples 
were mounted with Gel/Mount (Natutec, Germany) and examined by confocal 
laser scanning microscope (CLSM, LeicaTCS-NT, Leica Microsystems, Germany).  
 
2.5. Alkaline phosphatase (ALP) staining 
 
ALP staining was performed using a diagnostic phosphatase kit (Sigma-Aldrich, 
Germany) as described by the manufacturer. Briefly, the adherent cell cultures 
were washed with PBS, fixed with citrate-acetone-formaldehyde fixative solution 
for 30 sec, then stained with an alkaline-dye mixture at room temperature for 15 
min. Naphthol AS-MS phosphate and Fast Red Violet B were used as substrate 
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and for enzyme activity detection, respectively. ALP staining was examined by 
CLSM at λ
Ex
 =633 nm. 
 
2.6. Extracellular matrix (ECM) formation by collagen assay 
 
The total collagen content of cell cultures was determined using the SircolTM 
Collagen Assay Kit (Biocolor, UK), to assess ECM formation, according to the 
manufacturer's instructions. SircolTM soluble collagen assay is a dye-binding 
method for the analysis of acid and pepsin-soluble collagens. The reagent binds 
to hydroxyproline, although it does not discriminate between collagen types I 
and V present in the ECM. 
Briefly, the culture medium was removed and each well was washed with PBS. 
500 µL of 0.1 mg/mL of pepsin solution in 0.5 M acetic acid (Sigma-Aldrich, 
Germany) was added to each well. The samples were incubated at 4ºC overnight. 
Then, 50 µL of acid neutralising reagent (Biocolor, UK), 100 µL of cold isolation 
and concentration reagent (Biocolor, UK) were added. The tube contents were 
mixed by tube inversion and incubated overnight at 4ºC. Afterwards, the tubes 
were centrifuged for 10 min at 12 000 rpm. Pellets were re-dissolved in 0.5 M 
acetic acid and 1 mL of SircolTM dye reagent, which specifically binds to collagen. 
The reagents were mixed for 30 min. After centrifugation, pellets were 
suspended in 250 mL of the alkali compound included in the kit and optical 
density was evaluated using a microplate reader (GENios plus, TECAN, Germany) 
at the 540 nm. Each value of test samples was compared to the values obtained 
with collagen standard solutions provided by the manufacturer and used to 
construct a standard curve. 
 
2.7. Statistical analysis 
 
All data are presented as mean ± standard error of the mean (SEM). Statistical 
analysis was performed with GraphPad Prism version 5.0 and statistical 
significances were evaluated using the Student’s t-test. A difference between 
experimental groups was considered significant with a confidence interval of 
95%, whenever P<0.05.  
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3. Results  
 
3.1. Levels of VEGF, bFGF, IL-8 and TGF-ß1 in cocultures by indirect contact 
 
The amounts of VEGF, bFGF, IL-8 and TGF-ß1 were determined in the 
supernatant of cocultures of ECs and fibroblasts in indirect contact, ECs and 
fibroblasts growing in close proximity since they were separated by a transwell 
coated with collagen, as well as in the controls (monocultures of HUVECs, 
HDMECs and HDFs) in one side of the transwell membrane. In monocultures of 
HUVECs and HDMECs the presence of VEGF could not be detected (Fig. 1). On 
the other hand, in HDF monocultures VEGF was detected and significantly 
increased from day 1 to 7. No VEGF could be detected in the supernatants 
collected from cocultures of HUVECs or HDMECs with HDFs. 
The growth factor bFGF was included in the culture media, since it is necessary 
for ECs culture viability [24]. The presence of bFGF in HUVEC and HDMEC 
monocultures was detected both on day 1 and day 7 (Fig. 1). In monocultures of 
HDMECs a significant decrease in bFGF levels was observed on day 7 compared 
to day 1 (Fig. 1), that also being observed in monocultures of HDFs as well as in 
its cocultures with HUVECs or HDMECs. Thus, in cocultures, no production of 
bFGF occurred.  
On the other hand, in all conditions tested with ECs a significant increase in IL-8 
production on day 7 compared to day 1 was observed. In HDF monocultures no 
IL-8 was detected (Fig. 1).  
The amount of TGF-ß1 present in the media increased after 7 days under all 
conditions tested, compared to day 1 (Fig. 1).  
 
3.2. Expression of endothelial and fibroblastic markers in cocultures in 
direct contact 
 
HUVECs and HDMECs in direct contact cocultures with HDFs resulted in different 
cell behaviour. HDMECs formed more colonies (open arrowheads) of cells 
compared to HUVECs (Figs. 2B and A, respectively) after 3 days. The HDFs, 
identified by nuclear staining (blue), showed some positive staining for α-SMA 
(Figs. 2A and B). In Fig. 2C, HDFs were stained positively for vimentin (green) 
surrounding a colony of HDMECs stained positively for vWF, although ECs also 
show some green fluorescence, as vimentin marks both fibroblastic and 
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endothelial phenotypes After 21 days in coculture with HDFs, HUVECs and 
HDMECs formed a well-defined network of microcapillary-like structures (Figs. 
2D and E respectively), while in monoculture neither HUVECs nor HDMECs 
formed similar structures. All cell types in these cocultures were stained for 
nuclei (both HDFs and ECs, blue) and ECs for CD31 (endothelial cell-specific 
marker, green), allowing the observation of strings of microcapillary-like 
structures formed by HUVECs or HDMECs (Figs. 2D and E, respectively; stained 
green for CD31, arrows) amongst HDFs (blue nuclei and no CD31 staining, Figs. 
2D and E, open arrows). 
 
VEGF bFGF 
  
  
IL-8 TGF- β 1 
  
 
 
Figure 1. Concentration of VEGF, bFGF, IL-8, and TGF-? 1 in supernatants of 
monocultures of HUVECs, HDMECs or HDFs and of indirect contact cocultures of HUVEC 
or HDMEC with HDFs in tranwell systems after 1 and 7 days. Results are shown as mean 
± SEM (n=3). * p<0.05. 
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3.2. Expression of endothelial and fibroblastic markers in cocultures in 
direct contact 
 
HUVECs and HDMECs in direct contact cocultures with HDFs resulted in different 
cell behaviour. HDMECs formed more colonies (open arrowheads) of cells 
compared to HUVECs (Figs. 2B and A, respectively) after 3 days. The HDFs, 
identified by nuclear staining (blue), showed some positive staining for α-SMA 
(Figs. 2A and B). In Fig. 2C, HDFs were stained positively for vimentin (green) 
surrounding a colony of HDMECs stained positively for vWF, although ECs also 
show some green fluorescence, as vimentin marks both fibroblastic and 
endothelial phenotypes After 21 days in coculture with HDFs, HUVECs and 
HDMECs formed a well-defined network of microcapillary-like structures (Figs. 
2D and E respectively), while in monoculture neither HUVECs nor HDMECs 
formed similar structures. All cell types in these cocultures were stained for 
nuclei (both HDFs and ECs, blue) and ECs for CD31 (endothelial cell-specific 
marker, green), allowing the observation of strings of microcapillary-like 
structures formed by HUVECs or HDMECs (Figs. 2D and E, respectively; stained 
green for CD31, arrows) amongst HDFs (blue nuclei and no CD31 staining, Figs. 
2D and E, open arrows). 
In Fig. 2G, HDFs stained for nuclei (blue) showed that cells began to grow in 
multilayers and most likely created a 3D environment that stimulated HDMECs 
(stained for CD31, arrows, green) to organize into microcapillary-like structures 
(arrowheads, Fig. 2G). Thus, direct cell contact between HDMECs or HUVECs with 
HDFs was required to observe the microcapillary-like formation by ECs.  
 
3.3. Colocalization of microcapillary-like structures and expression of 
alkaline phosphatase 
 
When HDFs were cocultured with HUVECs or HDMECs in direct contact for 7 days 
(Figs. 3A and B, respectively) areas with positive (red) and negative staining for 
ALP were observed. In both cocultures of HUVECs/HDFs and HDMECs/HDFs the 
presence of microcapillary-like structures was detected, which stained positively 
for CD31 (green) and nuclei (blue), while HDFs stained negatively for CD31 and 
positively for nuclei (blue). The presence of microcapillary-like structures could 
be colocalized with areas staining positively for ALP and thus further 
experiments were carried out to study the consistency of this phenomenon. 
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Figure 2. Microvessel-like structure formation in direct contact cocultures of endothelial cells 
with fibroblasts. HUVECs and HDMECs were cocultured with HDFs for 21 days. (A) 
HUVECs/HDFs at day 3, with HUVECs stained for vWF (open arrowhead, red), HDFs with DAPI-
stained nuclei (arrow, blue) and negative for vWF, and active fibroblasts stained for α-smooth 
muscle actin (α-SMA; arrowhead, green); (B) HDMECs/HDFs at day 3, with HDMECs stained for 
vWF (open arrowheads, red), HDFs with DAPI-stained nuclei (arrows, blue) and negative for 
vWF, and active fibroblasts stained for α-SMA (arrowheads, green); (C) HUVECs/HDFs at day 3, 
with HUVECs stained with vWF (open arrowhead, red), HDFs stained more strongly for 
vimentin (arrow, green) than do ECs and nuclei for DAPI (blue). (D) HUVECs/HDFs at day 21, 
with microvessel-like structures (CD31, green, arrowheads) and nuclei (DAPI, blue); (E) 
HDMECs/HDFs at day 21, with microvessel-like structures (CD31, green, arrowheads) and 
nuclei (DAPI, blue). Not all HDMECs formed microvessel-like structures (open arrow heads); 
and HDFs with nuclei stained for DAPI (arrows, blue) and negative for CD31; (F, G) 
magnification of microvessel-like structure formed by HDMECs (CD31, green, arrowheads), 
surrounded by HDF (nuclei stained with DAPI, blue, arrows) in HDMECs/HDFs cocultures at 
day 21.  
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HUVEC/HDF HDMEC/HDF 
  
 
Figure 3. Cocultures of HUVECs or HDMECs with HDFs after 7 days in culture. Staining 
reactions for alkaline phosphatase (ALP) with Fast Red Violet B (red), HUVECs or HDMECs 
with CD31 (green, arrowheads) and nuclei with DAPI (blue). HDFs stained positively for 
DAPI (nuclei in blue, arrows) and negatively for CD31. Capillary-like structure formation 
was observed in areas stained positively for ALP.  
 
 
 
 
 
 
 
Figure 4. Confocal laser scanning microscopy images of 
cocultures of HDMECs with HDFs after 14 days. (A, E) 
Monoculture of HDFs staining positively for α-smooth muscle 
actin (α-SMA, arrows) (green); (B, F) Monoculture of HDFs 
staining positively for ALP (red); (C, G) Monoculture of HDFs 
staining positively for DAPI (nuclei, blue); (I) Monoculture of 
HDMECs staining positively for CD31 (green, open arrowheads); 
(J) Monoculture of HDMECs staining negatively for ALP (red); (K) 
Monoculture of HDMECs staining positively for DAPI (nuclei, 
blue); (M) Cocultures of HDMECs/HDFs staining positively for 
CD31 and microcapillary-like structure formation (green, 
arrowheads); (N) Cocultures of HDMECs/HDFs staining 
positively for ALP (red); (O) Cocultures of HDMECs/HDFs 
staining positively for DAPI (nuclei, blue); (Q) Cocultures of 
HDMECs/HDFs staining positively for α-SMA (green, arrows); (R) 
Cocultures of HDMECs/HDFs staining positively for ALP (red); (S) 
Cocultures of HDMECs/HDFs staining positively for DAPI (nuclei, 
blue); (D, H, L, P, T) Merged images of each of the horizontal 
lines. Scale bars=50 µm.  
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To further characterize this behavior, the expression of ALP, CD31 and α-SMA 
was analyzed in cocultures of HUVECs or HDMECs with HDFs after 14 days in 
culture (monocultures were used as controls). HDF monocultures stained 
positively for ALP (red) throughout the culture (Figs. 4B and F), although the 
positive staining for α-SMA was irregular: some areas showed only 1 to  3 cells 
with positive staining for α-SMA (Fig. 4A) while others showed  extensive 
positive staining (in the same monoculture, Fig. 4E). HDMEC monocultures 
stained negatively for ALP (Fig. 4J, red),  and positively for CD31 (Fig. 4I, green), 
although no formation of microcapillary-like structures could be observed in 
these monocultures (Fig. 4I). However, in the cocultures of HDMECs with HDFs 
(HDMEC/HDF) areas with high expression of ALP (red) were observed (Figs. 4N 
and R). Furthermore, in ALP expression areas HDMECs in cocultures with HDFs 
organized into microcapillary-like structures, with positive staining for CD31 (Fig. 
4M, green) and showing sprouting and cell tip structures (Fig. 4M, arrowheads). 
Also, in areas of high expression of ALP (Figs. 4R, red), cocultures of 
HDMECs/HDFs cells stained positively for α-SMA (Fig. 4Q). Positive staining for 
CD31 and α-SMA could not be observed in areas with low ALP expression in 
HDMECs/HDFs cocultures. Table 1 summarizes the data collected from this 
experiment. Similar results were obtained for cocultures of HUVECs/HDFs. 
 
 
Table 1. Summary of the results from Fig. 4. 
Cultured cells ALP  CD31 (capillary-like 
structures) 
α-SMA 
HUVEC - - - 
HUVEC/HDF + (spots) + ++ 
HDMEC - - - 
HDMEC/HDF + (spots) + ++ 
HDF + - + 
(-) absent; (+) present (few); ++ present (abundant); ALP: alkaline phosphatase; α-SMA: α-
smooth muscle actin; HDF: monoculture of human dermal fibroblasts; HDMEC: 
monoculture of human dermal microvascular endothelial cells; HUVEC: monoculture of 
human umbilical vein endothelial cells; HDMEC/HDF: coculture of HDMECs with HDFs; 
HUVEC/HDF: coculture of HUVECs with HDFs. Four different fields of the sample where 
used.  
 
 
Chapter III 
 
 
 
91 
 
3.4 Influence of collagen production on microcapillary-like structure 
formation in cocultures of endothelial cells with fibroblasts 
 
In order to investigate whether the formation of microcapillary-like structures 
could be related to collagen production, collagen levels in the extracellular 
matrix of cocultures of HUVECs or HDMECs with fibroblasts were quantified after 
7, 14 and 21 days using the SircolTM assay. Monocultures of HUVECs, HDMECs 
and HDFs were used as controls. Fig. 5 shows, at day 21, significant increases in 
the amount of collagen in all conditions tested compared to day 7. The amount 
of collagen significantly increased between day 14 and 21 in cocultures of 
HUVECs/HDFs and of HDMECs/HDFs, as well as in monocultures of HUVECs and 
of HDMECs. Thus, the production of collagen seems to have been influenced by 
the two cells types in the cocultures. 
 
 
Figure 5. Collagen production after 7, 14 and 21 days of monocultures of HUVECs, 
HDMECS or HDFs, or of cocultures of HUVECs or HDMECs with HDFs. The results are 
presented as mean ± SEM (n=3). * p<0.05, ** p<0.01,*** p<0.001. 
 
 
3.5 Levels of VEGF and TGF-β1 in cocultures by direct contact  
 
In order to investigate if the formation of microcapillary-like structures and the 
increase in collagen levels in cocultures of HUVECs or HDMECs with HDFs would 
influence the media levels of VEGF and TGF-β1 supernatants of the 
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monocultures and cocultures were collected and analyzed by ELISA at days 7, 14 
and 21. In agreement with the previous results from indirect coculture studies, 
VEGF was detected in HDF monocultures (Fig. 6A). VEGF levels at day 7 were 
significantly higher than at days 14 and 21. In both cocultures tested very low 
amounts of VEGF were measured at days 7 and 21. Contrary to results obtained 
with indirect contact cocultures, TGF-β1 levels were detected in HUVECs/HDFs 
(at days 7 and 14) and HDMECs/HDFs cocultures (at day 7), at low amounts (Fig. 
6B). TFG-β1 was not observed in any of the monocultures tested.  
 
 
  
 
Figure 6. Cellular production of growth factors (VEGF and TGF-β1 ) by cells in 
monoculture and in direct contact cocultures, at 7, 14, and 21 days of culture. (A) VEGF 
and (B) TGF-β1 were quantified in the supernatants of HUVECs/HDFs and HDMECs/HDFs 
cocultures in direct contact, as well as in their monocultures (controls). Results are 
shown as mean ± SEM (n=3, *p<0.05).  
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4. Discussion 
 
In vitro coculture systems have proven to be excellent models to analyse the 
cellular role of vascular-associated factors and to help elucidate their 
intracellular signalling pathways [33].  The in vivo microenvironment has diverse 
and complex interactions between multiple cell types and extracellular matrix 
(ECM) components that can be simulated in different combinations of coculture 
systems [33].  
In order to investigate the interactions between endothelial cells (ECs) and 
fibroblasts and their effects on vascularization coculture systems of 
ECs/fibroblasts were established. Different cell types, such us pericytes and 
smooth muscle cells, are known to support the behaviour of ECs and thus play a 
prominent role in angiogenesis, but the role of fibroblasts in modulating 
vascularization is still poorly understood.  Thus, an in vitro model was used here 
to assess the interaction between fibroblasts (human dermal fibroblasts, HDFs) 
and ECs from both the macrovascular (HUVECs) and the microvascular system 
(HDMECs).  
The results obtained using indirect cocultures (transwells) showed that VEGF 
was not present in cocultures of HUVECs/HDFs or HDMECs/HDFs, although 
HDFs had the capacity to produce VEGF. It has been previously shown that 
stromal fibroblasts are an important source of the pro-angiogenic VEGF [7, 8]. A 
decrease in the amount of bFGF in time (from days 1 to 7) was observed, in HDF 
and HDMEC monocultures as well as in HUVEC/HDF and HDMEC/HDF cocultures. 
IL-8 was produced by HUVECs and HDMECs since no amount of IL-8 was 
observed in HDF monocultures. ECs are known to release IL-8 and this 
influences cell migration [34, 35]. In all cultures TGF-β1 was present and 
increased with time. TGF-β1 is known to influence the assembly and maturation 
of blood vessels [36], the production of collagen [37] and the activation of 
fibroblasts [38]. When fibroblasts are activated they stained positively for alpha-
smooth muscle actin (a-SMA) [39]. 
In direct contact cocultures of HUVECs/HDFs and HDMECs/HDFs microvessel-like 
structures were observed. These microvessel-like structures were present in 
areas with high expression of alkaline phosphatase (ALP) and activated 
fibroblasts. Collagen production increased in all the cultures during an 
observation period of 21 days. On the other hand, VEGF production was high in 
HDF monocultures but observed only at much lower levels in cocultures of 
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HUVECs/HDFs and HDMECs/HDFs. Low levels of TGF-β1 were also observed in 
cocultures. These facts could indicate a consumption of VEGF by ECs, as 
required for their survival, migration and differentiation [40, 41]. Another 
possibility is the presence of ECM in direct contact cocultures, which could be 
responsible, to a certain degree, for the entrapment of growth factors produced 
by the cells [21]. 
It seems relevant to regenerative medicine to try and understand what 
biochemical cues influencing fibroblasts to contribute to regeneration instead of 
fibrosis are involved in this process. Fibroblast activation plays an important role 
in regulating immune responses [17, 18] and it is also known that small 
peptides released during remodeling of the extracellular matrix have profound 
effects on cellular immune responses [17, 42, 43]. Fibroblasts exhibit 
considerable intra-line plasticity that is dependent on the microenvironment. 
Recently, it has been reported that adult fibroblasts can be converted into 
pluripotent stem cells by transfection with only four transcription factors (oct3/4, 
Sox2, c-myc and Klf4) [20, 44]. Nanog, a transcription factor that regulates early 
development [45], has been found to be present in porcine [46] and human 
dermal fibroblasts [20] suggesting that nanog is important in maintaining the 
plasticity found in fibroblasts in vivo [20]. The present results further suggest 
that fibroblasts are not a passive cell-type in the complex signalling pathways of 
angiogenesis. Fibroblasts influenced the formation of microcapillary-like 
structures and collagen deposition, suggesting a dependency between the 
formation of microcapillary-like structures and the organization and thickness of 
the ECM, which is in agreement with previous studies [39].  
Martins-Green et al. [20] have previously shown that peri-endothelial cells can 
arise by differentiation from fibroblasts and that they require interaction with 
ECs for that purpose. Faggin et al. [19] suggested that fibroblasts appear to 
serve as vascular cell progenitors in the injured rabbit carotid artery. In the 
present study, and in agreement with Nigau et al. [20], it was observed that, in 
the vicinity of the capillary-like structures, some fibroblasts became positive for 
α-SMA. Although the stimuli are not known, it is likely that cellular crosstalk 
between ECs of the capillary-like structures and fibroblasts results in the 
expression of such fibroblastic activation markers.  
Alkaline phosphatase (ALP) is a widely used marker for the differentiation of pre-
osteoblasts or human mesenchymal stem cells (hMSC) under osteogenic 
conditions [23, 47]. Previous studies have used ALP as a marker to assess the 
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differentiation of hMSCs into osteoblasts in coculture with ECs [48]. Here, the 
modulation of ALP produced by fibroblasts cocultured with HUVECs or HDMECs 
was investigated. Although the expression of ALP has been widely related to 
osteoblast differentiation and bone mineralization [49, 50], other perspectives 
and roles regarding ALP have been described. ALP has also been implicated in 
the regulation of cell growth and apoptosis [51]. In addition, ALP expression is 
often restricted both temporally and spatially to the population of cells involved 
in migration or morphogenesis [52], suggesting its involvement in cell guidance 
and migration. In the present study, microvessel-like structures were co-
localized with areas with high levels of ALP expression in cocultures of ECs with 
fibroblasts, while this phenomenon was not observed in monocultures (controls). 
As far as we know, this is the first study showing the colocalization of 
microvessel-like structures with ALP. These findings support a possible role of 
ALP in cell-cell interaction (ECs-fibroblasts) [53] and cell migration [54-57]. 
Supporting this hypothesis, Friis et al. [58] reported an anti-angiogenic, dose-
dependent, potential effect of levamisole on ECs propagated with fibroblasts, 
both in vitro and in vivo in a hetero-transplantation tumor model. Levamisole is 
a well-described and widely used tissue-non-specific alkaline phosphatase (TNS-
ALP) inhibitor [59]. Levamisole-induced inhibition of microcapillary-like 
structures has been demonstrated although no clarification was provided about 
the roles of cell-cell interaction or cell migration in the ability of TNS-ALP to 
influence this process [58]. Furthermore, TNS-ALP has been reported to bind to 
collagen in the ECM [60, 61], which, together with our results, suggests an 
involvement of TNS-ALP in the angiogenesis process and particularly in the 
crosstalk between ECs and fibroblasts. Taken together, these results suggest a 
possible role of ALP in the modulation of angiogenesis and in cell adhesion that 
may be relevant for the development of new cell therapies in tissue regeneration.  
Collagen is one of the major proteins in the ECM and is produced by fibroblasts 
in wound healing. In cocultures of ECs and fibroblasts it was demonstrated that 
the presence of fibroblasts influenced the increase of collagen production with 
time. This observation suggests that the presence of collagen, and the fact that 
fibroblasts formed multilayers of cells in culture, induced ECs organization into 
microvessel-like structures, while these structures were absent in EC 
monocultures. Collagen type I is also known to drive EC migration by 
chemotaxis and haptotaxis [13]. In bone tissue engineering strategies the 
deposition of an extensive network of collagen by osteoblasts has been shown 
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to provide an essential 3D support for ECs to migrate and to organize into 
microcapillary-like structures by providing ECs with the chemical and physical 
cues for migration and proliferation [12]. Studies with cultured skin fibroblasts 
from a series of patients with osteogenesis imperfecta, a heritable defect that 
makes bones brittle, demonstrated that the mutations produced specific 
disruption in the biosynthesis of collagen type I, thus generating abnormal 
collagens fibrils [62]. These facts will influence matrix composition and the 
interaction with growth factors and cytokines important in cell behavior [63]. 
The coculture model presented here offers the possibility to delineate how 
specific proteins and growth factors are regulated as a result of interactions 
between fibroblasts and endothelial cells.  Further studies are required to 
delineate the different subtypes of collagen produced in the cocultures 
compared with monocultures. 
 
 
5. Conclusions 
 
In the present study fibroblasts and endothelial cells (from macro or 
microvasculature) were cocultured and the production of growth factors was 
modulated by the crosstalk between these two cells types. The crosstalk 
occurring between ECs-fibroblasts appears to stimulate fibroblasts to produced 
collagen and growth factors that can positively influence the formation of 
microvessel-like structures. In addition, the interaction between these two cell 
types leads to the activation of fibroblasts (expressing α-smooth muscle actin) 
and to the expression of alkaline phosphatase near the microvessel-like 
structures.  The latter raises the possibility that alkaline phosphatase could be 
involved in the process of vascularization. 
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Abstract 
 
 
The vascularization of new tissue within a reasonable time is a crucial 
prerequisite for the success of different cell-and-material-based strategies. 
Considering that angiogenesis is a multi-step process involving humoral and 
cellular regulatory components, only in vivo assays provide the adequate 
information about vessel formation and the recruitment of endothelial cells. The 
present study aimed to investigate if neonatal human dermal fibroblasts could 
influence in vivo neovascularization. Results obtained showed that fibroblasts 
were able to recruit endothelial cells to vascularize the implanted matrix, which 
was further colonized by murine functional blood vessels after 1 week. The 
vessels exhibited higher levels of hemoglobin, compared to the control matrix, 
implanted without fibroblasts, in which no vessel formation could be observed. 
No significant differences were detected in systemic inflammation. The presence 
of vessels originated from the host vasculature suggested that host vascular 
response was involved, which constitutes a fundamental aspect in the process of 
neovascularization. Fibroblasts implanted within matrigel increased the 
presence of endothelial cells with positive staining for CD31 and for CD34 and 
the production of collagen influencing the angiogenic process and promoting 
the formation of microvessels.   
New strategies in tissue engineering could be delineated with improved 
angiogenesis using neonatal fibroblasts. 
 
 
Keywords: Angiogenesis, endothelial cells, fibroblasts, regenerative medicine, 
tissue engineering, vascular networks. 
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1.Introduction 
 
Angiogenesis represents the process of formation of new blood vessels out of 
pre-existing ones, with significant value in development, reproduction and 
repair [1]. The basic vascular network is formed by endothelial cells, through 
which the exchanges of gases, growth factors, nutrients and elimination of 
metabolites between blood and tissue occur [2]. In fact, the diffusion distance of 
nutrients and oxygen out of blood vessels ranges from 100 to 200 µm [3]. In 
this context, the vascularization of new tissue within a reasonable time is a 
crucial prerequisite for the success of different cell-and-material-based 
strategies in the context of regenerative medicine [4]. One of the challenges in 
tissue engineering has become the development of artificial extracellular 
matrices that promote the ingrowth of microvessels in the injured site, for 
instance through the delivery of growth factors [5]. Alternatively, endothelial cell 
delivery systems, including their cocultures for instance with osteoblasts or 
mesenchymal stem cells in the framework of bone regeneration strategies, have 
also been shown to constitute adequate strategies to promote the formation of 
capillary networks, even without further addition of growth factors, indicating 
that the interaction between these cells types assures the release of the required 
growth factors [6, 7].  
In tissue engineering strategies, where the vascularization of implanted cell-
scaffold constructs is a requirement, with view to the use of a cell-scaffold 
construct, the interconnectivity between pores, in the case of porous scaffolds, 
or matrix timely degradation, are essential prerequisites for the success of both 
host cell invasion and proliferation and migration of implanted cells [8-11]. 
Additionally, the vascular networks formed need to be guided by the implanted 
artificial matrix to promote anastomosis into the host vasculature [12-14]. 
Matrigel has been extensively used as an artificial extracellular matrix to study 
angiogenesis in vitro and in vivo due to its unique characteristics. Matrigel is a 
mixture of extracellular matrix and basement membrane proteins extracted 
from the mouse Engelbreth-Holm-Swarm (EH) sarcoma that forms a hydrogel 
[15]. Considering that angiogenesis is a multi-step process, involving humoral 
and cellular regulatory components [16], in vivo angiogenesis assays constitute 
the most informative experiments in terms of vessel formation, endothelial cells 
recruitment and vessel functionality through analysis of anastomosis with host 
vasculature. Matrigel is especially suited for in vivo studies of angiogenesis due 
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to its similarity with the natural extracellular matrix, despite containing a 
number of growth factors believed to play key roles in the process. In the 
attempt to reduce the influence of the growth factors in angiogenesis 
experiments a reduced growth factor matrigel (GFR-matrigel) was developed. 
The subcutaneous implantation of matrigel with mesenchymal progenitor cells 
into mice showed the capacity of these cells to induce angiogenesis, and has 
been suggested as a model in development of approaches to improve 
neovascularization of engineered human tissues and organs [14].  
The role of fibroblasts in tissue regeneration is probably underestimated in 
tissues other than the skin. Fibroblasts already constitute the dermis component 
of the commercial tissues engineered for dermal replacements used to improve 
the repair of chronic foot ulcers [17]. A cardiac patch using these cells has also 
been used to support the angiogenesis in infarcted heart tissue in animals 
models [18, 19]. Fibroblasts are known to maintain the structural integrity of 
connective tissues by continuously secreting growth factors and extracellular 
matrix precursors, which are essential for endothelial cells adhesion and 
spreading [20]. Furthermore, Kern et al. reported the lower immunogenicity of 
allogeneic fibroblasts grown in 3D comparing to fibroblasts grown in 
monoculture [21]. In the present work, it was hypothesized that neonatal human 
dermal fibroblasts may influence the neovascularization of the GFR-matrigel. In 
order to provide information about the morphology of fibroblasts and how they 
could influence the neovascularization an in vivo GFR-matrigel plug assay was 
used. Hemoglobin content and inflammatory levels were measured, and 
histological analyses were performed. 
 
 
2. Materials and Methods 
 
2.1. Culture of fibroblasts 
 
Neonatal human dermal foreskin fibroblasts-1 (from American Type Culture 
Collection, ATCC, USA) were cultured in Dulbecco's Modified Eagle Medium 
(DMEM, Gibco) with high glucose and with L-glutamine, supplemented with 15% 
v/v inactivated fetal bovine serum (FBS, from Gibco), 100 U/mL penicillin G and 
100 µg/mL streptomycin (Gibco). The cells were maintained at 37ºC in a 
humidified 5% CO
2
 atmosphere and they were cultured until 90% confluence was 
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reached. Fibroblasts were used at passages 6-8 in every experiment and the 
culture medium was changed every 2 days.  
 
2. 2. In vivo angiogenesis assay  
 
Animal experiments were conducted according to accepted standards of human 
animal care, namely European Community guidelines (86/609/EEC) and 
Portuguese Act (129/92). In vivo matrigel plug assay was performed using a 
mixture of growth factor reduced Matrigel® (GFR-Matrigel®, BD Science) and 
heparin (25 U/mL, Sigma) with 106 fibroblasts. 500 µL of the GFR-Matrigel® 
mixture were subcutaneously inoculated into eight-weeks-old C57BL/6 male 
mice, from Charles River, (n=7). A control group was used, without cells (n=7). 
After 1 week mice were anesthetized by intraperitoneal injection of 
pentobarbital sodium (200 mg/kg body weight) and euthanized, the matrigel 
plugs were removed, weighted, photographed and fixed. Mice blood was also 
collected for evaluation of inflammatory markers (N-acetylglucosaminidase 
activity and nitric oxide production). The formation of the functional vasculature 
in the matrigel plug was evaluated by determination of the hemoglobin 
concentration in the homogenized plug.  
 
2.3 Determination of hemoglobin 
 
Hemoglobin (Hb) content was determined in matrigel plugs collected 1 week 
after implantation, using a previously described procedure [22]. Matrigel plugs 
were homogenized in a water-heparin solution and centrifugated at 1500 g for 
15 min at 20ºC. The Hb content was measured in the supernatant (100 µL) 
according to the Drabkin’s method (Sigma) at 540 nm. 
 
2.4 Determination of N-acetylglucosaminidase activity 
 
Systemic inflammation can be ascertained measuring the activity of the 
lysosomal enzyme N-acetylglucosaminidase (NAG) in the serum, an enzyme 
present in high levels in activated macrophages. The blood was collected 
allowed to clot at room temperature for 30 min, followed by centrifugation at 
1500 g for 15 min at 25ºC in order to obtain the serum. The serum was 
incubated during 10 min at 37ºC with 100 µL of p-nitrophenyl-N-acetyl-beta-D-
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glucosaminide solution in a 96-well plate. The reaction was stopped by the 
addition of 0.2 M glycine buffer (pH 10.6) and the substrate hydrolysis was 
measured at 405 nm [22].  
 
2.5 Determination of nitric oxide  
 
Nitric oxide (NO) production was measured indirectly using the Griess Reaction 
system, which uses 1% sulphanylamide and 0.1% N-1-napthylethylenediamine 
dihydrochloride under 2.5% phosphoric acid to measure nitrite (NO
2
-) in serum. 
100 µL of serum and 100 µL of Griess Reagent were added to a 96-well plate. 
After 15 min at room temperature, protected from light, the azo product was 
measured at 550 nm.  
 
2.6. Histological and immunohistological analyses 
 
The explanted matrigel plugs were fixed in buffered formalin solution (10%), 
dehydrated using a graded ethanol series and automatically embedded in 
paraffin according to standard procedures. Paraffin sections of 4 µm thickness 
were cut, rehydrated and histochemically stained with hematoxylin and eosin 
staining according to standard procedures. To identify fibers built by fibroblasts 
the Elastica van Gieson (EvG) staining was performed according to laboratory 
standard methods.  
The immunohistological detection of CD31 and CD34 was carried out with the 
peroxidase method by using DAB as chromogene. For this purpose monoclonal 
antibodies against CD31 (dilution 1:400, Santa Cruz, USA) and CD34 (dilution 
1:200, Santa Cruz, USA) were used. The immunohistological stainings were 
automatically performed with help of an Autostainer plus (Dako, Germany) and 
the appropriate Dako-Staining kits. After the immunodetection the nuclei of cells 
were stained by hemalaun.  
 
2.7 Transmission electron microscopy 
 
For transmission electron microscopical analyses samples of 0.5 x 0.5 cm were 
cut out of the explants, fixed in buffered glutaraldehyde (2.5%) over night, 
contrasted with OsO
4
 and then embedded in Agar 100 (Plano, Germany), which 
polymerized for at least 24 hours. After trimming first semithin sections were 
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performed to identify the region of interest, which was then cut ultrathin with 
the Ultracut E microtome (Leica, Germay). Transmission electron microscopical 
analyses were performed with a Phillips EM 410 (Phillips, Netherlands). 
Visualizations took place at 80 KV and were fotodocumented.  
 
2.8 Statistical analyses 
 
All experiments were performed at least in triplicate. Quantifications are 
expressed as mean ± standard error of the mean (SEM). For comparison between 
two groups the Student’s t-test was used. A difference between experimental 
groups was considered significant with a confidence interval of 95%, whenever 
p<0.05. 
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3. Results  
 
3.1. Hemoglobin content 
 
To evaluate if the implanted human neonatal fibroblasts could modulate the 
angiogenic process in vivo, and the recruitment of endothelial cells from the 
host in particular, the matrigel plug angiogenesis assay was used. Upon removal 
the plugs were easily distinguishable from the surrounding tissues, and a well-
defined plug between skin and muscles could be excised for the preparation of 
histological sections. The extension of functional neovascularisation was 
evaluated by measuring the amount of hemoglobin (Hb) present in the matrigel 
plugs implanted with or without fibroblasts after 1 week. Matrigel implants were 
inoculated with fibroblasts induced vascular development (Fig. 1B) contrary to 
what was observed in the control conditions, where no cells were implanted (Fig. 
1A). The plugs implanted with fibroblasts showed an angiogenic response, 
highlighted by the red colour spread in the whole plug (Fig. 1C; arrows show 
vessels formed in the matrigel plug implanted with fibroblasts). As can be seen 
in Fig. 1D the Hb levels were significantly increased in the matrigel plugs 
implanted with fibroblasts compared to the control group (without fibroblasts).  
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Figure 1. In vivo evaluation of angiogenesis using the matrigel plug assay. A mixture of 
matrigel and heparin, with or without fibroblasts (control), were implanted 
subcutaneously into C57BL/6 mice, and removed after 1 week. (A) Representative 
macroscopic visualization of matrigel plugs implanted without fibroblasts, which appear 
avascular; (B) macroscopic visualization of matrigel plugs implanted with fibroblasts; (C) 
magnification of image B, with arrows showing the vessels formed; (D) Quantification of 
haemoglobin (Hb) in the retrieved plugs, showing a significant increase in Hb levels 
upon fibroblasts implantation. The presence of fibroblasts increased vessel formation in 
the plug, significantly differing from the control. Results are means ± SEM of 
independent experiments (n=6). *p<0.05 vs. control. 
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3.2. Inflammation factors determination 
 
To assess if implanted fibroblasts developed inflammation in mice during the 
experiment, NAG activity was evaluated in the serum of each mice. The results 
revealed no significant difference between the serum NAG activity levels of mice 
transplanted with fibroblasts compared to controls, indicating that no 
inflammatory response to fibroblasts implanted could be detected (Fig. 2A). 
Regarding the production of NO, no significant differences between the two test 
groups were detected either (Fig. 2B), confirming that no differences were 
obvious within these two groups.  
 
A B 
  
 
Figure 2. Determination of (A) N-acetylglucosaminidase (NAG) activity and (B) nitric 
oxide (NO) in mice serum. Results are means ± SEM of independent experiments (n=6).  
 
3.3. Histological and immunohistological analyses 
 
The histological analyses allow a microscopical view of the cell populations 
within the plugs in the two analyzed groups. All explanted plugs showed a slight 
inflammatory reaction with granulocytes and lymphocytes in the surrounding 
tissue after one week. Regarding the inflammatory reaction no differences could 
be found between the two analyzed groups. Furthermore, in all examined plugs 
an infiltration of cells could be found (Fig. 3). In matrigel with fibroblasts it was 
observed an accumulation of cells not only at the border but also in the 
periphery and the center of the plug (Fig. 3B). In this group, numerous groups of 
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circular arranged cells could be detected within the matrigel, which 
immunhistologically expressed CD31 (Fig. 3D, arrows). In the specimens without 
fibroblasts capillary-like tubes (black arrow) could be found solely in the 
periphery of the plugs but not in the center (Fig. 3C), which correspond to the 
small amount of hemoglobin detected in the control group.  
In matrigel plugs implanted with fibroblasts the presence of some vessels inside 
(center) the implant was observed (Fig. 4A). Inside de matrigel, tube-like 
structures branching capillary arranged structures, aligned by endothelial cells, 
could also be identified, with erythrocytes and inflammatory cells within the 
lumen and near the periphery (Fig. 4B). 
 
 
Control Fibroblasts 
A B 
  
C D 
  
  
Figure 3. Representative images of hematoxylin & eosin staining of matrigel plugs 
implanted subcutaneously in C57BL/6 mice with (B and D) or without fibroblasts 
(control; A and C). (B) Asterisk pointing out population of cells in the border of the plug; 
(C) capillary-like tubes, arrow. (D) circular arranged cells, arrow. Original magnification: 
400x (A, C and D) and 200x (B). 
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A B 
  
Figure 4. Branching network of vessels within the matrigel plus implanted with 
fibroblasts, with erythrocytes and inflammatory cells in the lumina: (A) vessel in the 
center of the matrigel; (B) interconnected vessels near the periphery of the matrigel plug. 
Original magnification 400x. 
 
 
The in vivo recruitment of angiogenic network into the matrigel plugs implanted 
with or without fibroblasts was also evaluated. In order to visualize the 
formation of new blood vessels in the implanted plugs, histological sections 
were stained with antibodies against CD31 for the endothelial cells (mature 
vessels) and CD34 for progenitor endothelial cells that may also be present in 
initial steps of vessels formation.  Neovascularization of the implanted matrigel 
plugs with fibroblasts was observed within 1 week after the injection. At this 
time it was possible to observe endothelial cells lining together and forming new 
blood vessels (Figs. 5B and 6A). The positive immunohistochemical staining for 
CD31, a marker for endothelial cells (black arrow, Fig. 5B), revealed the 
presence of microvessels  (black circle, Fig. 5B). On the contrary, in the control 
group (Fig. 5A), only few endothelial cells were noticeable, marked positively for 
CD31, that were not organized in vessel structures. 
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In matrigel plugs implanted with fibroblasts (Fig. 6) it was also possible to 
observe endothelial progenitor cells, which collaborated in the process of 
formation of the blood vessels, and stained positive for CD34 (Fig. 6B). Near the 
periphery, it was observed vessel formation from the host vasculature staining 
positively for CD31 (Fig. 6C) and CD34 (Fig. 6D), indicating that both the mature 
and the progenitor endothelial cells participated in the process of 
vascularization.  
 
 
Control Fibroblasts 
A B 
  
  
Figure 5. Cellular phenotypes colonizing matrigel plugs after 1 week of implantation. 
Representative images for CD31 staining: (A) matrigel implanted without fibroblasts 
(control) and (B) matrigel implanted with fibroblasts - arrow pointing out the CD31 
positive cells and circular structures indicating the microvessels. Original magnification: 
400x. 
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Figure 6. Cellular phenotypes colonizing matrigel plugs implanted with fibroblasts after 
1 week of implantation. Representative images of stainings for CD31 and CD34: (A) 
microvessels formation, with arrows pointing CD31 staining; (B) microvessels formation, 
with arrows pointing CD34 staining; (C and D) consecutives images (C - CD31 staining; 
and D - CD34 staining), with arrows pointing the vessels formed from the periphery to 
inside the plug. Original magnification: 400x. 
 
 
To access the presence of fibrillar collagen and to understand if the cells during 
the migration into matrigel leave a track of collagen that could guide the 
endothelial cells during angiogenesis, the Elastic van Gieson staining was used. 
Fig. 7A shows a track of collagen observed in the control samples (without 
fibroblasts). On the other hand, in the matrigel plugs implanted with fibroblasts 
(Fig. 7B) the collagen was observed in localized areas and around the 
microvessel (black arrow). This could be related with different time points of the 
vascularization of the matrigel.  
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Control Fibroblasts 
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Figure 7. Elastic van Gieson staining identifying fibers such as collagen (pink color).  (A) 
Matrigel implanted without fibroblasts (control), with arrows pointing the track of 
collagen. (B) Matrigel implanted with fibroblasts, with arrow pointing out the collagen in 
microvessels. Original magnifications: 400x. 
 
Then, in order to access if fibroblasts produced collagen in the matrigel plug, 
ultrastructural studies (TEM) were performed in the explants after 1 week. In Fig. 
8A fibroblasts are indicated by black arrows and the collagen produced by these 
cells are pointed out by black arrowheads. The high activity of protein synthesis 
that could be observed may be related with rough endoplasmic reticulum (RER, 
white arrow) presented over a large area of the cell (Fig. 8B). It was possible to 
observe the well-organized collagen bundles (black arrowhead) surrounded by 
the filopodia extensions of the fibroblast (white arrowhead, Fig. 8B). 
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Figure 8. Ultrastructure of fibroblasts immobilized in a matrigel plug after 1 week of 
subcutaneous implantation by transmission electron microscopy. (A) The implanted 
fibroblasts produced collagen in the matrigel (black arrowhead indicates collagen; black 
arrows indicate fibroblasts); amplification: 6500x. (B) Magnified view of a fibroblast 
(black arrow), rough endoplasmic reticulum with high activity, high protein synthesis 
(white arrow), collagen (black arrowhead) surrounded by filopodia extensions of 
fibroblasts (white arrowhead); amplification: 17500X. 
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4. Discussion 
 
Understanding how to promote angiogenesis in a damaged tissue, using cells 
embedded in an injectable biomaterial, continues to be a challenge in tissue 
regeneration. The need for proper vascularization, which involves the assembly 
of a microvascular network and its anastomosis to the host vasculature, remains 
one of the major hurdles for clinical success of complex tri-dimensional tissue 
engineered structures [23]. In order to address if neonatal human dermal 
fibroblasts could influence the formation of early microvascular structures the 
matrigel plug model was used. The matrigel plug assay has been described as a 
good model to study angiogenesis because it protects growth factors from 
degradation and dispersion [24] and additionally provides the embedded cells a 
viable environment to proliferate and differentiate without scattering [24].  
The present in vivo study supports the hypothesis that implanted fibroblasts 
were able to recruit endothelial cells to vascularize an implanted artificial 
extracellular matrix with functional vessels after 1 week. As observed the same 
matrix implanted without fibroblasts did not vascularized, as confirmed by 
hemoglobin levels. 
Soluble factors produced by fibroblasts, such as vascular endothelial growth 
factor (VEGF) and basic fibroblast growth factor (bFGF), probably influenced the 
interactions with endothelial cells and their recruitment. VEGF is required for 
survival, differentiation, and network formation of endothelial cells [24]. bFGF 
promotes both endothelial cell scattering, that is required during the first step 
of the angiogenesis process, and the formation of the cell-cell interactions 
required for vessel maturation [24].  
Angiogenesis and inflammation are intimately related since immune cells 
produce cytokines and growth factors that target endothelial cells and 
stimulated angiogenesis and, in turn, the new vessels formed transport oxygen 
and nutrients, as well as immune cells [25]. In tissue regeneration it seems 
important to modulate inflammation to an adequate level [26]. So, it was 
evaluated if the fibroblasts transplanted with matrigel changed the inflammatory 
profile, measuring inflammatory markers, namely NO and NAG. NAG is a 
lysosomal enzyme which activity is increased with monocytes and macrophages 
activation during inflammatory diseases [27]. NO is related with general 
inflammation and it is a vasodilator [28]. No significant differences were 
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detected in systemic inflammation between matrigel implanted with or without 
fibroblasts.  
In matrigel plugs implanted with fibroblasts the presence of vessels with 
different endothelial cells, namely some with positive staining for CD31 and 
others for CD34, a marker for endothelial progenitor cells (EPC), outlines 
different stages of vascularization. The presence of vessels originating from the 
host vasculature is a remarkable observation, showing that host vascular 
response was involved, which is a key step for the clinical success of 
vascularization strategies. These findings indicate that the environment created 
by fibroblasts favors the recruitment of endothelial cells as well as the ingrowth 
of vessels from the host vasculature. EPCs are involved in promoting physiologic 
and pathologic neovascularization but questions remain about the magnitude of 
their contribution to newly forming blood vessels [29]. Melero-Martin et al. 
implanted EPCs in matrigel and reported no secretion of VEGF and no 
stimulation of murine vessel infiltration, although in cocultures of EPCs with 
mesenchymal stem cells better vascularization was observed [24]. 
Another key step in angiogenesis and vasculogenesis seems to be the 
production of new matrix. Mercier et al. reported that neurogenesis and 
vasculogenesis have implicated the participation of macrophages, fibroblasts 
and collagen [24]. Anghelina et al. reported that vascularization in a matrigel 
plug supplement with bFGF was influenced by initial cellular infiltration, with a 
predominant population of monocytes and macrophages [24]. The cells left a 
track forming cell columns after 1 week of implantation through secretion of 
angiogenic factors and enzymes able to degrade the matrix. A similar 
mechanism of cell invasion has been reported for leukocytes and tumor cells 
penetrating the matrix, or osteoclasts degrading and invading bone [24]. The 
amount of fibrillar collagen produced, apparently by fibroblasts, could derive 
from the circulating fibrocytes [30]. The present results showed the presence of 
collagen in matrigel plugs implanted with fibroblasts. By TEM, it was possible to 
observe the higher activity of the rough endoplasmic reticulum of fibroblasts, 
which is related with the production of collagen. Collagen acts as a potent pro-
angiogenic milieu in itself [24], whereas the matrix-associated fibroblasts could 
lead the orientation of new blood vessels [31]. In addition, the 
microenvironment present in the implant is very important for cell fate. For 
instance, Yin et al. reported that the extracellular microenvironment (soluble 
factors, cell-matrix or cell-cell interactions) could influence the chondrogenic 
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differentiation of dermal fibroblasts [24], although Reddi et al. reported that the 
transformation of fibroblasts to chondroblasts was unstable when compared to 
osteoblasts [24]. Also, related with the ability of fibroblasts to synthesize 
collagen, Kellar et al. reported that dermal fibroblasts cultured in tridimensional 
structures could be used as a support or delivery system of cells, like stem cell 
populations in cardiac diseases [32]. Dermal fibroblasts have also been 
described as a population of cells with mesenchymal origin having a crucial role 
in communication with other cell types in response to contextual signals in skin 
physiology [33].  The present strategy revealed to provide an adequate 
environment stimulating collagen production by transplanted fibroblasts 
contributing to formation of new vessels as well as to the ingrowth of vessels 
from the host vasculature. 
The matrigel plug assay is referred as an adequate model for in vivo studies of 
angiogenesis and vasculogenesis. Anghelina et al. suggested the use of matrigel 
plugs as experimental models of tissue regeneration, in which 
neovascularization is related with fibrosis and organogenesis and where 
inflammatory cells play a key structural role [24]. However, matrigel is not 
approved for use in humans. Taking this into account, new hydrogel systems 
need to be designed, providing an adequate microenvironment mimicking the 
natural extracellular matrix, with its capability to assure the signalling 
properties of soluble and insoluble components of the matrix. Alternative 
biofunctional hydrogels have been shown to provide adequate in vivo models of 
tumour angiogenesis [24]. New and complex biofunctional hydrogel matrices 
based on alginate have been recently developed, mimicking the extracellular 
matrix in its cell-specific adhesion and susceptibility to cell-driven proteolysis 
[24]. Other hydrogel-based systems have been reported as promising injective 
artificial extracellular matrices for cell transplantation and delivery [24] 
 
5. Conclusions 
 
The present in vivo study supports the hypothesis that fibroblasts embedded in 
matrigel plugs implanted in mice are able to recruit endothelial cells, including 
progenitor endothelial cells, to vascularize the matrix. The implanted matrigel 
with fibroblasts were further able to synthesize collagen and promote the 
ingrowth of vessels from the host vasculature. In the absence of an acute 
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inflammation the current strategy provides an adequate microenvironment for 
new strategies in tissue engineering, where neovascularization is essential.  
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Tissue engineering is a multidisciplinary field, which integrates knowledge from 
biomaterials science, molecular biology and biochemistry among others. The 
purpose of this field is to improve the quality of life of patients and increase 
their life expectancy. According to most of the data obtained on tissue 
engineering so far, one of the remaining limitations is the need of 
vascularization of the implant. However, many questions arise in order to 
understand what would the cues be in tissue regeneration to promote 
vascularization. Step by step, many improvements have been made in terms of 
biomaterial systems, in order to promote the delivery of endothelial cells and 
the recruitment of the host endothelial cells to the damaged area in different 
organs. The exact mechanism by which the extracellular matrix (ECM) acts to 
regulate migration, proliferation and differentiation of endothelial cells during 
the regenerative process needs to be elucidated, given the relevance of this 
phenomenon in tissue regeneration. The incorporation of growth factors and 
prevascularization of the implant could be a solution in order to create a 
microenvironment that allows the integration of the implant with host tissue in 
the right timing. Depending on the organ or tissue to regenerate, different 
strategies using heterotopic cell cultures were proposed. Nonetheless, the use 
of autologous bone marrow stromal cells as a source of different cell types 
related to the capacity of the cells to differentiate in different lineages opens a 
window in regenerative medicine. Stem cell properties of derived-bone marrow 
cells have been demonstrated [1]. Mesenchymal stem cells have been used in 
many studies to regenerate tissues. However, it has been demonstrated that 
mesenchymal stem cells and fibroblasts share much more features in common 
than it was established in the past [2]. In addition, fibroblasts were used to 
provide the appropriate niche for stem cell maintenance and differentiation in 
vitro. Nevertheless, fibroblasts have been shown to present different gene 
expression profiles depending on the specific tissue due to differential 
expression of homeobox (HOX) genes [3]. Beyond the roles usually attributed to 
fibroblasts in pathological conditions, namely contribution to pathological tumor 
development or fibrosis [4, 5], recent findings suggest that fibroblasts also play 
an important role in the angiogenesis process in tissue engineering [6-8]. 
Angiogenesis is a complex multistep process that requires the involvement of 
many cells types. Different cell types, such as pericytes and smooth muscle cells, 
are known to support the behaviour of ECs, thus playing a prominent role in 
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angiogenesis. However, the role of fibroblasts in modulating vascularization is 
poorly understood in the framework of tissue regeneration. 
In this thesis (chapter II) alginate hydrogels were formulated to serve as 
implantable scaffolds to deliver fibroblasts and growth factors released by the 
cells. Previous reports showed that RGD-alginate microspheres support viability 
of pre-osteoblasts and mesenchymal stem cells [9, 10]. Although human 
umbilical ven endothelial cells (HUVEC) are a primary cell culture, not used for 
clinical application, our group has immobilized these cells in RGD-alginate as 
well and used this approach as an endothelial model to examine the interplay 
between endothelial cells (EC) and osteoprogenitor cells. This approach revealed 
that the presence of distinct types of cells (vascular wall cells and 
osteoprogenitor cells) enhanced each other’s viability. Corroborating these 
findings, the use of growth factors such as VEGF and bFGF improved HUVECs 
viability in the 3D system, implying the relevance of interaction between distinct 
cell types in maintaining cells viability. In agreement, angiogenesis depends on 
major interactions between distinct cell types that release growth factors and 
ECM components [11]. Interactions between mesenchymal and epithelial cells 
are known to play an important role in orchestrating the development and 
morphogenesis of tissue and organs [3]. In order to create a microenvironment 
that could lead to the recruitment of host endothelial cells to the injury place, in 
vitro angiogenesis assays were performed in the current study. Fibroblasts 
entrapped in the RGD-alginate system were able to support the assembly of 
capillary-like structures by the HUVECs in matrigel-coated plates, and also 
influenced the area of sprouting in the aortic ring assay experiment. Both cell 
types produced soluble factors and this crosstalk probably activates signaling 
pathways that influenced sprouting and the organization of endothelial cells into 
a capillary-like structure in the extracellular matrix.  
The presence of the RGD sequence in alginate promoted cell adhesion and 
probably mediated survival signals that involve α
V
β
3
 integrin signaling pathways 
[9, 11-13], which will influence neovascularization in the implanted zone. Singh 
et al. found that fibroblasts immobilized in alginate produce collagen type I, 
leading to the assumption that these cells are capable of producing extracellular 
matrix inside the biomaterial, which can mediate growth factors release and 
cells differentiation [14]. Accordingly, another study highlighted the importance 
of osteoblasts producing collagen I that filled the spaces in the biomaterial and 
improved the formation of the microvessels structures when cocultured with 
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endothelial cells [15]. Levenberg et al. reported a close relationship between the 
neosynthesis of ECM and increasing levels of VEGF by fibroblasts in the 
formation and maintenance of the microvasculature [16]. Fibroblasts 
immobilized in the RGD-alginate increased the length of the capillary-like 
structures formed by endothelial cells, which is important for implant 
vascularization. These results suggest that growth factors produced by 
fibroblasts could act in a paracrine manner to induce and maintain capillary-like 
structures. The stimulation of production of metalloproteinases by the cells 
entrapped in alginate also seems to be important to neovascularization since it 
affects the degradation and remodeling of the extracellular matrix in the tissue 
[17]. The extracellular matrix is critical for blood vessel growth and maintenance 
by acting as scaffold support through which endothelial cells may migrate, and 
as a reservoir and modulator for growth factors. The present study was able to 
show that fibroblasts immobilized in RGD-alginate improved the heterotypic 
interactions within the microenviroment, resulting in a direct mechanism 
required for capillary formation. 
Fibroblasts localize in peri-vascular regions of both small and large caliber 
vessels. To further investigate the interaction between ECs and fibroblasts, on 
chapter III, cocultures of endothelial cells from the macrovasculature (HUVECs) 
and microvasculature (HDMECs) with fibroblasts were used. Fibroblasts have 
been shown to exhibit plasticity by differentiating into other members of the 
connective tissue family, including cartilage, bone, adipose tissue and smooth 
muscle cells [18]. So far, it is not clear if fibroblasts present within the 
connective tissue, besides maintaining the ECM and connective tissue 
homeostasis, also act as tissue-resident progenitors cells [19, 20]. In vitro 
coculture systems have proven to be excellent models to analyze the cellular 
role of vascular-associated factors and to elucidate their intracellular signaling 
pathways [21]. In this study, fibroblasts were able to produce VEGF, explaining 
the effect on endothelial cell migration and microvessels formation in the 
literature [22, 23] and, in chapter II, when entrapped within alginate 
microspheres. ECs are known to release IL-8 that influences cell migration [24, 
25]. In all cultures tested TGF-β1 was present and increased with time. TGF-β1 is 
known to influence the assembly and maturation of blood vessels [26], the 
production of collagen [27] and the activation of fibroblasts [4]. When 
fibroblasts are activated they became positive for alpha-smooth muscle actin (α-
SMA) [28]. Cocultures of HUVECs or HDMECs established in direct contact with 
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human dermal fibroblasts (HDF) resulted in tubule-like structures formation. 
These vessel-like structures were present in areas with high expression of 
alkaline phosphatase (ALP) and activated fibroblasts. At the same time, collagen 
production increased in the cocultures along the experiment. On the other hand, 
VEGF production was high in HDF monocultures but observed only at much 
lower levels in cocultures of HUVECs/HDFs and HDMECs/HDFs. Low levels of 
TGF-β1 were also observed in cocultures in comparison to monocultures. These 
findings led us to hypothesize that VEGF is probably consumed upon activation 
of VEGFR2 in ECs cell membrane, resulting in survival, migration and 
differentiation of these cells [29, 30]. Another possibility is the presence of ECM 
in direct contact cocultures, which could be responsible, at least to a certain 
degree, for the entrapment of growth factors produced by the cells [31].  
Fibroblasts activation plays an important role in regulating immune responses 
[18, 32] and it is also known that small peptides released during remodeling of 
the extracellular matrix have profound effects on cellular immune responses 
[18, 33, 34]. Fibroblasts exhibit considerable intra-line plasticity that is 
dependent on the microenvironment. Recently, it has been reported that adult 
fibroblasts can be converted into pluripotent stem cells by transfection with only 
four transcription factors (oct3/4, Sox2, c-myc and Klf4) [20, 35]. Nanog, a 
transcription factor that regulates early development [36], has been found to be 
present in porcine [37] and human dermal fibroblasts [20] suggesting that 
nanog is important in maintaining the plasticity found in fibroblasts in vivo [20]. 
The present results further suggest that fibroblasts are not a passive actor in 
the complex signaling pathways of angiogenesis. Rather, fibroblasts influence 
the formation of microcapillary-like structures and collagen deposition, 
suggesting a dependency between the formation of vascular structures and the 
assembly and thickness of the ECM, which is in agreement with previous studies 
[28]. Martins-Green et al. [20] have previously shown that peri-endothelial cells 
arise by differentiation from fibroblasts and that they require interaction with 
ECs for that purpose. Faggin et al. [19] suggested that fibroblasts appear to 
serve as vascular cell progenitors in the injured rabbit carotid artery. In the 
present study, and in agreement with Nigau et al. [20], it was observed that, in 
the vicinity of the capillary-like structures formed, some fibroblasts became 
positive for α-SMA. The extent of time of interaction between ECs of the 
capillary-like structures and fibroblasts could be a reason for these differences 
in terms of expression of activation markers.  
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Alkaline phosphatase (ALP) is a widely used marker for the differentiation of pre-
osteoblasts or human mesenchymal stem cells (hMSC) under osteogenic 
conditions [10, 38]. Previous studies have used ALP as a marker to assess the 
differentiation of hMSCs into osteoblasts in coculture with ECs [11]. Although 
the expression of ALP has been widely related to osteoblasts differentiation and 
bone mineralization [39, 40], other perspectives and roles regarding ALP have 
been proposed. ALP has also been implicated in the regulation of cell growth 
and apoptosis [41]. In addition, ALP expression is often restricted both 
temporally and spatially to the population of cells involved in migration or 
morphogenesis [42], suggesting its involvement in cell guidance and migration. 
As far as we know, this is the first study showing the colocalization of 
microvessel like-structures with ALP. These findings support a possible role of 
ALP in cell-cell interaction (ECs-fibroblasts) [43] and cell migration [44-47]. 
Supporting this hypothesis, Friis et al. [48] reported an anti-angiogenic, dose-
dependent, potential effect of levamisole on ECs propagated with fibroblasts, 
both in vitro and in vivo in a hetero-transplantation tumor model. Levamisole is 
a well-described and widely used tissue-non-specific alkaline phosphatase (TNS-
ALP) inhibitor [49]. Levamisole-induced inhibition of microcapillary-like 
structures has been demonstrated although no clarification was provided about 
the roles of cell-cell interaction or cell migration in the ability of TNS-ALP to 
influence this process [48]. It was speculated that, in fibroblasts, ALP is a 
functional marker for a cellular subtype that is specialized in matrix degradation 
[50]. Furthermore, TNS-ALP has been reported to bind to collagen types I, II and 
X in the ECM [51, 52], which, together with our results, suggests an involvement 
of TNS-ALP in the angiogenesis process and particularly in the crosstalk between 
ECs and fibroblasts. Taken together, these results open the possibility of an 
important role of ALP in the modulation of angiogenesis and in cell adhesion 
that may be relevant for the development of new cell therapies in tissue 
regeneration.  
Collagen is one of the major proteins in the ECM and is produced by fibroblasts 
in wound healing, and it is also known to drive ECs migration by chemotaxis and 
haptotaxis [53]. This observation suggests that the presence of collagen, and 
the fact that fibroblasts formed multilayers of cells in culture, induced ECs 
organization into microvessel-like structures, while these structures were absent 
in EC monocultures. Studies with cultured skin fibroblasts from a series of 
patients with osteogenesis imperfecta, a heritable defect that makes bones 
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brittle, demonstrated that the mutations produced specific disruption in the 
biosynthesis of collagen type I, thus generating abnormal collagens fibrils [54]. 
These facts will influence matrix composition and the interaction with growth 
factors and cytokines that is important in cell behavior [55]. The coculture 
model presented here offers the possibility to delineate how specific proteins 
and growth factors are regulated as a result of interactions between fibroblasts 
and endothelial cells.  
Understanding how to promote angiogenesis in a damaged tissue, using cells 
embedded in an injectable biomaterial, continues to be a challenge in tissue 
regeneration. The need for proper vascularization, which involves the assembly 
of a microvascular network and its anastomosis to the host vasculature, remains 
one of the major hurdles for clinical success of complex tri-dimensional tissue 
engineered structures [56]. In chapter IV, in order to address how human 
dermal fibroblasts may influence the early microvascular structures formed on 
hydrogels and to observe the composition and fate of cellular infiltration, a 
Matrigel plug in vivo model was used. The present in vivo results support the 
hypothesis that fibroblasts can recruit endothelial cells from the host to 
vascularize the inoculated matrix. The Matrigel plug assay has been reported as 
a good model because it protects growth factors from degradation and 
dispersion [57, 58] and provides the embedded cells a viable environment to 
proliferate and differentiate without dispersion [59, 60].  
Angiogenesis and inflammation seem to be interconnected processes, 
particularly in pathological situations. In fact, immune cells produce cytokines 
and growth factors, targeting endothelial cells to produce angiogenic factors. 
On the other hand, the newly formed vessels provide oxygen and nutrients for 
the immune cells [61]. Inflammation is a physiological response against harmful 
situations such as infection or tissue injury. In tissue regeneration, it seems 
important to prevent an exacerbated inflammation. For this reason, it was 
evaluated if the presence of fibroblasts in Matrigel would promote an increase in 
inflammatory markers (NO and NAG). No differences were observed in the levels 
of these markers in the presence and in the absence of fibroblasts inoculated 
within the Matrigel. Therefore, these findings suggest that the environment 
created by fibroblasts favors new vessels recruitment.  
As previously mentioned, soluble factors produced by fibroblasts, such as VEGF 
and eventually others, required for the survival, differentiation, and network 
formation of ECs [29], could influence EC interactions in a paracrine manner. 
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Altogether, the previous findings led to the assumption that the transplantation 
of fibroblasts or other low differentiated cell types, results in the development 
of other cell phenotypes. Adipogenesis seems to be one of these responses [57]. 
Kawaguchi et al. [57] suggested the possibility that mesenchymal stem cells with 
fibroblasts morphology remain even in adulthood and differentiate into 
adipocytes, when invasion of fibroblast-like cells into a neovascularized Matrigel 
plug occurs. Therefore, neovascularization and adipogenesis seem to be parallel 
processes [57, 60]. On the other hand, Mercier et al. reported that neurogenesis 
and vasculogenesis involve the participation of macrophages, fibroblasts and 
collagen [62]. Endothelial progenitor cells (EPC) are implicated in promoting 
physiologic and pathologic neovascularization during wound healing and tumor 
growth, but questions remain about the magnitude of their contribution to 
newly forming blood vessels. Melero-Martin et al. implanted EPCs in Matrigel and 
reported no secretion of VEGF and no stimulation of murine vessel infiltration, 
although cocultures of EPCs with mesenchymal stem cells have shown a 
reciprocal and beneficial interrelationship between the two cell types, and 
relevant for vascularization strategies in regenerative medicine [59].  
Anghelina et al. reported that vascularization in a Matrigel plug supplemented 
with bFGF is influenced by initial cellular infiltrate, predominantly composed by 
monocytes and macrophages [60]. The cells left a track forming cell columns 
after one week of implantation by secretion of angiogenic factors and enzymes 
capable of degrading the matrix. A similar mechanism of cell invasion has been 
reported for leukocytes and tumor cells penetrating the matrix, or osteoclasts 
degrading and invading bone [60]. The amount of fibrillar collagen, apparently 
produced by fibroblasts, could derive from the circulating fibrocytes [63]. The 
present results revealed the presence of fibroblasts secreting collagen by TEM 
analysis. The higher activity of rough endoplasmatic reticulum observed in 
fibroblasts was related with the production of collagen. Collagen acts as a 
potent pro-angiogenic milieu [64], whereas the matrix-associated fibroblasts 
guide new blood vessels [65]. From the standpoint of Kellar et al., dermal 
fibroblasts cultured in tridimensional structures could be used as a support or 
delivery system of cells like stem cell populations in cardiac diseases [66]. 
Dermal fibroblasts represent an essential population of cells with mesenchymal 
origin and have a crucial role in communication with other cell types in response 
to contextual signals in skin physiology [67].  
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Despite the relevance of the present findings, these studies were performed 
using Matrigel, a commercially available connective tissue, which is inadequate 
for implantation in humans. New and complex biofunctional hydrogel matrices 
based on alginate have been recently developed, mimicking the extracellular 
matrix in its cell-specific adhesion and susceptibility to cell-driven proteolysis 
[68]. These matrices, as well as other hydrogel-based systems, have been 
reported as promising injectable artificial extracellular matrices for cell 
transplantation and delivery and could be used instead of Matrigel [10, 68-73]. 
Nevertheless, these findings indicate that the microenvironment created by the 
stromal cells in the scaffold modulates angiogenesis through secretion and 
release of growth factors and collagen synthesis, which are likely to play key 
roles in the whole process of neovascularization. 
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Although many interesting results were obtained in the present work, many 
other new questions arose and several issues should be further addressed in the 
future with the aim of generating a vascular network capable of rapidly 
anastomosing with the host vasculature in order to support the viability and 
integration of an implant.  
The cell source used for cellular therapies aiming at promoting vascularization is 
a key issue. Fibroblasts are considered an important type of seed cell for tissue 
engineering and relevant in the crosstalk with endothelial cells and the immune 
system. However, the mechanisms behind these interactions are not yet clarified. 
The studies developed in this thesis were performed using HUVECs and HDMECs 
primary cell cultures, which are established and commercially available cell 
cultures. Since they cannot be used in the clinic, future work needs to be done 
using progenitor endothelial cells that have been reported to improve the 
development of vascular networks [1-3]. On the other hand, mesenchymal stem 
cells (MSCs) have been shown to serve as perivascular cells for in vivo 
vasculogenesis and could be used as a cell source for similar studies [4]. In 
addition, MSCs are one of the cell types under clinical trials for treatment of 
ischemic heart disease [6]. Moreover, MSCs may be isolated by minimally 
invasive procedures from a diversity of human tissues, including bone marrow 
[5], umbilical cord blood [6, 7], and adipose tissue [8]. It has also been reported 
that MSCs could differentiate into endothelial-like cells [9, 10], although the 
transplantation of MSCs alone promoted less vascularization than when MSC 
were accompanied with differentiated progenitor endothelial cells [4]. Dermal 
fibroblasts have been used in wound healing for chronic foot ulcers [11]. 
Nonetheless, for clinical use in ischemic situations other than in the skin, 
fibroblasts derived from other sources should be used. Taking into account that 
MSC and fibroblasts share some characteristics, it would be useful to 
understand if phenotypic alterations in mesenchymal stem cell-derived 
fibroblasts [12] could be influenced by soluble factors (VEGF, bFGF, TGF-β1, IL-8, 
among others) or extracellular matrix (ECM) components (collagen types I and IV, 
laminin and fibronectin). In addition, examining cell phenotypic alterations by 
immunocytochemistry and flow cytometry along the time (CD90, CD44, CD73, 
CD105, CD29, CD31, α-SMA, desmin, vimentin) would also enable to confirm the 
differentiating status of cells and their phenotypic profile.  
Understanding the influence of bioactive molecules in cell differentiation is 
mandatory in order to achieve effective therapeutic strategies using 
Chapter VI 
 
 
148 
 
prevascularized biomaterials. The developmental status of tissues and different 
disease stages alter the microenvironmental regulation of stem cell behavior 
[13]. Endothelial-extracellular matrix crosstalk has been shown to require many 
biological factors, including VEGF, FGF and PDGF [14]. Cocultures of 
mesenchymal stem cells-derived fibroblasts with endothelial progenitor cells 
provide a means to examine how extracellular matrix components interfere with 
the organization of these cells and influence cell function. Technologies such as 
confocal laser microscopy, time-lapse microscopy using labeled cells and single-
cell RT-PCR, single-cell microarrays and proteomics will be essential to identify 
the molecular mechanisms implicated. In addition, bioimaging analyses are an 
excellent tool to process this information.  
Alkaline phosphatase (ALP) seems to play a part in angiogenesis as revealed by 
the present results, which indicated a crucial role in enhancing cell migration in 
the ECM. To further elucidate this phenomenon, gene and protein expression 
and colocalization studies, using fluorescent reported gene expression assays, 
as well as the inhibition of different ALP isoforms (such as tissue nonspecific, 
intestinal, and placental ALP), should be performed. These studies would enable 
the identification of the most relevant isoforms involved in this crosstalk 
between fibroblast-derived ECM components and angiogenesis, which can result 
in therapeutic benefits. Although Langer et al. reported that TNS-ALP represents 
the only ALP isoform present in the endothelium of blood vessels in brain [15], 
its role in angiogenesis and neurogenesis is still unclear. 
The remodeling of the ECM plays a major role in controlling angiogenesis. The 
way in which biomaterials, as artificial ECMs, may enhance this role needs to be 
explored in cocultures of endothelial cells and fibroblasts. Taking this into 
account, it is important to evaluate the activity of metalloproteinases (MMP) and 
the ECM-derived proteins present in the supernatant of coculture assays (by 
zymography) since some of them could have pro- or anti-angiogenic effects. It is 
widely accepted that the pore size of scaffolds and their pore interconnectivity 
will influence the migration and organization of the pre-implanted cells. Instead, 
hydrogels susceptible to local proteolysis, such as RGD-alginate with a cleavable 
peptide by the action of MMPs [16], could be used to develop this 
prevascularized network. In addition, this biomaterial is free of proteins and 
growth factors, rendering this assay useful when compared to collagen gels or 
Matrigel. In addition, the presence of immune cells in cocultures should be 
investigated as well. Moreover, in vivo studies using these hydrogels would 
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provide valuable cues about the system’s improvement. A valuable assay to 
assess vascularization of a therapeutically relevant clinical situation would 
consist in implanting, in a bone site, the this biofunctional alginate with 
cocultures of MSC-derived fibroblasts and EPCs to investigate promotion of 
vascularization (as well as anastomosis) and bone tissue regeneration in vivo. 
The sex-mismatch model, i.e., implanting male cells into female mice, allowing 
to examine the presence of colocalization for Y-chromosomes in the new vessels, 
seems to be a good model for in vivo studies and fate mapping.  
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ABSTRACT: A variety of natural polymers and proteins are
considered to be 3D cell culture structures able to mimic the
extracellular matrix (ECM) to promote bone tissue regenera-
tion. Pectin, a natural polysaccharide extracted from the plant
cell walls and having a chemical structure similar to alginate,
provides interesting properties as artificial ECM. In this work,
for the first time, pectin, modified with an RGD-containing
oligopeptide or not, is used as an ECM alternative to immo-
bilize cells for bone tissue regeneration. The viability, metabolic
activity, morphology, and osteogenic differentiation of immo-
bilized MC3T3-E1 preosteoblats demonstrate the potential of
this polysaccharide to keep immobilized cells viable and differentiating. Preosteoblasts immobilized in both types of pectin
microspheres maintained a constant viability up to 29 days and were able to differentiate. The grafting of the RGD peptide on
pectin backbone induced improved cell adhesion and proliferation within the microspheres. Furthermore, not only did cells grow
inside but also theywere able to spread out from themicrospheres and to organize themselves in 3D structures producing amineralized
extracellular matrix. These promising results suggest that pectin can be proposed as an injectable cell vehicle for bone tissue
regeneration.
1. INTRODUCTION
Natural polymers secreted by plants and bacteria are involved
in the growth of organisms and in the intercellular signaling by
regulating the ionic exchange at the cell surface.1,2 They also
protect the living organism by creating a molecular architecture
acting as a barrier against external threats.
In tissue engineering, an ideal biomaterial would be able to
reproduce these complex functionalities by mimicking the nat-
ural extracellular matrix (ECM), thus providing biospecific cell
adhesion and the subsequent control of cellular functions. With
this aim, the extracellular natural polymers from different sources
can be considered to be potential candidates for substituting the
ECM because of their typical gel-forming capability.
Among these polymers, alginates and pectins are polyuronates
physiologically subjected to calcium-induced gelation,3 resulting
from specific and strong interactions between calcium ions and
carboxyl groups of guluronate and galacturonate blocks in alginate
and pectin, respectively.4 The resulting egg-box structure can be
reproduced in vitro5 by interaction of the polymer with divalent
cations, therefore allowing the immobilization of bioactive compo-
nents or cells inside the gel structure. However, as other natural
polymers, alginates and pectins resist protein adsorption and cell
adhesion because of their hydrophilic nature.6
Cell adhesion to the matrix is required for the survival of many
cell types. In particular, integrin-dependent cell adhesion, which
consists of the interaction between integrin receptors and ECM,
plays critical roles in many cellular functions, including migra-
tion, proliferation, differentiation, and apoptosis.7,8 The RGD
(Arg-Gly-Asp) sequence, present in adhesive ECM proteins, was
identified by Pierschbacher et al.9 as the minimal peptide se-
quence required for the adhesion of integrins to the ECM
components.10-12 Rowley et al.6 first described the modification
of alginate with an RGD-containing oligopeptide using the car-
bodiimide chemistry to graft covalently the oligopeptide to the
carboxyl groups of alginate. Further studies showed that the
immobilization of preosteoblasts or osteoprogenitor cells within
RGD-modified alginate promoted cell viability, metabolic activ-
ity, adhesion, and differentiation.13,14
In this work, we propose to use pectin as a cell carrier able to
stimulate bone tissue formation. Pectin was modified with RGD-
containing oligopeptides through the carbodiimide chemistry
(Figure 1) and compared with unmodified pectin in promoting
cell adhesion. Pectin and RGD-pectin microspheres are here
proposed as a cell vehicle for bone tissue regeneration.
Pectins are mainly used as thickeners or jellifying agents in the
food industry, and they have also been recently considered for
Received: September 17, 2010
Revised: January 14, 2011
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drug delivery. In particular, pectin gels or tablets are used for
targeted drug release in the colon because of pectin’s ability to
remain intact throughout the gastrointestinal tract and to be
degraded by the colon’s microflora.15,16 In recent works, pectin
has been proposed for cancer treatments because of its intrinsic
properties17-19 and for gene therapy.20,21 However, only a few
studies have investigated the use of pectin as a biomaterial for
tissue regeneration.22,23
In a bone tissue engineering context, pectin was found to have
a great potential. Previous studies demonstrated that it is possible
to trigger the growth and differentiation of mammalian bone cells
by enzymatically modifying the branched regions of pectin
(rhamnogalacturonan I and rhamnogalacturonan II). Kokkonen
et al.24 used two enzymes to obtain different pectin branched
regions from apple tissues. It was reported that local bone growth
and differentiation can be stimulated by rhamnogalacturonans
with shorter side chains.
Pectin gels are attractive cell carriers also because their
solubility can be more easily modulated compared with other
natural polymers, such as alginates. Calcium ions can be quickly
displaced from pectin egg-box structure by other counterions
(such as Naþ), leading to the formation of soluble pectin from
the insoluble gel. Therefore, pectin gels may be considered as
externally tunable systems for the release of immobilized cells
or therapeutic agents. Furthermore, the gels can promote the
nucleation of a mineral phase on pectin microspheres,25 with the
formation of biomimetic constructs, better mimicking the natural
architecture of the bone.
2. MATERIALS AND METHODS
2.1. Pectin Purification and Coupling with G4RGDSP Oli-
gopeptides. Lowmethoxyl (LM) pectin, kindly provided byHerbstreit
& Fox Neuenbuerg (Germany), was purified by washing pectin
(10 g) in ethanol (100 mL, 50% (v/v)) for 30 min, followed by
separation through filtration. Then, pectin was rinsed twice with ethanol
(75 mL 50% (v/v) and 50 mL 95% (v/v)) and finally dried until
constant weight.
Pectin was covalently modified (Figure 1) with the oligopeptide (gly-
cine)4-arginine-glycine-aspartic acid-serine-proline (Commonwealth
Biotechnologies, Richmond, VA), using aqueous carbodiimide chem-
istry6 as follows: Pectin solution (1% (w/v)) was prepared by dissolving
pectin overnight in 2-(N-morpholino) ethanesulfonic (MES) acid buffer
(0.1 MMES buffering salt, Sigma, and 0.3 M NaCl, Merck), and the pH
was adjusted to 6.5 with 1 M NaOH. Then, sulfo-NHS (Pierce
Chemical, 27.40 mg), EDC (Sigma, 48.42 mg), and the oligopeptide
(16.70 mg) were added per gram of pectin, and the solution was allowed
to react for 20 h under constant stirring. The reaction was quenched with
hydroxyl amine (Sigma, 18 mg), dialyzed against distilled water and
NaCl for 3 days, then treated with activated charcoal (Sigma, 0.5 g) for
30 min, filtered, and lyophilized.
2.2. Cell Immobilization Inside Microspheres. MC3T3-E1
preosteoblasts (purchased from ECACC - European Collection of Cell
Culture, Porton Down, Salisbury Wiltshire, U.K.; from mouse calvaria)
below passage 15 were cultured in 300 cm2 flasks and grown in R-mini-
mum essential medium (R-MEM, Gibco), supplemented with fetal
bovine serum (FBS 10% (v/v), Gibco) and penicillin/streptomycin
(P/S 1% (v/v), Gibco). Cells were kept at 37 !C with 5% CO2 and 95%
humidity, and the medium was changed every 2 days.
Microspheres of pectin and RGD-coupled pectin (RGD-pectin)
were prepared from aqueous solutions (2.4% (w/v)) filtered with
0.2 μm filters. The cells were harvested by trypsin treatment after
reaching 90% confluence and were carefully mixed with pectin or
RGD-pectin solutions (at a density of 20 " 106 cells/mL) using a
dual-syringe system to obtain homogeneous mixtures, as previously
described.13,14 Microspheres without cells were also generated as
control. Microspheres were obtained using an electrostatic bead
generator system (VarV1 encapsulation unit, from Nisco) at a speed
of 20 mL/h and 5 kV electrostatic potential using an isotonic CaCl2
solution (0.1 M) as gelling agent. After gelation, the microspheres
were washed twice with R-MEM and incubated in complete R-MEM
under dynamic conditions in spinner-flasks up to 29 days. The culture
medium of pectin and RGD-pectin microspheres carrying cells was
supplemented with ascorbic acid (Merck, 50 μg/mL) and β-glycero-
phosphate (Sigma, 10 μg/mL) to induce osteogenic differentiation.
The experiment was repeated twice to check for the reproducibility of
the results.
2.3. Microsphere Dissolution Test. Pectin and RGD-pectin
microspheres (1 g/mL) were incubated in phosphate-buffered saline
(PBS, pH 7.4) at 37 !C after preparation. In each time stage, the
incubation solution was removed, and the microspheres were dried at
37 !C until constant weight. The dried mass variation was determined
with the following eq 1
Δw ¼ ðwt - w0Þ 3 100
w0
ð1Þ
wherewt is the dry weight at time point t andw0 is the initial dry weight of
the microspheres. Analyses were performed using six samples per time
point, and the error was calculated with standard deviation.
Figure 1. Functionalization of pectin with the RGD-containing oligopeptide.
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2.4. Cell Characterization. 2.4.1. Cell Metabolic Activity. The
resazurin reduction assay was performed on the cells within micro-
spheres after 1, 3, 6, 8, 10, and 13 days of dynamic culture to measure cell
metabolic activity. This assay depends on the ability of metabolically
active cells to reduce the amount of oxidized resazurin (blue) to reso-
rufin (red), which exhibits strong emission at wavelengths >550 nm.
Pectin and RGD-pectin microspheres, with or without cells, were
recovered from the spinner flasks and incubated with resazurin solution
(200 μL, 10% in complete R-MEM) in a 96-well culture plate for 4 h.
The absorbance of 100 μL of each well was measured with a KC4
Synergy HT (Biotek Instruments) plate reader (absorbance read at
570 nm with reference to 600 nm). Microspheres containing cells were
subsequently dissolved in each well plate using ethylenediaminetetra-
acetic acid (EDTA 50 mM, Sigma), and the cells were counted. Cell
Table 1. Dissolution of Pectin Microspheres at High
Concentration in PBS (1g/1 mL)a
time
weight variation [%]
pectin RGD-pectin
0 0( 0 0( 0
10 min þ60 ( 9 þ1( 11
30 min þ33( 14 þ3( 12
1 h -20( 11 þ1( 11
4 h -62( 37 -51( 13
24 h -85( 17 -98( 7
a Positive or negative values indicate an increase or decrease in weight of
microspheres, respectively, in relation to the reference (weight of
microspheres at time 0). After 24 h, pectin and RGD-coupled pectin
microspheres were completely dissolved. Values indicated are mean(
standard deviation.
Figure 2. Diameters and spherical morphology of (A) pectin and (B) RGD-pectin microspheres acquired by optical microscopy. Structure and porosity
of microspheres, acquired by CryoSEM of (A) pectin and (D) pectin coupled with a peptide containing the RGD sequence after cross-linking with
calcium ions. Optical microscopy images of MC3T3-E1 cells distribution inside (E) pectin and (F) RGD-pectin microspheres. Scale bars of optical
microscopy images = 200 μm.
Figure 3. Metabolic activity of MC3T3 cells immobilized in pectin and
RGD-pectin microspheres measured after 1, 3, 6, 8, 10, and 13 days of
dynamic culture. The metabolic activity of the first day after cell
immobilization was taken as the reference (100%).
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metabolic activity was quantified for each well using the following
eq 2
ðAbscell - AbsÞ = n ð2Þ
where Abscell is the absorbance of microspheres with cells, Abs is the
absorbance values of microspheres without cells, and n is the number of
counted cells.
2.4.2. Cell Structure. At days 1, 3, 8, 16, 23, and 29 postimmobiliza-
tion, samples of microspheres were washed inCaCl2 (0.1M) and fixed in
formaldehyde (3.5% (v/v)). The microspheres were incubated with
Alexa Fluor 488 phalloidin (6.6 μM in 0.1 M CaCl2, Molecular Probes,
Ex 495/Em 518 nm) at 37 !C for 20min to stain actin filaments (f-actin)
and then with DAPI (1.5 μM) for 10 min at room temperature to
visualize the cell nuclei. Images were acquired by laser scanning confocal
microscopy (Leica SP2 AOBS SE, Leica Microsystems, Germany)
through the objective HC PL APO Lbl. Blue 20#/0.70 IMM/CORR
(used with water).
2.4.3. Osteocalcin Expression. After 1, 8, and 29 days of in vitro
culture, samples of microspheres were collected and dissolved in EDTA
(50 mM). Cells were washed in cold PBS by centrifugation. Total RNA
was extracted from the cells and purified using RNeasyMini Kit (Qiagen);
RNA (500 ng) was used as template for single-strand cDNA synthesis with
the Superscript II reverse transcriptase kit (Invitrogen) in a final volume
(20 μL) containing oligo(dT) 12-18 (0.5 μg/μL), dNTPs (10mM), RT
buffer (10#), MgCl2 (25 mM), DTT (0.1 M), and RNaseOUTribonu-
cleaseRNase inhibitor. Real-time semiquantitative PCRwas performed in a
reaction (final volume 20 μL) containing cDNA (1 μL), the primers
sequence (200 nM), SYBR Green (10 μL, Invitrogen), and sterile distilled
water. Primers for osteocalcin (OCN) (forward 50-CTCTGTCTCTC-
TGACCTCACAG-30, reverse 50-CAGGTCCTAAATAGTGATACCG-
30) and -actin (forward 50-GTGGGCCGCTCTAGGCACCAA-30, and
reverse 50-GTCTTTGATGTCACGCACGATTTC-30) were used at the
annealing temperature of 56 !C.
2.4.4. Histochemical Staining. The osteogenic differentiation of the
immobilized cells was evaluated through Von Kossa, Alizarin red, and
Masson’s Trichrome stainings after 1, 3, 9, 16, 23, and 29 days of dyna-
mic culture. The microspheres were collected, fixed in formaldehyde
(3.5% (v/v)), dehydrated with a graded series of ethanol, and embedded
in paraffin blocks. Sections (8 μm of thickness) were prepared, dewaxed
in xylene (Merck), and rehydrated in a decreasing graded series of
ethanol followed by pure water.
Von Kossa and Alizarin red stainings allow the detection of matrix
mineralization induced by differentiated osteoblastic cells. The Von
Kossa staining is based on the combination of silver with insoluble salts
like phosphates and carbonate bound to calcium, whereas Alizarin red
complexes with calcium in a chelative process. For Von Kossa staining,
Figure 4. Confocal microscopy images of F-actin staining of cells
immobilized on pectin and RGD-pectin microspheres: phalloidin marks
the actin of the cytoskeleton (green) and DAPI labels the nuclei (blue)
of MC3T3 cells. From day 8 of incubation onward, cells immobilized in
RGD-pectin microspheres exhibited spreading and adhesion to the
matrix (B) and created 3D connections among different microspheres
(D and H). Cells immobilized in pectin microspheres, instead, main-
tained the round shaped morphology (A,C,G) during the 29 days of
dynamic culture. The dashed lines indicate the borders of the micro-
spheres or of the aggregates of microspheres. Images of single cells were
acquired at higher magnification (40#) at day 23 to show round cells
immobilized in pectinmicrospheres (4E) and spread cells growing in the
space between adjacent microspheres (4F).
Figure 5. Osteocalcin (OCN) gene expression of immobilized cells.
Expressed data are relative to day 1. The amount of the OCN gene
expressed by cells increased with time. When MC3T3-E1 cells were
immobilized in RGD-pectin microspheres, gene expression of OCN
increased significantly, compared with pectin microspheres.
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the sections were incubated in silver nitrate (Merck, 2.5% (w/v)) for 30
min, followed by incubation in sodium thiosulfate (Sigma, 5% (w/v)) for
3 min. In the case of Alizarin red staining, the sections were incubated in
Alizarin red solution (2% (w/v), pH 4.3) for 10 min. The slides were
kept at 4 !C until observation by optical microscopy.
The Masson’s trichrome staining was performed as indicated by the
manufacturer (Sigma kit HT15-1KT), allowing us to investigate the
formation of collagen fibers in the ECM.
2.5. CryoSEM and EDS Analyses. Images of the microspheres
were acquired by cryoSEM (cryo scanning electronmicroscopy) at days 1,
8, and 29 postimmobilization. The microspheres were rapidly immersed
in liquid nitrogen (T =-210 !C) for 3 min and vacuum-transferred to an
Alto 2500 (Gatan) cryo preparation chamber coupled to the JEOL JSM
6301F scanning electron microscope. Frozen samples were mechanically
fractured, and the temperature was set at-95 !C for 2.5 min to sublimate
the water from themicrospheres. Finally, the fracturedmicrospheres were
coated with Au/Pd and observed at-130 !C using a primary accelerating
voltage (15 kV). Microanalysis was performed with an energy dispersive
spectrometer (EDS) to identify and label the atoms of interest.
2.6. Statistical Analyses. All measurements regarding cell viabi-
lity, metabolic activity, and gene expression were tested in triplicate.
Student’s t test was used to make comparisons among the data, and the
results were considered statistically different when p < 0.05.
3. RESULTS
3.1. Preparation of Pectin Microspheres. Homogeneous
and spherical pectin and RGD-pectin microspheres were obtained
using an electrostatic bead generator system. The diameter of the
microspheres varied from 300 to 530 μm (Figures 2A,B,E,F), and
their internal structure was found to be dependent on the
presence, or not, of the peptide containing the RGD sequence.
By using the cryoSEM technique, it was observed that RGD-pectin
microspheres (Figure 2D) showed a different texture in compar-
ison with pectin microspheres (Figure 2C), namely, an apparently
tighter pore structure, which is probably related to the RGD
grafting. Nevertheless, although the RGD graftingmodified pectin
structure, thus affecting hydrophilicity and the ability to form
cross-links, these structural changes did not produce noticeable
effects on the swelling tests performed (data not shown), where no
differences between pectin and RGD-pectin microspheres were
measured.
3.2. Microsphere Dissolution Tests. Pectin microspheres,
modified or not, resulted highly susceptible to ion exchange:
when suspended at low concentration in phosphate-buffered
saline (PBS), tris-buffered saline (TBS), or other solutions con-
taining Naþ ions, they rapidly dissolved. Using higher amounts of
microspheres, they dissolved as well, but the solubilization was
found to be slower (Table 1). For this reason, the protocols origi-
nally used to prepare and characterize alginate microspheres13
were slightly modified, using an isotonic CaCl2 solution (0.1 M)
for washing the microspheres instead of TBS.
3.3. Viability and Metabolic Activity of Immobilized Cells.
MC3T3-E1 preosteoblasts were used as a model cell line because
of their high growth rate and because of the fact that they can be
easily differentiated into the osteogenic pathway in vitro.
The immobilized cells were homogeneously distributed
within the microspheres (Figure 2E,F), and the majority of
Figure 6. (A) Von Kossa and (B) Alizarin red staining of MC3T3-E1
cells immobilized in pectin and RGD-pectin microspheres after 3 and 29
days of dynamic culture. Phosphates and carbonates bound to calcium
are stained in brown (A), and calcium deposits in red (B). The arrows
indicate some of the immobilized cells.
Figure 7. Masson’s trichrome staining, which stains collagen in blue,
cytoplasm in red and nuclei in black, performed on MC3T3-E1 cells
immobilized in pectin and RGD-pectin microspheres after 3 and 29 days
of dynamic culture. The arrows show the presence of collagen in RGD-
pectin microspheres after 29 days of incubation. Scale bars = 50 μm.
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the cells remained viable throughout the 29 days of the
experiment.
MC3T3-E1 cells immobilized in pectin microspheres exhib-
ited a constant metabolic activity, which was significantly lower
than the metabolic activity measured for cells immobilized in
RGD-pectin microspheres at any time point analyzed (Figure 3).
A significant increase in the metabolic activity of cells loaded in
RGD-pectin microspheres was observed after the sixth day of
dynamic culture (Figure 3). The metabolic activity could not be
measured from the 13th day of incubation onward because of the
consistent mineralization of pectin and RGD-pectin micro-
spheres promoted by cells, which hindered the dissolution of
the microspheres.
3.4. Cell Structure. MC3T3-E1 cells immobilized within
pectin microspheres maintained a round morphology during
the 29 days of the experiment, as shown by the fluorescence
staining of F-actin (Figure 4A,C,E,G). On the opposite, cells
immobilized within RGD-pectin microspheres were already
adhered and spreading to the RGD-pectin matrix after 8 days
of dynamic culture (Figure 4B). Furthermore, it was possible to
observe connections between cells from adjacent microspheres,
constituting a 3D bridge-like structure. The mineralized ECM
matrix produced by these cells embedded several adjacent RGD-
pectin microspheres in insoluble aggregates and did not allow
staining the core of these microspheres (Figures 4D,F,H).
3.5. Cell Differentiation. OCN gene expression was assessed
to evaluate the osteogenic differentiation. After 29 days of
dynamic culture, MC3T3-E1 immobilized in pectin or RGD-
pectin microspheres highly expressed the OCN gene (Figure 5).
Moreover, at days 8 and 29 postimmobilization, the cells
immobilized in pectin grafted with the RGD-containing oligo-
peptide showed a significantly higher OCN gene expression, as
compared with nonmodified pectin.
MC3T3-E1 cells loaded in pectin and RGD-pectin micro-
spheres produced a mineralized matrix, as shown by Von Kossa
(brown deposits) and Alizarin red (red deposits) stainings of the
microspheres (Figure 6). The mineralization appeared to be
produced earlier from day 3 onward, by cells immobilized in
RGD-pectin microspheres, although after 29 days of culture, it
was comparable to that produced by cells immobilized in pectin
microspheres (Figure 6). The Masson’s trichrome staining
showed the formation of a collagen-containing ECM after 29
days of incubation (Figure 7).
The EDS analyses confirmed these results: the presence of
calcium phosphates (calcium and phosphorus peaks at 3.7 and
2.1 keV, respectively) was detected on the surface of cells and on
the internal structure of the microspheres (Figures 8 and 9).
Calcium phosphates were found on pectin structure after 29
days of incubation in a-MEM (Figure 10). When in the presence
of cells, this deposition appeared to start earlier and to be
promoted in the surroundings of cells after 8 days of incubation.
In this stage, mineralization in acellular microspheres (Figure 10A)
did not occur. In addition, after 29 days of immobilization, the more
consistent calcium phosphate deposition was observed over cells or
in their vicinity rather than in areas in which no cells were present
(Figure 8C,D and G,H) for either pectin or RGD-pectin micro-
spheres.
The Ca/P ratio of calcium phosphates formed by preosteo-
blasts immobilized in RGD-pectin (Ca/P = 1.61; spectrum 3 of
Figure 9) and in pectin microspheres (Ca/P = 1.48; spectrum 1
of Figure 9) was closer to Ca/P ratio of hydroxyapatite (Ca/P
close to 1.7) than in the case of acellular microspheres (Ca/P =
2.62; spectrum 1 of Figure 10).
4. DISCUSSION
In this work, the use of pectin microspheres as cell carriers for
bone tissue regeneration was investigated. According to the
literature, size and porosity of microspheres are two important
conditions to take into account because they deeply affect cell
viability.26 In this study, the parameters of electrostatic bead
generation were optimized to obtainmicrospheres with diameters in
the range of 300-500 μm. These dimensions are considered to be
suitable to convey the incoming flow of oxygen and the outgoing
of catabolites according to literature, where the maximum dia-
meter permitting convenient oxygenation was suggested to be
1 mm.27 Pectin and RGD-pectin microspheres presented similar
dimensions and showed comparable homogeneous distribution of
Figure 8. CryoSEM images of immobilizedMC3T3-E1 cells after 8 and
29 days of culture inside unmodified and RGD-grafted pectin micro-
spheres. (A-D) Cells immobilized in pectin microspheres were kept
round and produced mineralized nodules. Cells immobilized in RGD-
pectin microspheres adhered and spread (E-H) with observable
cytoplasmic extensions (F). After 29 days of incubation, mineralization
could be observed both on the cells and on the internal structure of the
microspheres (C,D and G,H). The circles identify the regions where
images at higher magnification were acquired. The blue labels indicate
the spots where the EDS analyses were performed.
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immobilized cells. MC3T3-E1 cells maintained their viability
during the 29 days of the experiment both in pectin and in RGD-
pectin microspheres, thus emphasizing the potential of pectin
microspheres as a cell vehicle for bone tissue regeneration.
The possibility of using sodium-containing compounds to
dissolve easily pectin microspheres is here proposed as an
interesting way to trigger their in vivo dissolution: the controlled
release of cells from the microspheres possibly placed in a bone
defect could be stimulated by injecting small volumes of physio-
logical solution. Alternatively, an additional thin coating with
controllable fast degradation could provide the release of sodium.
Bone tissue engineering requires the ability to induce cell
proliferation and differentiation by regulating the cellular re-
sponse through the physicochemical environment. Accordingly,
the mimicking of the physiological environment can be obtained
with the design of new functionalized biomaterials. Some bone
ECM proteins, such as fibronectin, osteopontin, bone sialopro-
tein, thrombospondin, type I collagen, and vitronectin, have
chemotactic or adhesive properties because they contain an RGD
sequence that specifically binds to integrin transmembrane
receptors.7
Osteoblasts adhesion is essential for signal transduction and for
the regulation of gene expression because the ECM-mediated cell
spreading can stimulate the nuclear matrix and therefore modify
gene expression, inducing cell proliferation and differentiation.28
The biomimetic modification of biomaterials with RGD-contain-
ing peptides thus constitutes a promising approach for bone tissue
regeneration by promoting cell adhesion.
Figure 9. EDS analysis of the regions labeled in Figure 8. Calcium (peak at 3.7 keV) and phosphorus (peak at 2.1 keV) are revealed both on the surface
of MC3T3-E1 cells (spectra 1 and 3) and on pectin structure (spectrum 2), where nodules of mineralization were observed. A spot of an RGD-pectin
microsphere where no cells were present was also analyzed (spectrum 4) and did not show evidence of mineralization nodules.
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In this work, remarkable differences were observed in the
structure of microspheres prepared from pectin or from pectin
modified with the oligopeptide RGD (RGD-pectin) (Figure 2C,
D). Also, and based on previous findings,13 cells were immobi-
lized at a high density (20! 106 cells/mL) to facilitate cell-cell
interactions inside the microspheres. The present work shows
that MC3T3-E1 preosteoblasts were able to spread and to
establish contacts between cells of the same or from adjacent
microspheres when pectin was modified with a peptide contain-
ing the RGD sequence (Figure 4B,D,F,H). The process of
integrin-mediated cell adhesion in RGD-pectin microspheres
comprised a cascade of different events:29,30 at first, cells estab-
lished contact with the RGD-coupled material, and they began to
flatten. This led to actin filaments elongation (Figure 4B), which
linked the ECM to the molecules of actin cytoskeleton. Cyto-
plasmatic extensions were visible from 8 days of incubation
onward (Figures 4B,D,F and 8F-H). On the contrary, MC3T3-E1
cells immobilized in unmodified pectin microspheres did not adhere
to the material and retained a round morphology over the experi-
mental time period (Figures 4A,C,E,G and 8A-D). Although the
round morphology of preosteoblasts may be related to cell death,
in this case, the up-regulation of OCN and the production of
a calcium- and phosphorus-containing mineral phase suggest
that cells were alive up to the end of the experiment (29 days),
as confirmed also by live/dead assay performed (data not shown).
As expected, the metabolic activity of MC3T3-E1 cells re-
sulted enhanced for RGD-pectin microspheres when compared
with that in pectin microspheres (Figure 3).
Preosteoblasts were found only inside the core of the pectin
microspheres, whereas interestingly, they were able to spread out
from the RGD-pectin microspheres and establish 3D contacts
connecting adjacent microspheres (Figure 4D,F,H). Cell growth
outside the microspheres was not observed in a previous study
performed with microspheres made of alginate coupled to
RGD.13
Some hypotheses may explain the different behavior of cells
immobilized in the two different polysaccharides. First, the cell
behavior may be related to the molecular structure of pectin,
characterized by the long side chains, rhamnogalacturonan I and
rhamnogalacturonan II, which are not present in the linear
unbranched structure of alginate. Also, the anchorage of cells
to the favorable conformation of pectin modified with the RGD
motif may have stimulated cell growth on the surface of the
microspheres, with a consequent enhancement of viability and
metabolic activity. In this case, a better exchange with the culture
medium and with oxygen is established, thus resulting in
improved proliferation and secretion of new ECM components,
connecting cells on adjacent microspheres. It is not clear how
cells could reach the external surface of the microspheres. A
migration from the core of the microsphere can be considered,
coupled to a possible partial dissolution of pectin, exposing the
previously immobilized cells to the surrounding environment.
Finally, this work shows that preosteoblastic cells immobilized
inside pectin microspheres, and particularly inside RGD-pectin,
are able to differentiate into the osteoblastic phenotype. OCN, a
specific marker of the bone differentiation, was expressed by
MC3T3-E1 immobilized in both pectin types but in higher
amounts in pectin modified with the RGD sequence (Figure 5).
Even though the significant upregulation of OCN is suggestive of
osteogenic differentiation, the expression of other osteogenic mark-
ers (osteopontin, alkaline phosphatase, or RUNX2, for instance)
should be further investigated.
Pectin, as other natural polymers, is known tomineralize in the
presence of media having specific ionic species in adequate
concentrations (e.g., SBF).25,31 However, the autocalcification
of pectin microspheres prepared without cells as control appeared
not before 29 days of incubation (Figure 10B), whereas cells
immobilized in pectin microspheres were found to produce
mineralization nodules already after 8 days of culture
(Figure 8A,B), whose Ca/P ratios suggest an atomic composition
similar to the one of hydroxyapatite. Hence, it is possible to
conclude that the calcium phosphate phase produced by cells
appeared earlier and seemed to induce an intense mineralization
on pectin and RGD-pectin structures.
Preosteoblasts immobilized in RGD-pectin microspheres
seem to induce additionally the synthesis of a new ECM with
collagen fibers (Figure 7), which eventually results in a more
complex and natural new tissue. Also, when the cells were
immobilized in RGD-pectin microspheres, mineralization ap-
peared to occur earlier than in pectin microspheres.
Figure 10. CryoSEM images of pectin microspheres without cells after (A) 8 and (B) 29 days of incubation and EDS analyses of the labeled regions.
Calcium (peak at 3.7 keV) and phosphorus (peak at 2.1 keV) are revealed on pectin structure (spectrum 1), where nodules of mineralization were
observed.
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Previously, only enzymatically modified high-methoxyl pectin
was tested as a coating for tissue engineering,22,24 showing
interesting properties to improve the biocompatibility of implant
materials. Here we demonstrated that even unmodified LM
pectin itself is suitable for tissue engineering. Indeed, pectin
microspheres can be used to immobilize cells under conditions
compatible with high cell viability and metabolic activity. Pectin,
especially if grafted with the RGD sequence, can promote the
osteoblastic differentiation of MC3T3-E1, as shown by histo-
chemical analyses and OCN expression.
The use of pectin microspheres as injectable scaffolds for
bone tissue regeneration may avoid the dispersion of cells
after injection and provide a complete adaptation to the bone
defect. Biodegradation is a fundamental requirement for
tissue regeneration: biodegradable microspheres can serve
as carriers to provide initial mechanical support and a replace-
able matrix for the ingrowth of new tissue. As new bone tissue
forms inside and on the surface of microspheres, pectin seems
capable of gradually degrading, thus allowing sufficient time
for a physiological regeneration of damaged tissues. The de-
gradation products are eliminated through the natural meta-
bolic pathways of the organism. The possibility of inducing
pectin dissolution through an adequate amount of sodium-
containing solutions may be useful to obtain controlled and
adjustable biodegradation.
This work provides a model of injectable microspheres loaded
with preosteoblasts aimed at bone tissue regeneration, although
other cell types (especially stem cells) or even cocultures may be
in principle successfully immobilized in pectin microspheres for
soft or hard tissue engineering. Furthermore, pectin micro-
spheres can be employed for the in situ controlled release of
growth factors, drugs, enzymes, or proteins, in combination with
cells, to treat different pathologies.
5. CONCLUSIONS
In this work, a model for cell delivery and tissue regeneration
has been developed, and encouraging results have been obtained.
The present findings confirmed the possibility of using unmodi-
fied and modified LM pectin as an innovative biomaterial,
showing interesting properties for bone tissue regeneration.
For the first time, the possibility of using pectin microspheres
not only as drug delivery systems but also as injectable tissue
regeneration scaffolds has been assessed. The chemical grafting
of the peptide containing the RGD sequence on pectin structure
improved preosteoblasts adhesion, stimulating their metabolic
activity and differentiation. Furthermore, pectin and RGD-pectin
microspheres incubated in the culture medium induced the
deposition of calcium phosphates, thus behaving as biomimetic
scaffolds. When in the presence of preosteoblasts, mineralization
occurred earlier, and it was more consistent in the cell surround-
ings, thus providing interesting properties as scaffolds for bone
repair.
In vitro and in vivo studies with human cells are now needed to
better explore the potential of this system to promote bone tissue
regeneration.
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